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ABSTRACT 
The aim of this study is to explore predictor of health outcomes among Malaysian 
hypet1ensive patients attending a standard hypertension intervention programme. 
Among the psychological predictors studied are illness perception, health locus of 
control, and self-efficacy. Quality of life, anxiety and depression and demographic 
variables are among the predictors included in the study. Two series of studies were 
conducted to answer the research question formulated for each study. Study 1 aims to 
determine the psychological predictor of health outcomes among Malaysian 
hypet1ensive patient. This Study 1 examines the differences in physical and medical 
indices as well as psychological predictor across three periods of time (baseline, after 
intervention complete and at six month upon completion of the initial intervention) 
between intervention and waiting list control group. Study 2 explored the 
determinant of successful control of hypertension among Malaysian patients. This 
study aims to explore patients' knowledge and understanding of their condition and 
illness; factors that facilitate patients to change and barrier to change and patients' 
views of current intervention. 
In order to adequately answer the research question posted by both studies, both 
quantitative and qualitative modes of study were selected and patients were recruited 
from two selected community health centres located in Malaysia. Study 1 constituted 
67 patients who were recruited twice (November - January 2006 and July- August 
2007). A set of questionnaire including all selected psychological predictors was 
distributed before, after completion of intervention and again six months after 
completion of the initial intervention programme. In Study 2, the interview study 
method was employed and six participants (three successful and three unsuccessful 
controlled of hypertension) were selected fi:om Study 1 so as to explore the three 
main issues mentioned earlier through the interview schedule. 
The finding of the Study 1 highlight the physical and medical indices (weight, BMI, 
SBP, DBP, creatinine level and urea) of the intervention group did significantly 
change (P<.OS) over three times period with a medium to large change seen at Timet 
to Time3 with effect size ranged between -.41 to -.85.However, significant difference 
was found between intervention and waiting list control groups' physical and 
medical indices (SBP, DBP and HDL-C) at Timel and Time3 (p<.OS). Next, 
significant changes among intervention group can be seen over three times period in 
the Eating self-efficacy; Exercise self-efficacy; three ofiPQ; three ofMHLC-Form B 
and two of MHLC- Form C; quality of life (MINICHAL) and GHQ-12 subscales 
(P<.OS) and a medium to large sized effect (r=-.38 to -.87). There was significant 
differences in mean score of Eating self-efficacy; IPQ; MINICHAL; MHLC and 
GHQ-12 subscales between groups over Time1 and Time3 (p<.OS). Finally, the 
analysis showed a positive relationship between socially acceptable circumstances of 
Eating self-efficacy with changes in BMI (p<.OS); SBP with Negative Affect of 
Eating self-efficacy (p<.OS); Total cholesterol and HDL-C associated with Chance 
subscales ofMHLC Form C (p<.OS); and creatinine change with Chance subscales of 
MHLC Form C (p<.OS). However, this finding has unable to provide answer to the 
question of why some patients undergone an intervention and do well while others do 
not still remain a question. 
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The findings of the Study 2 highlight the similarities and differences of successful 
and unsuccessful control of hypetiension participant's view on the determinant of 
successful controlled of hypertension from Malaysian patients perspective. The 
content analysis conducted on the six interviews revealed both successful and 
unsuccessful control of hypertension pruiicipants shared similar views on the three 
aspects (i.e. knowledge of condition; factors motivate lifestyle change or barrier to 
change; and view on current intervention programme) covered during interview. But, 
both group had slightly different view about control and lifestyle change a11d it's due 
to insufficient knowledge of the aspect discuss during interview or some patiicipant 
felt satisfied with their condition and they feel it is sufficient for them to ensure that 
they are cw·e or some felt not ready to commit to any change. Another possible 
reason for these differences because they just had been few months diagnosed with 
hypertension. 
In conclusion, the findings of this research project highlight the importance of futiher 
studying the contributing factors which create a gap or discrepancy among those 
hypetiensive patients who has been attending intervention programme. This 
discrepancy may comes in vruious form which either from the patient themselves or 
health care provider or the environment. The study outcome also highlighted the 
importance for the health care provider to discuss the actual fact about the patient's 
condition every time patient's attending follow-up clinic. The implication of this 
practice will limit the patient with whatever knowledge they have on their illness 
without perceiving illness control should be practiced as a whole. In other words, all 
the control measures include compliance to medication, controlling diet, regular 
exercising, and live stressful lifestyle should be perceived as inter-related and not to 
be selected based on any preference as to ensure positive health outcome. 
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AIMS AND OVERVIEW OF STUDIES 
The aim of this study was to study associated predictors and he<l.lth outcomes among 
Malaysian patients attending Standard Hypertension Interventio.q. PrograiDJne using a 
combination of longitudinal and interview study method. The hypothesis model (see 
Figure2.1) addresses the longitudinal relationships between associated psychological 
predictors and health outcomes. The research questions specific to each study were 
formulated based on study aims. 
Chapte1· 1 present an overview of the magnitude of Hypertension, definition and 
classification, mechanism of blood pressure, and aetiology from two perspectives: 
world and Malaysia in pru1icular. This chapter also covers reviews on treatment and 
intervention which are available to treat hypertension. 
Chapter 2 reviews the literature on studies looking at the psychological predictors of 
health outcomes and changes in cognitive, emotion, behaviour and clinical outcome 
among patients with chronic diseases, specifically hypertension in the west. The focus 
of this review is on three aspects of psychological predictors of health outcomes: 
illness perception, health locus of control, eating and exercise self-efficacy. Other 
factors reviewed in this chapter are quality of life, general health status and 
demographic variables. This chapter also demonstrated the diagram hypothesising the 
psychological predictors associated with health outcomes within Malaysian context. 
Lastly, this chapter also cover psychosocial aspect of hypertension intervention, 
critically discussing the finding of studies conducted to date. 
Chapter 3 present the research methods used to address the research question for the 
Study 1. Study 1 (N=67) was conducted to assess the longitudinal relationship 
between psychological predictors and changes in health outcomes among Malaysian 
hypertensive patients across three periods: baseline, immediately after intervention 
and at six month follow-up. The data obtained from Study 1 is combined, analysed 
and discussed with Study 2 as to demonstrate more clear and representative 
information relevant to the study. 
v 
Chapter 4 A interview study method was adopted to explore Malaysian hypertensive 
patients' illness perception, behaviour change factors and barrier to change, and 
knowledge of intervention programme. Thus the exploratory strategy was used to 
answer the research question of why some patients who undergo intervention do well 
while others do not. Therefore, a semi -structured interview schedule covering three 
main sections was developed and includes topic on knowledge of condition and 
disease, lifestyle change and barrier to change, knowledge of current intervention. Six 
participants were selected from a pool of participants in Study 1. The data obtain was 
analysed using Content Analysis as to explore the individual patients' personal life 
experience and how they making sense their personal life in term of controlling 
hypertension. 
Chapter 5 draws together the discussion and implications across this two serial of 
studies conducted for this research. The findings of this study are discussed in term of 
(1) the evaluation of associated psychological predictors to health outcome presented 
in the west from Malaysian context, (2) making sense hypertensive patients' 
experiences of their condition and its implication towards patients care. 
vi 
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CHAPTER! 
HYPERTENSION: AN OVERVIEW 
Aim 
Chapter 1 will introduce an overview of Hypertension from two perspectives: 
worldwide and Malaysia in particular. The discussion includes the overview on the 
magnitude of Hypertension, followed by its definition and classification, mechanism 
of blood pressure, and aetiology of Hypertension. This chapter also covers reviews 
on treatment and intervention which are available to treat Hypertension. 
LO Prevalence of Hypertension 
The emerging of an epidemic of non-communicable diseases in the developed 
countries statied in the 1950s at1d 1960s. Most of these developed countries had 
experienced steady improvement in the general health of their population due to the 
better control of communicable diseases and economic stability. Nonetheless, the 
quality of life of people at large was now seriously affected by non-communicable 
diseases (Shafie et al. 2003; Omar et al. 2002). In the 1997 World Health Repoti, it 
was estimated that non-communicable diseases are responsible for about 56 percent 
of deaths world wide. Among these deadly serious non-communicable diseases were 
cardiovasculru· diseases (CVD); cerebrovascular diseases including stroke and 
hypertension; cancer, diabetes and respiratory diseases (Shafie et al. 2003; Arif, 
2003). 
The emergence of non-cormnunicable diseases is believed to be due to the changes in 
demographic structure pruiicularly an increase in the proportion of the elderly 
population, urbanization, economic affluence, the growth of sedentary occupations 
and stressful lifestyles. According to The World Health Report 2002, the related risk 
factors of non-communicable diseases were high blood pressw·e, smoking, alcohol 
consumption, high cholesterol level, and obesity. Furthermore, the swift 
augmentation of the prevalence and incidence of non-communicable diseases posed 
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significant challenges in providing efficient health care services and support systems 
in managing chronic patients (Arif, 2003). 
Malaysia, likewise is not free from an increased in the burden of non-communicable 
diseases. The downward trend of the incidence of infectious diseases in Malaysia 
was as a result of the general improvement in socioeconomic status, environmental 
sanitation, better disease surveillance and better interagency collaboration. This shift 
from communicable to non-communicable diseases has left Malaysia facing an 
increased incidence of chronic and degenerative diseases related to lifestyle and 
behaviour (Arif et al. 2003). 
The best known chronic and lifestyle disease is cardiovascular diseases. These 
compnse of heart disease, hypettension, disease of pulmonary circulation and 
cerebrovascular accident. These diseases have become the principal cause of 
hospitalization and mortality in Malaysia. In 1990, 78,800 hospital admissions were 
due to cardiovascular diseases and this figure had increased by 37.2 percent in 2000 
making the total of 108,087 adtnissions (Samad et al. 2002). On the other hand, 
hypertension was also prevalent as a cardiovascular risk factor in the Malaysian 
population. The population studies conducted in various western countries showed its 
prevalence varied from one to over thitty percent. A similar trend was found in 1986 
and 1996 Malaysia National Health Survey and other epidemiological surveys (Lim 
and Morad, 2004 ). Hospital admission caused by hypertension also showed a similar 
trend with an increase of 22.3 percent from 1999 to 2000. The increment could be 
due to better detection, follow-up and reporting systems, and I or an increased 
awareness of cardiovascular diseases (Samad et al. 2002). 
Hypertension or high blood pressure is the most common chronic lifestyle disease in 
many countries. The epidemiological studies on the association between 
hypertension and other cardiovascular diseases are well documented. Hypertension 
was linked to the morbidity and mot1ality of cardiovascular diseases such as heart 
failure, coronary heart disease and stroke. Early studies of hypertension and heart 
failure (Nicholls, 1996; Waltman and Hellerstein, 1943; Clawson, 1941) suggested 
that hypertension was the commonest cause of non-rheumatic heart failure. Eriksson 
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et al. (1989) reviewed these data in 1989 and concluded that hypertension and 
smoking were the major independent risk factors for the development of congestive 
heart failure. Long-term prospective studies such as the Framingham Study indicated 
that hypet1ension was the most important single factor contributing to the increased 
incidence of cardiovascular diseases in western countries. A review on the National 
Health and Nutrition Examination Survey (NHANES) data from 1988 to 2000 show 
that Hypeliension prevalence is increasing in the United State (Hajjar et al. 2003). 
Furthermore, an overview of antihypertensive drug trials ｩｮｾｩ｣｡ｴ･､＠ that 
pharmacological therapy of hypertension reduced the incidence of heart failure by 
approximately 50 percent. Therefore, patients with hypertension should be informed 
of the importance of controlling hypertension, with the aim of delaying the process 
of developing cardiovascular disease in the long run (Nicholls et al. 1997). 
The outcomes of various studies signify the importance and seriousness of 
hypertension as a related-risk factor in other cardiovascular diseases as well as a 
disease on its own (Samad et al. 2002). The number of people suffering from 
Hypertension has significantly increased. It is estimated that more than 30 percent of 
the adult population from both developed and developing countries were suffering 
from this disease. The prevalence of hypertension is very high when a threshold 
value of 140/90 mm Hg is used as a cut-off-point. In 2001, Hypet1ension is estimated 
to have caused about 13 percent of total deaths worldwide. 
The Malaysia National Health and Morbidity Survey I reported that 14.4 percent of 
adult aged 25 years and above in Peninsular Malaysia have an elevated blood 
pressure, whilst the 1996 Malaysia National Health and Morbidity Survey indicated 
that the prevalence of Hypertension among adult aged 30 years and over is about 
29.9 percent (Arif, 2003). Fmiher analysis by locality showed that 27.6% of urban 
and 32.6% of rural population have diastolic blood pressure equal to more than 
90mm Hg (Samad et al. 2002). It was also found that many patients who have 
hypet1ension are unaware of the disease. The study conducted by Lim et a!. (2004) 
indicated that 30 percent or 2.6 million Malaysian adult had hypeliension. This result 
is consistent with the outcome of the second MalaysiaN ational Health and Morbidity 
Survey. The prevalence of Hypet1ension by gender presented that women have a 
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higher prevalence than men; at the same time as observing by age-gender-ethnic 
group, there was a higher prevalence among Malay women in comparison with other 
indigenous group. Considering the issue of patient awareness of treatment and 
control of the disease; only one third was aware of their hypeltension status, 
followed by 3.1 percent who has remained treatment, but only 26 percent of them has 
continued with the treatment. Apalt from that, women were found to be more aware 
of their Hypeltension status and more compliant towards their treatment as compared 
to men. The outcome of this study shows without doubt that Malaysia has a serious 
problem with hypeltension, and its detection and treatment is less than satisfactory. 
The finding of this study is consistent with Hyman et al. (200 1) indicated 
independent predictors of lack of awareness and poor controlled of Hypeltension 
were associated with age, gender and race. The International Collaborative Study of 
Cardiovascular Disease in Asia in year 2000 to 2001 show percentages of those with 
Hypeltension, who are aware, treated and controlled are unacceptably low in China 
(Gu et al. 2002). 
The findings of these studies showed that the problem was more serious than had 
been demonstrated in recent studies (Henauw et al. 1998; Kastarinen et al. 1998; 
Colhoun et al. 1998; Burt et al. 1995; Joffres et al. 1992) assessing the effectiveness 
of hypeltension control in different population (Lim et al. 2004). This situation was 
rather grave and public health efforts were required to detect, treat and control 
hypeltension in the community. The lack of better hypertension control is as a result 
of the existent multilevel problem which involving the patient, health care provider, 
and health care systems. There are several factors lead to this problem: lack of 
patient's understanding of the impot1ance of blood pressure control, failure of patient 
returning for follow-up, lack of recognition of the impot1ance of treating systolic 
blood pressure, and failure of health care provider linking the impot1ance of 
compliance to medication to the goal blood pressure level (Miller, 2003). 
1.1 Definition and Classification of Hypertension 
The definition of hypeltension was reviewed by various authorities which included 
the World Health Organisation/International Society of Hypeltension (WHO/ISH) 
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and The Joint National Committee on the Detection, Evaluation and Treatment of 
High Blood Pressure (JNC). Table 1.1 illustrates the defmition and classification of 
high blood pressure and was adopted from The Fifth Report of the JNC (Malaysian 
Hypertension Consensus Guideline, 1998). These classifications of blood pressure 
provided a categorization of adult blood pressure which is able to state the impact of 
high blood pressure on the risk of developing cardiovascular diseases. The extent to 
which high blood pressure contributes to the development of cardiovascular diseases 
varies; the higher the blood pressure, the greater was the risk. Moreover, all 
categories of hypetiension are associated with the increased risk of non-fatal and 
fatal cardiovascular diseases. Stage I hypertension was the most common form of 
high blood pressure among the adult population and was responsible for a large 
proportion of the tnorbidity and mortality associated with hypertension (Malaysian 
Hypertension Consensus Guideline, 1998). 
Table 1.1: Classification of Blood Pressure for Adults Age 18 Years and Older 
Category Systolic (mm Hg) Diastolic (mm Hg) 
Normal < 130 <85 
High Normal 130-139 85-89 
Hypertension: 
STAGE I (Mild) 140- 159 90-99 
STAGE II (Moderate) 160- 179 100 -109 
STAGE III (Severe) 180-209 110-119 
STAGE IV (Very severe) > 210 > 120 
Malaysian Hypertension Consensus Guidelines, 1998 
1.2 Blood Pressure 
Hypertension is typically determined by measuring the blood pressure or arterial 
pressure. Blood pressure is a measurement of the force exerted by the blood 
circulating in the arteries. The blood pressure is influenced by the force or pressure 
generated within the arterial system as the heart pwnps blood, the constriction and 
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dilation of the blood vessels and the volume of circulating blood. These pressures in 
the cardiovascular system are expressed in millimetre of mercury (mm Hg) above 
atmospheric pressure (Klabunde, 2005, p.4-5). 
The blood pressure measurement is usually expressed in two figures which are 
systolic and diastolic blood pressure. Systolic pressure is a peak pressure of the aortic 
pulse as a result of the ejection of blood into aorta by the left ventricle. The average 
normal reading is less than 120 mm Hg but greater than 90 mm Hg. The pressure 
changes accordingly in response to the body daily activity and stress. Secondly, the 
diastolic pressure is · the lowest pressure in the aorta which found just before the 
ventricle ejects blood into the aorta. It occurs dw·ing the relaxation and refilling of 
the left ventricle of the heart. The average normal reading is less than 80 mm Hg but 
greater than 60 mm Hg. Thus, hypertension is defined by most authorities as 
elevation of arterial pressw·e where systolic pressure is equal to or greater than 140 
mm Hg and diastolic pressure is equal or grater than 90 mmHg respectively 
(Klabunde, 2005, p.94-95). 
Raised blood pressw·e increases the workload on the heart and damages the 
endothelial lining of blood vessel. It also increases the infiltration of lipid into the 
arterial wall, exacerbating endothelial damage, enhancing atherosclerotic deposition 
and ultimately increasing cardiovascular risk. The point at which raised blood 
pressure becomes clinically significant depends on the patient's age and overall 
cardiovascular risk (Thomas, 2001, p. 534 ). 
1.3 Diagnosis and Assessment 
In general practice before one individual is diagnosed with Hypertension, it is 
essential for his or her blood pressure to be taken at different periods of time under 
relaxed conditions. This is important because blood pressure varies from moment to 
moment throughout the day (McMahon, 1984, p.1 ). The Malaysian Hypeliension 
Consensus Guideline (1998) outlined that hypertension should not be diagnosed on 
the basis of a single measurement unless there is target organ damage or systolic 
blood pressure of 210 mm Hg or diastolic blood pressw·e of 120 mm Hg. Otherwise, 
the initial elevated blood pressure reading should be confirmed on at least two 
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subsequent visits. The re-examination may be done within days or weeks depending 
upon the level of the initial blood pressure. 
Next, a complete medical history and physical examination is conducted before an 
individual can be confirmed having hypertension. Physical examination is performed 
aiming at assessing target organ damage and excluding secondary causes of 
hypertension and identifying concomitant risk factors such as diabetes, obesity and 
hyperlipidemia. These include measuring height, weight, blood pressure, radio-
femoral delay, cardiac and respiratory examination, abdominal masses, carotid bruit, 
renal artery btuit and peripheral pulses and fundoscopy. An initial laboratory 
investigation is also performed such as urinalysis and microscopy, serum urea, 
creatinine and uric acid, serum electrolytes, fasting glucose and lipids, 
electrocardiogram (ECG) and chest x-ray. If the examination or investigations 
suggest any secondary causes the patient will be referred for further evaluation 
(Malaysian Hypel1ension Consensus Guideline, 1998). 
1.4 Types of hypertension 
1.4.1 Essential hypertension 
An essential (or primary) hypertension account for approximately 90 to 95 percent of 
patients diagnosed with hypertension and is associated with an increased risk of 
cardiovascular diseases (Johnston, 2001, p.500). Essential hypertension is idiopathic, 
that is, there is no known cause of this form of hype11ension. Much research has been 
done on essential hypertension, but there is no unifying hypothesis to account for 
pathogenesis of essential hypertension (Klabunde, 2004, p.20 1; Beevers et al. 2001 ). 
However, the natural progression of this disease suggests that early elevations in 
blood volume and cardiac output might initiate subsequent changes in the systemic 
vascular resistance. This has led some researchers to conclude that the basic 
underlying defect in hypertension patients is the inability of the kidney to adequately 
control sodium. This condition subsequently increases blood volume and systemic 
vascular resistance because of the thickening of the wall of resistance vessels and 
reduction in lumen diameters. Furthermore, it increases circulation of angiotensin II 
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which causes smooth muscle to contract, leading to vascular hypertrophy or 
hyperinsulinemia, and hyperglycemia in Type 2 diabetes which than causes 
endothelial dysfunction (Klabunde, 2004, p.202; Beevers et al. 2001 ). 
Essential Hypertension is related to heredity, age, race and socio-economic status. 
The hereditary factor is associated with genetic abnotmalities in renal function and 
neurohumoral control mechanistns. The incidence of essential hypertension increases 
with age and it is more likely to develop among people African than of Caucasian 
descent. Furthermore, stress could elevate arterial pressure through activation of the 
sympathetic nervous system which then increases cardiac output and systemic 
vascular resistance (Klabunde, 2004, p.202). 
1.4.2 Secondary Hypertension: 
Secondary hypetiension accounts for approximately five to ten percent of all 
hypertensive cases. There are several known causes for secondary hypertension: 
renal artery stenosis, renal disease, primary hyperaldosteronism, hypetthyroidism, 
pheochromocytoma, preaclampsia, Cushing's syndrome and aortic coruiation 
(Klabunde, 2004, p.203 ). 
1.5 Aetiology of hypertension 
1.5.1 Risk factors ofhypertension: 
The aetiology of hypertension is associated with four intenelated risk factors: are 
classified into four: genetic predisposition, environmental, iatrogenic causes and 
unknown components. The extent to which each risk factor contributes to the onset 
of Hypertension vades; the higher the blood pressure and more risk factors involved, 
the higher is the risk. There are several established causes or risk factors of 
Hypertension, which ru·e common to the other cardiovasculru· diseases. Some of these 
risk factors associated with Hypertension are reversible or modifiable and some are 
not; namely age, gender, ethnicity, heredity. Table 1.2 summarises the risk factors 
associated with Hypertension. 
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Table 1.2 Risk Factors Associated with Hypertension 
Risl{ Factor 
1.5.2 Irreversible risk factors 
Reversible 
Physical Inactivity 
Stnoking habit 
Alcohol constm1ption 
Obesity 
Sodium intake 
High cholesterol diet 
Stress 
Irreversible 
Age 
Gender 
Ethnicity origin 
Heredity 
Other related diseases 
Blood pressure reading and the prevalence of hypertension increase progressively 
with age. Recent data from the Framinghatn Heatt Study shows that nonnotensive 
individuals aged 55 years have a 90 percent lifetime risk for developing 
Hypertension (JNC 7 Report, 2003). This might be due to the aging process or 
hardening of the arteries which subsequently reduces the vascular elasticity and 
creates high blood pressure and increased peripheral vascular resistance (Elliott, 
2006). Although systolic blood pressure rises with age and increases the likelihood of 
developing vascular diseases, diastolic blood pressure tends to level off after the age 
of 60. The reason for the flattening out of the diastolic blood pressure at the age of 60 
might be related to declining of cardiac function, genuine fall in blood pressure or 
failure to rise (Whelton et al. 2002; Beevers et al. 2001). 
Generally, untreated hypertension relentlessly and insidiously escalates over a period 
of 15 to 30 years in 100 percent of individuals (Fair, 2003; McMahon, 1984, p.11 ). 
The estimated life-time risk of developing hypertension is 90 percent (Appel et al. 
2003). Hypertension is more prevalent among the middle aged and elderly, the obese, 
heavy ､ｲｾ･ｲｳ＠ and women on contraceptive pills. At the age of 80 years old, more 
than 70 percent of the population have hypertension as compared to those age 30-39 
years old (Havas et al. 2004). Fwthetmore, Hypertension is more common in men 
than in women although the incidence in women rises after menopause (Beevers et 
al. 2001; Murray, 1991). Having family members with high blood pressure increases 
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your risk of developing the condition especially those with diabetes mellitus, gout or 
renal diseases (Murray, 1991). 
Finally, ethnic differences may be important in calculating the risk of hypertension 
and stroke. Most studies among western societies showed a higher prevalence in 
Afro-Caribbean people than Caucasians. The possible predisposing factors leading to 
high prevalence of hypertension in Afro-Caribbean were the rennin-angiotensin 
system, genetic factors, salt sensitivity, lower potassium diet, and obesity. People 
from the Indian subcontinent residing in western countries have similar blood 
pressw·es to Caucasians. Coronary heart disease was found to be major a cause of 
death in people from the Indian subcontinent (Beevers et al. 2001 ). A study among 
British people of Asian, Caribbean and West African ethnic origin in South London 
shows that hypertension and diabetes are two to three times higher among these 
ethnic groups. The increment of these diseases is usually associated with obesity, 
derangement of glucose lipid metabolism, type 2 diabetes mellitus (Elliott, 2006; 
Cappuccio et al. 1997). 
1.5 .3 Reversible risk factors 
Smoking is regarded as one of the major risk factors in Hypertension. The chemicals 
in the tobacco can damage the lining of the artery walls, then causing the arteries to 
accumulate fatty deposits. Nicotine also constricts the blood vessels and forces yow· 
heart to work harder (MayoClinic.Com). People with Hypertension who smoke have 
two to three times greater incidence of stroke and CHD than those with comparable 
blood pressw·e who do not smoke (Arif, 2003) 
Obesity is another modifiable risk factor associated with Hypertension. It is often 
defined as an abnormal condition or excessive fat accumulation in adipose tissue, to 
the extent that might affect health. One of the most commonly used indices to 
measw·e weight is the Body Mass Index (BMI). Table 1.3 illustrates the classification 
of overweight in adults according to Body Mass Index following the classification 
proposed by World Health Organization, 1998. 
10 
Table 1.3 Classification of overweight in adults according to Body Mass Index 
Classification BMI (kg/ tn2) Risk of co-tnorbidities 
Underweight <18.5 Low (but risk of other clinical probletns 
increased) 
Nonnal Range 18.5-24.9 Average 
Overweight: ｾＲＵ＠
Pre-obese 25-29.0 Increased 
Obese class I 30.0- 34.9 Moderate 
Obese class II 35.0- 39.9 Severe 
Obese class III ｾＴＰＮＰ＠ Very severe 
Guideline for Prevention of Obesity in Malaysia, 2004 
Obesity is associated with a higher prevalence and incidence of hypeliension. It also 
increases the risk of developing coronary heart disease, stroke, diabetes and ce11ain 
types of cancers, and aggravates at1hritis and breathing problems. The American 
Society of Acturu·ies repolied that obesity was one of the conditions most associated 
with hypeliension. The outcome of a study conducted by Langford et al. (1982) 
showed that withdrawing antihypet1ensive drugs led to a greater increase in the 
incidence and degree of severity of hypeliension among hypeliensive obese patients 
than among non-obese patients (McMahon, 1984, p.46). 
The accumulation of fat in an individual requires more blood to supply oxygen and 
nutrients to nourish the fat tissues. Therefore, the volume of blood circulated through 
the blood vessels increases and creates extra forces on the rutery walls. This in turn 
condition strains the hea11 and tends to increase blood pressure (Kaplan et a/. 1993, 
p. 227). 
Another reversible risk factor is physical inactivity; blood pressure elevates shat-ply 
during physical activity. Studies show that undeliaking regular exercise would make 
an individual become fitter, healthier and have lower blood pressure. However, these 
benefits are only seen when individuals also have healthy diet, do not smoke, and 
drink moderately. Vigorous physical activity is known to have a number of beneficial 
effects, including a reduction in body weight, body fat, skin fold thickness and girth. 
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Prolonged exercise will also result in changes in the lipoprotein profile where the 
total triglyceride levels falls and HDL-C is rising (Northcote, 1991). 
Adequate significant evidence on the association of diet and nutrition as risk factor in 
Hypertension is available fi·om studies conducted worldwide. Excess sodium in the 
diet often causes retention of fluid in the body and subsequently increases blood 
pressure; while dietary potassium could lower the risk of Hypertension and stroke 
(Renddy and Katan, 2004). Numerous studies have been published indicating that 
sodium is one of the risk factors in essential or primary hypertension. 
Epidemiological studies such as Oliver et al. 1975; McMahon et al. 1973 have 
shown that hypertension prevalence is low in uncultured populations with low levels 
of salt intake. As urbanization and other adaptations to modern sedentary lifestyle 
take place, the amount of salt intake increases and as well as the prevalence of 
hypertension. This situation has led health experts to urge individuals with a family 
history of essential hypertension to accustom themselves and their children a low salt 
diet (McMahon, 1984, p.38). In general, sodium restriction is beneficial to patients 
with essential hypertension. Studies (e.g. Watt et al. 1981; MacGregor et al. 1981; 
Parfrey et al. 1981; Morgan et al. 1981; Morgan et al. 1978) have fotmd that 
moderate dietary sodium restriction can lower blood pressw·e (McMahon, 1984, 
p.40). 
Consuming a high cholesterol diet can put one at risk of developing Hypertension. 
Cholesterol is a waxy substance necessary for the manufacture of body cells and 
ho1mones. It is essential to life but in excess quantities cholesterol can threaten life in 
condition such as hypercholesterolemia. The waxy nature of cholesterol allows it to 
dissolve in blood and travel to the body cells. The means of transportation to transmit 
cholesterol and fat throughout the human body is called lipoprotein. There are three 
types of lipoprotein that are mostly associated with cardiovascular diseases, namely 
high-density lipoprotein or good cholesterol, low-density lipoprotein and 
triglycerides or bad cholesterol. An increased amount of bad cholesterol leads to 
cholesterol deposits in the arteries and the formation of plaque (Kaplan et al. 1993, p. 
215,217). High serum cholesterol, i.e. high low-density lipoprotein cholesterol and 
low high-density lipoprotein cholesterol appear to increase risk of atherosclerotic 
12 
complication of hypertension (Arif, 2003). A diet high in saturated and trans-fats is 
associated with increased risk of cardiovascular diseases, whilst polyunsaturated fat 
is known as protective fat (Renddy and Katan, 2004 ). 
Last but not least, drinking alcohol and stress are other risk factors associated with 
Hypettension. Drinldng regularly and in large an1ounts increases the blood pressure. 
This means drinldng more than one daily drink for won1en or two for n1en (American 
Heart Association, 2003). It has also been suggested that psychological or 
envirotunental stress n1ay play a role in the aetiology of hypertension. Although 
stressful stimuli n1ay cause an acute rise in blood pressure, it is still doubtful whether 
it has any significance in the long-term (Beevers et al. 2001 ). Hormones released by 
your body when you are under stress can increase your blood pressure. This may 
aggravate high blood pressure in genetically susceptible individuals. (American 
Heart Association, 2003) 
1.5 .4 Complication of hypertension: 
Hypertension was also known as a "silent killer" because one third of adults were not 
aware of being hypertensive due to its asymptomatic nature and its damaging effects 
can only be observed after experiencing a stroke, myocardial infarction, or renal 
dysfunction. Hypertension is much more than a cardiovascular disease because it 
affects other organ systems of the body such as the kidney, brain and eyes. The 
damage to other organ systems is due to irreversible harm from long-term elevation 
in blood pressure. An elevation in one of the pressures, either systolic or diastolic, 
can result in long-term health consequences. The complications include stroke, heart 
disease, peripheral vascular disease, renal failure, and retinopathy (Klabunde, 2004, 
p.201; Beevers et al. 2001, p.2). 
Stroke is one of the most devastating consequences of hypertension which can lead 
to death and significant disability. Stroke accounted for about 12 percent of death 
and 25 percent of stokes occurred in patients aged 65 years and below. In 
hypertensives, 80 percent of stroke incidents are caused by intra-arterial thrombosis 
or embolization from the heart and large ru.ieries and the remaining 20 percent are 
due to haemonhage which may also relate to very high blood pressure. In the United 
13 
Kingdom, 40 percent of stroke incidents are associated with high blood pressure of 
more than 140 mm Hg and the risk is four times higher among men aged between 40 
to 59 years. Various population studies have shown that a reduction in blood pressure 
may result in lowering ofthe incidence of stroke (Spencer, 1999). 
Heart disease is a common fotm of complication due to uncontrolled Hypertension. 
There are various forms of heart disease caused by hypertension such as left 
ventricular hypertrophy, heart failure and coronary heart disease. Coronary heart 
disease is six times more common among young hypertensives than stroke. 
Peripheral vascular disease is about three times more common among hypertensives. 
Many of them may also have renal artery stenosis, atheromatous disease, and 
extracranial carotid rutery disease (Beevers et al. 2001; Spencer, 1999). 
Finally, renal dysfunction is often found in hypertensives and malignant hypertension 
frequently leads to progressive renal failure. Hypertension can also cause 
retinopathy; a condition where vascular changes take place in the eye (Beevers et al. 
2001). 
1.6 Treatment of hypertension 
The goal of treatment in hypertensive patients is to prevent morbidity and mortality 
associated with hypertension. This can be accomplished by achieving and 
maintaining systolic blood pressure 140 mm Hg or more and diastolic blood pressure 
90 mm Hg or more and practising a healthy lifestyle. Treatment of hypertension 
encompasses pharmacology and non pharmacology. 
1.6.1 Phrumacological therapies: 
Prevention and control of hypertension struted in the early 1970s when clinical trials 
found that elevated blood pressures could be lowered and subsequently lives could 
be saved through an effective blood pressure medication. Pharmacological treatment 
is seen to be effective in decreasing blood pressure and subsequently cardiovascular 
events, although the blood pressure levels of treated patients may still be higher than 
those in normotensive persons (Aubert et. a!. 1998). There are many drugs available 
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for treating hypet1ension but six most commonly prescribed are: diuretics, beta 
blockers, calcium channel blocker, angiotensin-converting enzyme inhibitor (ACE), 
combination dtug and Angiotensin II antagonist (Blumenthal et al. 2002). 
Hypertension is a chronic condition which requires a lifetime drug therapy. Patients 
will be prescribed with two to three types of drugs to be taken regularly. However, 
drug therapies do not always work, due to patient non-compliance or forgetting or 
neglecting to renew prescriptions, and side effects. Numerous studies (Sofer and 
Paran, 1987; Kaplan et al. 1993; Hassan et al. 2006) have show that non-compliance 
has failed the aims of dtug therapy. Thus, this fmding demonstrates the impot1ance 
of understanding barriers to the initiation of antihypetiensive therapy and control of 
hypertension in the community. 
Research (Geary et al. 1985; Bloom et al. 1987; Mann et al. 1987; Weiss et al. 2004) 
into patient compliance has generated impot1ant information about patient decision 
making and commitment, adherence, support systems and identified other related-
behaviow·s besides high blood pressure that lead to disease. This has led to the 
introduction of patient-centred non-pharmacological therapy which demands more 
attention to gradual and complex lifestyle modifications such as reduced sodium 
intake, regular exercise and so forth (Hiroyasu et al. 1996; Haskell 2003; Hill et al. 
2003). 
1.6.2 Patient-centred non-pharmacology therapy: 
Current national recommendations for the prevention and treatment of high blood 
pressure emphasize the non-pharmacological therapies, or also termed lifestyle 
modification. Lifestyle modification was suggested to be an initial therapy for Stage I 
hypertension for up to 12 months in those without other risk factors or for 6 months 
in those with other risk factors. Table 1.4 illustrates the non-pharmacology 
management and its efficacy in lowering blood pressure. For individuals on drug 
therapy, it is recommended as a supplement therapy to lower blood pressure. The 
DASH Diet for instance emphasizes the consumption of fruits, vegetables and low-
fat dairy products and low sugar contained food or drink. The DASH Diet has 
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reduced levels of total fat, saturated fat and cholesterol and increased levels of 
potassium, calcium, magnesium, fibre and protein (Appel eta!. 2003). 
Ever since further studies (Whelton eta!. 1997; Vollmer eta!. 2001; Whelton et al. 
2002; Appel et al. 2003; Fair, 2003) have emerged to support the recommendation of 
non-phwmacology treatment as part of the primary prevention of hypertension. 
Lifestyle modification was used for lowering blood pressure and included reduced 
alcohol intake, reduced sodium chloride intake, increased physical activity and 
control of weight (Kyngiis and Lahdenpera, 1999). Lifestyle modification has the 
potential to reduce the need for or the amount of medication in hypertensive patients 
and to prevent high blood pressure from developing in those in the high normal 
group (Aubert eta!. 1998; Malaysiw1 Hypertension Consensus Guidelines, 1998). 
There is a lot of evidence which shows that lifestyle or non-pharmacological 
treatment is helpful in both prevention and control of hypertension. The adoption of 
healthy lifestyle by communities collectively and adherence to them by individual 
patients requires behavioural changes. In order to achieve such changes, there needs 
to be a collaborative effort among multidisciplinary health related providers as well 
as a sustained campaign in all sections and ages of the community (Arif, 2003). 
1.6.2.1 Weight reduction 
The Framingham Study has shown that men who lost 15 percent of their body weight 
dropped their systolic blood pressure by 10 percent. On the other hand, men who 
gained 15 percent more weight raised blood pressure by 18 percent (Arif 2003; 
McMahon, 1984, p.46). A systetnatic review conducted by Brand et a!. (1999) 
suggested that dietary measures which achieve 3 to 9 percent reduction in body 
weight were likely reduce systolic and diastolic pressures by 3 mm Hg (Thomas 
2001, p. 535). 
Weight reduction is most beneficial in patients who are more than 10 percent 
overweight and as far as possible aims for a body mass index of 20- 25 kg/m2 • A 
reduction by 5 percent in weight will result in significant lowering of blood pressure 
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(Malaysian Hypertension Consensus Guideline, 1998). Several studies (Tuck et al. 
1981; Ramsay et al. 1978; Reisen et al. 1978; Preble et al. 1973) have proven that 
weight reduction plays a vital role in lowering blood pressure. A study by Gillum et 
al. (1983) suggests that a combination of calorie-restricted and sodium restricted diet 
in the management of obese patients would substantially drop blood pressure. This 
type of management would be better started among obese patients with or at risk of 
Essential Hypertension (McMahon, 1984, p.50). Another study suggests that in order 
to ensure that desirable weight can be sustained weight management interventions 
should emphasize lifestyle change rather than dieting (Rapoport et al. 2000). 
1.6.2.2 Reduction of Alcohol Intake 
Numerous epidemiological studies (Mrumot et al. 1994; Wallace et al. 1981; Dyer et 
al. 1981; Harburg et al. 1980) have demonstrated an association between heavy 
alcohol consumption and the prevalence of hypertension. The Framingham Study 
similarly found hypertension twice as prevalent among those drinking 60 oz. alcohol 
per month (McMahon, 1984, p.64). Regular alcohol consumption raised blood 
pressure in both men and women in different ethnic groups. Reduction of alcohol 
intake over a period of one to four weeks results in lowering blood pressure. 
Randomized cross-over studies among hypertensive as well as normotensive 
participants revealed that a reduction in alcohol intake by 80 to 85 percent resulted in 
reduction of systolic blood pressure and diastolic blood pressure in both groups (Arif, 
2003). 
1.6.2.3 Physical activity 
Numerous studies (Nelson et al. 1986; Hagberg et al. 1989; Martin et al. 1990; Lee 
et al. 1995) demonstrated that increasing level of physical activity has shown 
reduction in systolic and diastolic blood pressure in hypertensive patients (Thomas 
2001, p.535; Blumenthal et al. 2002). A study among normotensives revealed that 
sedentary and unfit normotensive individuals have a 20 to 25 percent higher risk of 
developing hypertension, as compared to an active control group. Exercise lowers 
systolic blood pressure and diastolic blood pressure by 5 to 10 mm Hg. A meta-
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analysis of 22 studies revealed that a mean systolic blood pressure reduction of 6.4 
mm Hg and a mean diastolic blood pressure reduction of 6.9 mmHg were achieved 
through prescribed exercise (Arif, 2003). 
Although some studies have found physical activity effective in lowering blood 
pressure, the outcome is seen as flawed because changes in weight and sodium 
restriction were not reported and there was a lack of long-term follow-up after 
intervention was initiated. Furthermore, factors such as compliance might have an 
impact on the effect of physical activity in lowering blood pressure. Stamler et al. 
(1980) has conducted a large, long-term, prospective study on the effect of diet, 
exercise and weight loss on blood pressure. The results showed that the combination 
of dietary sodium restriction, weight reduction in obese, and regular exercise were 
seen to lower blood pressure particularly in hypertensive patients compared to the 
high normal blood pressure group (McMahon, 1984, p.54). 
1.6.2.4 Sodium and fat restriction: 
The role of sodium restriction in treatment of Hypertension is well documented in 
numerous epidemiological studies (He and Whelton, 1997; Elliot et al. 1996; Frost et 
al. 1991; Law et al. 1991) and clinical trial studies have shown a clear relationship 
between sodium intake and blood pressure (Thon1as 2001, p.536; McMahon, 1984). 
A meta-analysis of clinical trial in people with hypertension revealed a systolic blood 
pressure reduction of 4.9 mm Hg and diastolic blood pressure reduction of 2.6 mm 
Hg associated with a 56 mmol to I 05 mmol reductions in daily sodium intake (Arif 
2003). Numerous studies have been published implicating salt as a factor in the 
pathogenesis of essential hypertension. This situation has led experts to urge 
individuals with a family history of essential hypertension to accustom themselves 
and their children to diets restricted in salt (McMahon, 1984, p.38). Although sodium 
restriction seems to be proven effective, the biggest problem is patient compliance. 
Several short-term interventional studies (Puska et al. 1983; Rouse et al. 1983; Stem 
et al. 1980; Fleischman et al. 1979; Iacono et al. 197 5) on the role of fat intake have 
yielded interesting outcomes. These studies demonstrated a significant blood 
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pressure fall with a diet low in fat (i.e. diet high in polyunsaturated fat or vegetarian 
diet). Several studies (Kraemer et a/. 1982; Stein et al. 1982; Schaefer et al. 1981) 
have shown that a high polyunsaturated diet lowers total cholesterol and low-density 
lipoproteins by 10 to 15 percent (McMahon 1984, p. 58). 
The current evidence on dietary fat or cholesterol and sodium intervention suggests 
that success is comparable to weight management. Studies on sodium and fat intake 
(Gillum et al. 1983; Pirie et al. 1984; Langford et al. 1985; Whelton et al. 1997; 
Vollmer et al. 2001) often report a short-term result rather than the long-term 
outcome. Among the reasons is that people have reported experiencing difficulties in 
adhering to a major diet change (Jeffery, 1988). 
1.6.2.5 Smoking 
Cigarettes contain nicotine which raises blood pressure. Goodman and Gilman 
(1970) noted that a majority of individuals who smoke experienced a rise in both 
systolic and diastolic blood pressure. Although proof is lacking, it seems that 
abstinence from heavy cigarette smoking will successfully reduce hypertension. 
Nicholson et al. (1983) found a significant correlation between cigarette smoking 
and renovascular hypertension when compared with a matched cohort of patients 
with essential hypertension (McMahon, 1984, p.67). 
The situation is alarming and is a cause for growing public health concern. There are 
numerous efforts and initiatives undertaken by various sectors in combating this 
problem in Malaysia. These include thematic healthy lifestyle campaigns since 1991, 
screening programmes for cardiovascular diseases and diabetes, integration of 
services into primary care facilities, the enactment and enforcement of the Control of 
Tobacco Product Regulations and many other collaboration projects with non-
governmental agencies, universities and private organizations. However, there is 
insufficient evidence to show the itnpacts of these interventions on overall trends and 
prevalence rates, primarily due to a lack of a proper evaluation system, or good 
quality population-based study (Omar 2002; Omar et al. 2002; Arif et al. 2003). 
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Table 1.4 Efficacy ofNon-Pharmacology Management 
Treatment Intervention 
Dietary advice 
Sodium restriction Sodium intake (<100 mmol/day) 
Relaxation Relaxation techniques 
Weight loss Diet and exercise 
Exercise Aerobic exercise programme 
Malaysian Hypertension Consensus Guidelines, 1998 
BP reduction (mmHg) 
8- 15 systolic 
5-6 diastolic 
9 - 27 systolic 
4 - 16 diastolic 
9 - 27 mean arterial pressure 
6 - 13 systolic 
9- 12 diastolic 
Furthermore, a systematic review and meta-analysis of randomized controlled trial 
was conducted to esthnate the effects of various non-pharmacology treatments on 
blood pressure. The findings revealed that the majority of these randomized 
controlled trials conducted in short period of time without guidance on sustainability 
of effects and bias often over-shadow the changes observed and an overestimate the 
effects achieved by non-pharmacological intervention. Therefore, the study 
suggested that a large-scale, long-tetm trial of these non-pharmacological 
interventions need to be conducted in both hypertensives and normotensives to 
determine effect sizes more accurately (Ebrahim and Smith, 1998). 
1.7 Prevention and Control ofHypertension 
Prevention and control of Hypertension remains a major public health concetn in 
many countries. This is due to well established disease con1plication and its effect on 
the quality of life of individuals and communities in general. Great efforts have been 
made to prevention and control of Hypertension not only from the individual 
patient's perspective but, also for the community in general. The significance of 
prevention and control of Hypertension can be observed not only from the individual 
quality of life, but, it can also bring down the morbidity of related diseases such as 
cerebrovascular and cardiovascular diseases (Hobbs, 2004). 
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With due respect to delivering appropriate intervention in tackling health problem 
such as Hypertension, primary prevention has been considered to be the most cost 
effective, affordable, and sustainable course of action to cope with the chronic 
diseases epidemic worldwide. The public health approaches such as lifestyle or 
behaviour modification encouraging people to reduce salt and saturated fat intake, 
and increase physical activity can shift downward the distribution of population 
blood pressure. Thus, lifestyle or behaviour modification has been seen to have the 
potential to decrease blood pressure, reduce morbidity and tnortality and the lifetime 
risk of individuals becoming hypet1ensives. Moreover, if public health intervention 
addresses the diversity of racial, ethnic, culture, religious and social factors in the 
delivering of its approach, the likelihood of community acceptance might increase. 
Hence the changes that took place within the individual lifestyle may enhance drug 
therapy efficacy and also facilitate adherence to lifestyle interventions (Basler et al. 
1987; Arif, 2003; The JNC Report, 2003; Appel et al. 2003; Elmer et al. 2006). 
Various approaches have been introduced and all of them have generated a 
significant amount of literatures on their effectiveness in combating Hypertension. 
The community-based integrated intervention was internationally recognized as one 
of the effective methods used to modify lifestyle-related risk factors including 
diseases such as Hypertension. This method includes organizing effective health 
education and communication networks, delivering clinical preventive and curative 
services, and influencing policy makers (Arif, 2003). 
The general community-based national health programme has been developed and 
organized locally and internationally to generate and increase hypertension 
awareness among the public. However, the existing national programme organized at 
the community level has been perceived as revealing an unclear outcome. This is 
because no significant change whatsoever is seen in the community awareness, 
treatment and control of blood pressure. A population study conducted by Meissner 
et al. (1999) demonstrated that there is a decrease in community awareness and 
control of Hypertension and this result is consistent with previous population-studies 
conducted in the United States. Despite the current existing prevention programme 
for Hypertension, many more approaches have been introduced to serve the need to 
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fmd the effective methods of overcoming health problems such as Hypertension. But 
this approach has been found to be producing a modest impact and among the 
reasons are: lack of tailoring interventions to reach various segments of the 
population, trends of risk factors, statistical issues and smaller effect sizes than 
expected (Parker and Assaf, 2005; Fortmann et al. 1990; Strasser, 1987). 
However, the challenge faced by health care provider does not only ensure that there 
is some change occurring to the patient's lifestyle, there is also a need to teach the 
patients necessary skills which they can use to ensure long-term sustainable 
compliance. Various strategies have been developed to help patients learn to manage 
their own care and patient or family are actively integrated in the care process 
(Ruzicki, 1990). 
oach commonly used in public health is the individual or patient-
centered interve ion. This type of intervention includes the task-centered 
instructural progr e (Mann and Sullivan, 1987); the tailored-patient treatment 
(Bloom et a!. 1987; S cher et a!. 2002); the self-monitoring or self-management 
approach (Barlow et a . 2002; Lorig et al. 2003; McManus et al. 2007) and 
community-based educ tion classes (Hiroyasu et a!. 1996). Evidence-based review 
on behavioural interv tion suggests that blood pressure tend to improve through this 
combination ofm ods (Boulware eta!. 2001). 
A study conducted by Levine et a!. (1987) on the effectiveness of planned health 
education interventions on long-term control of high blood pressure and associated 
reduction on morbidity and mortality suggested that such long-term changes 
involved combinations of intervention necessary to persuade complex behavioural 
change. In order to sustain positive changes, an intervention should employ the 
integration of various factors. A study by Glanz et a!. ( 1981) study on patient 
responses to four patient educational interventions indicated positive responses from 
the patients. 
Weingarten et al. (2002) reviewed the types of intervention commonly used in the 
management of chronic diseases; and patient education was found to be the most 
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commonly used followed by education of health care providers and provider 
feedback. Most of the programmes used the multiple interventions approach and 
significantly improved patient disease control with effect sizes range from 0.22 to 
0.61. 
In Malaysia, the main objective of prevention and control of Hypertension is 
basically trying to reduce the incidence, prevalence and complication of 
Hypettension in the population as a whole. It also aims to reduce the causes of 
hypertension and gradually enhances the community quality of life. In order to 
achieve these objectives various strategies have been utilized in both primary and 
secondary prevention as it will reveal tnore concrete and significant outcomes 
(Samad et al. 2002). Appendix 1.1 illustrates the National Programme for the 
Prevention and Control of Hypertension in Malaysia. 
Thus, with the increasing demand for preventing and controlling non-communicable 
disease such as Hypertension, the Ministry of Health has put forward a 
comprehensive community-based campaign to promote healthy lifestyles among 
Malaysian. Phase one of the campaign aims to create awareness and educate the 
community with regard to the pruticular diseases. The campaign begun in 1991 with 
the theme of cardiovascular disease. This campaign continued in the following year 
with another five themes. After this series of six crunpaigns was accotnplished 
ru1other series of six campaigns was planned. These catnpaigns cover various themes 
which includes various life-style related risk factors (Suleiman, 1998). Above all, 
this campaign has the goal of finding out effective ways to tackle non-communicable 
disease. Table 1.5 illustrates the health campaign theme year by year. 
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Table 1.5 
Phase 1 
Phase 2 
National Health Campaign Themes by Year, Ministry of Health 
Malaysia 
Year Campaign Theme 
1991 Cardiovascular diseases 
1992 Aids disease 
1993 Food Safety and Hygiene 
1994 Child Health 
1995 Cancer 
1996 Diabetes Mellitus 
1997 Health Eating 
1998 Exercise 
1999 Injury: safety and Prevention 
2000 Mental Health 
2001 Health Family 
Like other national programmes conducted in western countries such general 
community-based programme does not reveal any significant improvement to the 
morbidity and mortality of Hypertension and other cardiovascular diseases. Among 
the reasons may be: lack of assessment of the impact of the prevention programme 
on the general public and specific target groups, scope of the programme is too 
general and there is no under-pinning theory or model to guide the planning, 
implementation and evaluation the outcome of the programme. 
This leads to the develop1nent of another type of standard intervention programme 
which is implemented in the government hospital. This standard patient education 
programme has been developed by the Malaysian Ministry of Health Education 
Division, Medical Services Division and State Hospitals. The programme generally 
aims to decrease the morbidity and mortality among the Malaysian hypertensives 
population. The patient education programme was integrated into the management of 
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Hypet1ension. The intervention consisted of four sessions with small groups 
conducted by a nurse educator and assisted by a dietician, physiotherapist and 
pharmacist (Protokol Pendidikan Pesakit Darah Tinggi Bagi Kakitangan Hospital, 
2005). 
Although most hypertensives patients completed the four sessions, no systematic 
evaluation has been undertaken to identify what aspects of the programme, if any, are 
effective or how it benefits patients particularly in terms of improving the patient's 
quality of life and health outcomes. This highlights the need for the present study 
which aims to identify the changes in both psychological and physical health 
outcomes in terms of cognitions, emotions, behaviours, and health among Malaysian 
hypertension patients after attending the hypertension patient education programme. 
In addition, the study aims to identify predictors of health outcomes among 
hypertensive patients in Malaysia. The identification of the key psychological and 
clinical predictors of health outcomes could permit the tailoring of the intervention 
programme with the goal of increasing its efficacy. 
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CHAPTE)l2 
PSYCHOLOGICAL ASPECTS OF HYPERTENSION: FACTORS AND 
PREDICTORS OF H;EALTH OUTCOME 
Aim 
The second chapter reviews the literatw·e on studies looking at the psychological 
predictors of health outcomes and changes in cognition, emotion, behaviour and 
clinical outcomes among patients with chronic diseases, specifically hypertension. 
Research in determining predictors of health outcome and changes in terms of 
patients' cognitions, emotions, behaviours, clinical indicators and quality of life is 
widespread, ranging from psychological factors that predict the engagement of 
celiain health behaviours by the patients to its role in relation to changing behaviour 
and subsequently improve health outcomes. This review only considers aspects 
deemed mostly relevant to this research project. 
The study predictors are drawn from existing models widely used in health research 
namely Laventhal's self-regulation of health and illness behaviour, Bandw·a's self-
efficacy model and Wallston's health locus of control. Among the psychological 
constructs drawn from these models are illness perception, health locus of control, 
eating and exercise self-efficacy. Other factors reviewed in this chapter are 
depression and anxiety state and demographic variables. 
Thus the focus of this review will be on psychological predictors and their roles in 
relation to changing hypertensive patients' health outcome, particularly cognition, 
emotion, behaviour, clinical indicators and quality of life. This chapter also 
demonstrates the diagram hypothesising the psychological predictors and their 
impact on health outcomes within Malaysian context. Lastly, this chapter also cover 
psychosocial aspects of hypeliension interventions, critically discussing the fmdings 
of studies conducted to date. 
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2.0 Background and significance 
Centres for Disease Control and Prevention (2003) defmed chronic diseases as 
illnesses that are prolonged, do not resolve spontaneously, and are rarely cured 
completely. Based on this definition, individual that has been diagnosed with chronic 
disease requires them to engage in a long-term basis of certain adjustment across the 
interrelated multiple life domains (interpersonal, cognitive, emotional, physical and 
behavioural) over time (Stanton, et al. 2007). 
Many countries in the twentieth century portray a growing public health concerned 
with the incidence and management of chronic condition such cardiovascular 
diseases and cancer. This growing concern has been addressed by various fields and 
perspectives include the social, behavioural and biotnedical. The outcomes of the 
studies conducted from these perspectives present behaviour as an impotiant 
mediator which affects health outcome of the population, though the relationship 
between psychological traits and health indicators did reflect the interaction of 
behaviour with other factors such genetic make-up or gene expression (Kaplan, 
1990). Behaviour, being a central focus of discussion in study searching ways to 
tackle the over growing of chronic health problems, its also becoming a desire 
primary outcomes of a range of intervention design to change behaviour. 
Fmthermore, behaviour is not an isolated entities but, it is part of a process that 
includes perception, understanding and preparatory behaviour (Michie, 2005). 
Ever since, the prevention and control of chronic condition has focuses on health 
behaviours which are related to both susceptibility and the management of chronic 
condition (Leventhal et al. 2008). 
Various studies by different areas of disciplines were conducted to determine factors 
that might increase the incident of Hypertension as well as successfully facilitate 
patients engaged in specific health behaviour, and then modified their behaviours and 
lifestyle. This evidence from various disciplines supports that psychosocial factors 
(negative emotional states; chronic and acute psychosocial stressor; social ties; social 
support and social conflict) contribute significantly as predictors and related to 
morbidity and mortality due to cardiovascular diseases. The relationship of 
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psychosocial factors on the development of cardiovascular diseases contributes to a 
higher frequency of health behaviours such as poor diet and smoking (Rozanski, et 
al. 1999; Everson-Rose and Lewis, 2005; Brummett, et al. 2005). The roles of 
psychosocial factors as symptom of anxiety and depression (National Health and 
Nutritional Examination Survey, 1997) and hostility and depressive symptoms 
(Coronary Artery Risk Development in Young Adult) in the development of 
cardiovascular disease have been of interest for many years (Davidson et al. 2000; 
Yan, et al. 2003). Psychosocial factors such as trait anger and long-term 
psychological stress seems to be significantly associated with progression from 
prehypertension to hypertension and increased risk of incident of Coronary Heart 
Disease in both male and female. It was also found that the trait anger was predictive 
for men only (Markovitz, et al. 1993; Player et al. 2007). Study on the impact of 
psychological factors on cardiovascular disease was extended into finding evident 
that support its roles in the process of disease recovery. The outcomes of the study 
indicated that psychological risk factors might contribute to negative effects on the 
course of treatment. For instant, the higher baseline levels of daily stress were 
associated with reliably smaller treatment effects on measures of ischemia frequency 
and treadmill exercise time and significant greater likelihood of reporting angina 
after treatment (p< .05) (Rutledge, et al. 1999). 
Rosenstock (1974), Taylor (1991) and Adler and Matthews (1994) stated that there 
are varieties of factors that might influenced the individual inclination to take up 
health behaviours. These include demographic factors such as age (Blaxter, 1990), 
gender (Waldron, 1988), socio-economic and ethnic status (Blaxter, 1990)), social 
factors such as peer influence in initiation of smoking (McNeil, 1988), cultw·al 
influence (Wardle and Steptoe, 1991), emotional factors, perceived sympton1s, 
factors relating to access to medical care, personality factors and cognitive factors 
such as knowledge or risk awareness (Conner and Norman, 1995, p.3). 
In the past health behaviour was assumed to be guided or driven by the patients' 
knowledge. Ever since providing a specific information or knowledge to the patients 
was seen to be influential factor to change behaviour. The patients' health-related 
behaviour was not only influenced by their present state of knowledge, but, it is very 
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much affected by the patients' attitude and belief. With regards to patients' health or 
ill-health, attitude and belief do play an important role in patients' action toward 
treatment or maintaining certain behaviour. Moreover, patients' attitude and belief 
does not come to shape just by having specific knowledge. However, various factors 
do affect patients' attitude and belief toward health such as other patient experiences 
or health care professional (Hirani and Newman, 2005). However, most of these 
factors served as a guide and motivators whereas they are unlikely to produce lasting 
behavioural changes unless the individual himself developed the means to exercise 
control over their motivation and health-related behaviour (Bandura, 2005). 
Hence, the individual patient himself is the key to the development and successful 
maintenance of health behaviour. Patients should be seen as an active processor and 
interpreter of their environment and belief they hold. Patients who confronted with 
symptom or illness and threat to their health tend to actively consttuct their own 
cognition and belief to conceptualize their condition. Subsequently, this event shape 
up patients' ideas or decision whether to manage their illnesses, then evaluate the 
treatment and seek potential recovery. Patients' cognition has significant role at all 
stages of their illness experiences which include: perception of symptom, searching 
for attribution for the underlying disease, changing personal behaviour to affect the 
course and development of their illness. All this action took place during patient 
undergoing treatment, rehabilitation or making decision to return to normal daily 
activity (Hirani and Newman, 2005). 
The needs to investigate further patients' belief and cognition are in relation to the 
shift in clinical practice to a more patient centred approach where patients' illness 
perception and its implication upon management of their condition are taken into 
consideration during health care. In present, variety of studies has been conducted to 
investigate certain health-related behaviours which enhance health status or prevent 
disease. A great deal of research effort has been addressed towards evaluating factors 
predicting health behaviour. Such information is important not only in designing an 
intervention but also to target such interventions effectively (Edelmann, 2000, p.21 ). 
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A range of psychosocial and environmental factors influenced the likelihood that an 
individual will or will not engaged in certain health behaviour. Thus, numerous 
models (motivation, learning and decision making) have been developed to guide on 
understanding, evaluating factors predictive to health behaviour and developing 
effective behaviour change strategies (Carmody, 1997). 
The theory of planned behaviotu is the dominant theory used to examine predictor of 
behaviour. The model proposed that perceived behaviour control, attitude and 
subjective norm are predictors of individual's intention to perform certain behaviour 
which leads to certain outcomes. On the other hand, question on whether perceived 
behaviour control mediate the effect of power belief on intention has been raised, and 
studies (Courneya, 1995; Nguyet, et al. 1996; Gagne and Godin, 2000) suggested 
that power belief is strongly associated with perceived belief control, while perceived 
belief control is associated with intention (Godin, et al. 2004). In mid 1990s, Social 
cognition models appear most frequently used tnodel in researches aiming at 
predicting and explaining health behaviour. This model described the important of 
cognitions and their intetTelationship in the regulation of health behaviour. Most 
research within this model tries to explain health-related behaviour and it responses 
to treatment (Conner, 1993), people respond to a range of serious illnesses such as 
cancer (Taylor et al. 1984); coronary heart disease (Affleck et al. 1987); diabetes 
(Tennen et al. 1984); and end stage renal failure (Witenberg et al. 1983). Another 
branch of this model tries to examine various aspects of individual's cognitions in 
order to predict future health-related behaviours and outcomes. Most common Social 
Cognitive Models used to predict health behaviour include the health belief model; 
health locus of control; protection motivation theory; theory of reasoned action; 
theory of planned behaviour; and self-efficacy theory. These social cognitive models 
provide the basic understanding of the determinants of behaviour as well as 
behaviour change (Cotmer and Norman, 1995, p.7). 
Foil owing with the expansion of health behaviour models and identification of 
factors predicting health behaviour, a number of research studies have been 
conducted to study the relationship between the performance a range of health 
behaviours and a variety of health outcomes (e.g. Doll and Peto, 1976; Gottlieb and 
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Green, 1984; Cox et al, 1987; Black et al, 1988; Whitehead, 1988; Blane et al, 1990; 
Blaxter, 1990; Marmot et al, 1991; Cox et al, 1993). These studies have 
demonstrated the role and impot1ance of behaviours for both morbidity and 
mo11ality. The impact of health behaviours upon an individual's quality of life has 
been noted and pointed out in several studies (e.g. Fries et a!, 1989; Stroebe and 
Stroebe. 1995). These suppol1 the role of health behaviour in producing a positive 
impact on quality of life via delaying the onset of chronic diseases and extending 
active lifespan (Conner and Norman, 1995, p.3). 
To date, there is also a growing need to develop interventions that are theoretically 
sound and usable in both clinical and community setting. It has been proposed that 
the effect of individual (Lerman, 2003) should be studied aiming to overcome the 
need of developing an effective and efficient intervention which applicable both in 
clinical and community setting (Leventhal et al. 2008). On the other hand such 
interventions should be also effective and efficient to facilitate individual initiating 
and sustaining healthy behaviour for reducing and controlling existing chronic 
diseases. Therefore, the focus should be around understanding the process how 
individual act to detect and manage their chronic condition. 
Not much is known, however, of psychological traits of Malaysian patients that have 
influence health outcotnes of chronic diseases, pal1icularly Hypertension. Research 
looking into the psychological aspects of Hypertension in Malaysia is still in infancy 
stage. Thus, this study highlights the impot1ance of understanding the psychological 
predictor of health outcomes specifically among Malaysia hypertensive patients. The 
finding may prove beneficial to the Malaysian health authorities in their effort to 
develop effective illness prevention, intervention and rehabilitation programmes for 
Hypertension patients in Malaysia. 
31 
2.1 Factors and predictors of health outcomes 
2.1.1 Illness perception 
The initial psychological adjustments following the diagnosis of a chronic disease 
generally involved issue related to a loss of function. Individual at the stage of 
diagnosis confront the reality that their state of health has inexorable changed. In 
other words, patient sees the integrity and function of their body has been limited in 
some way. The speed that individuals confi·ont this sense of loss can be strongly 
influenced by the nature of the illness (Petrie and Moss-Monis, 1997, p.84). 
Patients dealing with the on-going demands of a chronic disease often require those 
learning new skills and adjusting their daily lifestyle. Moos and Schaefer (1984) 
identified three illness-related task faced by patients dealing with chronic diseases. 
This set of illness-related task includes adjustment to the symptom and incapacities 
brought by the illness, dealing and learning special treatment required and 
maintaining adequate relationships with the health-care providers. Furthermore, an 
active awareness and monitoring of bodily function may be necessary in chronic 
disease like hypertension as to avoid complication (Petrie and Moss-Morris, 1997, 
p.84). 
Patient's ability to adjust to chronic diseases can be explained by their individual 
coping responses. The coping process is strongly affected by psychological and 
social influences. Currently, research has begun to investigate the role of the 
patient's own subjective understanding of their illness as a key factor in directing 
coping strategies and influencing adjustment. For example, a patient who belief that 
her hypertension is due to stress at work and who subsequently gives up her job only 
to find that this has made no difference to her level of blood pressure, may revise her 
view of the cause of her hypertension (Petrie and Moss-Morris, 1997, p.84). 
Illness is considered as the subjective experience of a disease or medical copdition 
and the key aspect of that subjective experience is one's illness perceptions. An 
individual's illness perception developed over time from a diverse range of sources 
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includes first-hand experiences with family member or others who suffered the 
similar illness, or from written infotmation or media (Speny, 2007). 
Studies (Lau and Ha11man (1983); Leventhal, et al. (1984, 1992, 2000); Tuck et al. 
(1986); Hampson, et al. (1990); Weinman, et al. (1996)) through triangulation of 
methods have come to a general consensus that patients' illness cognitions can be 
divided into five belief elements which then reflects an individual's perception of his 
or her illness. These five themes have guided the research on patients' belief and 
observe its impact on the health related behaviour. The five themes include: identity, 
causality, timeline, consequences and cure or control. These themes facilitate 
individual making sense of their symptom, assess their health status, take corrective 
action and cope with their medical condition (Sperry, 2007; Hirani and Newman, 
2005). 
Illness perception or cognitive representation viewed as one of the key factors to 
determinant of behaviour directed toward managing illness. The process took place 
when patient's perception and ideas about their illness changed. Patients' views of 
their illness or symptom are rarely sought in medical interview and patients tend to 
ignore, reluctant to discuss and hide it from their doctors. Among the reason is fear 
of being viewed as ignorant or misinformed (Petrie and Weinman, 2006; Speny, 
2007). 
Individual whose been diagnosed with illness or facing ce11ain symptom will 
developed their own cognitive models of their illnesses and this affect or determine 
how the patient respond to it. This cognitive representation or models are based on 
patient medical knowledge or personal experience of others, and it is regards to 
facilitate patient in reducing the threat of the symptoms or illnesses and 
simultaneously help patient to cope with it. Researchers noticed that patients tend to 
generate label to their illness and such symptoms experienced are perceived as 
relevant to their label although the illness may be asymptomatic such as 
Hypet1ension. They tend to use this symptom as a way of monitoring their illness and 
guide medication use (Petrie and Weinman, 2006). For example, hype11ension, as the 
symptoms lay persons identify as signs of hypel1ension are unrelated to tonic levels 
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of this condition. The other factor that has been shown to affect adherence to 
treatment is time-line, or perceived duration of an illness or health threat. 
Study conducted by Meyer et al. (1985) showed that 40 percent of patients initiating 
treatment for hypettension for the very first time believe that it is an acute disease; 58 
percent of these patients drop out treatment within 6 to 9 months in comparison to 17 
percent who believe the disease is chronic (Leventhal and Benyamini, 1997). In 
addition, a study conducted by Ross et al. (2004) indicated patients' belief of illness 
and treatment are interconnected. Belief about specific medications and 
Hypertension are found predictive of compliance. Furthermore, Ross and colleagues 
suggested that the self-regulatory model is useful in assessing patients' health belief. 
The information on health belief is important for an intervention aiming to improved 
cotnpliance. On the other hand, study conducted by Patel and Taylor (2002) 
indicated that despite of having patients' belief as important factors to ensure 
medication adherence, their finding suggested that patients' greater perception of 
control over trying to reduce blood pressure may lead to decrease reliance on 
medication and subsequently non-adherence to medication. 
Nevettheless, illness perception has been perceived as important and gradually 
associated with outcomes in number of illnesses. Patients might have developed 
negative illness perception of their condition and tends to feel less reassured with 
positive outcomes of their illnesses. The formation of a negative illness perception 
might be due to the illness requirement to modify or eliminate of ce1tain lifestyle 
behaviour. Some patient may encounter their negative illness perception by living in 
denial and ignoring their health problem (Wichowski and Kubsch, 1997). Moreover, 
a number of studies had shown that patient who hold general negative illness 
perception of their condition are associated with increased future disabilities and a 
slower recovery. 
A study aims to alter patients' illness perception through a cognitive behavioural 
intervention demonstrated a significant result, whilst patients' ilh1ess perception can 
be successfully altered through a brief cognitive-based intervention (Petrie and 
Weinmann, 2006). Illness perception found to be the best predictor and used to 
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distinguish patients' attendance at cardiac rehabilitation programme (Whitmarsh et 
al. 2003). Gassner eta!. (2002) suppotted the important of including patients' model 
of illness and belief in developing intervention to increase patients' participation in 
rehabilitation programmes. 
Cornwell and Schmitt (1990) suggested that self-esteem, locus of control, perceived 
support, and severity of impairment influenced individuals' perception of their 
illness. Those with positive self-esteem and internal locus of control believed do not 
have negative attitudes toward their illnesses. Frye (1986) found that inner strength 
and intetnallocus of control and level of self-confidence predicting health behaviour. 
The positive of inner strength and internal locus of control and level of self-
confidence stimulate patient to form positive self-concept on their illnesses 
(Wichowski and Kubsch, 1997). 
These structures of illness cognition and the self-regulation model itself provided an 
important framework to study patients' belief and the effect of each category on 
health-related behaviours, particularly in understanding the individual differences in 
patients' longer term adjustment to their condition. In addition, these elements of 
illness belief appear to have predictive power and thus proffer explicit strategies for 
developing intervention (Clark, 2003). 
2.1.2 Self-efficacy 
Self-efficacy is introduced by Bandura in the context of behaviour modification and 
it represents a key construct of social-cognitive theory. Bandura defined self-efficacy 
as an individual's subjective estimation or belief in his or her capability to engage 
and successfully performing particular behaviour task in a particular challenging 
situation. In other words, to ensure cettain behaviour change take place, an individual 
need to form a fmn confidence in their efficacy to increase effort and successfully 
achieve the goal or sustain the behaviour change. Similarly, the outcomes which an 
individual is expecting depend largely on their confidence and belief on their ability 
to perform in the given situation. Two individual who have similar skills might 
perform poorly, adequately or extraordinary depending on the fluctuation in their 
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belief of personal efficacy. In short, perceived self-efficacy is not merely about the 
number of skills one have, but believing in one capability can do with what one have 
under a variety of circumstances (Bandura, 1997). 
Furthermore, there are four principle sources of information that shape up the belief 
in self-efficacy. First is the enactive mastery experiences; secondly, vicarious 
experiences; next, verbal and allied types of social influences; and finally, 
physiological and affective state (Bandura, 1997). 
Perceived self-efficacy is seen as functional at different levels and point in time 
within a self-regulatory goal attainment process. Marlatt et al. (1995) introduced two 
self-efficacies phase-specific to represent these function which are: action self-
efficacy and coping self-efficacy. Individual who are high in action and coping self-
efficacy might responds positively to a new behaviour, anticipate potential outcomes 
of diverse strategies and take initiative to try to adopt a new behaviour. But those 
with low action and coping self-efficacy might imagine failure scenarios, harbour 
self-doubts and procrastinate (Schwarzer and Renner, 2000). 
Perceived self-efficacy (Bandura, 1992b, Schwarzer, 1992) is an important 
determinant of health promotive behaviour. There are two levels at which self-
efficacy plays an influential role in individual life: first level is where people's 
beliefs in their capability to cope with the stressor in their lives activate biological 
systems which then mediate health and disease. The second level is concerned with 
the exercise of direct control over the modifiable behavioural aspects of health and 
rate of ageing. In order to build people's sense of efficacy, then specific skill have to 
be developed to influence motivation and behaviour. In other words, individual will 
learn to monitor the behaviour they seek to change, set an attainable goals and direct 
effort to sustain the effort needed to succeed (Bandura, 1997). 
Study by Walker (2004) demonstrated that illness perception has a significant 
relationship with self-efficacy. The outcome of the study indicated that a patient with 
greater perceived consequences of their illness or condition has a lower self-efficacy 
to cope with their condition. Further, the longer patients' perceived time of illness or 
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condition, the higher the specific self-efficacy to maintain changed behaviour such 
diet control and performing exercise regularly. Walker (2004) in his study on self-
efficacy in relation to outcome expectancy demonstrated that efficacy had direct 
impact on intention and indirect impact through its effects on outcomes expectancy. 
In other words, the more efficacious people were the more positive the outcomes are. 
The study employing Social Cognitive Theory construct show a promising outcome 
and positive implication for developing intervention aiming at increasing the 
likelihood for individual to perform healthy activities. 
In health perspective, self-efficacy has been link with the adoption and performance 
of health behaviours and considered as a vital element of the behaviour change 
process. Studies (Strecher et al. 1986; Forster and Jeffery, 1986; Wadden and 
Letizia, 1992; Brownell and Cohen, 1995; Byrne, 2002; Linde et al. 2004; Martin, et 
al. 2004) on weight control have considered self-efficacy as an important mediator or 
predictor to successful weight loss or change behaviour and enhanced weight loss 
programme experiences. A study by Linde et al. (2006) identified that self-efficacy 
prospectively predicted weight control behaviour and weight change during active 
treatment, but not at follow-up. Other studies (Anderson et al. 2000; Resnicow et al. 
2000; Schwarzer and Renner, 2000; Schnoll and Zimmerman, 2001; Burke, et al. 
2007) associated self-efficacy with physical activity, changes in dietary fat 
consumption (Steptoe, et al. 2000; Liou, D. 2004), dietary behaviour and 
cardiovascular nutritional education (Carson, et al. 2002; Linde et al. 2006). Bane et 
al. (2006) and Lennon et al. (200 1) studied determinant of adherence among 
hypertensive patients and both studies demonstrated that self-efficacy is associated 
with adherence to medication. Further analysis with Theory of Planned Behaviour 
constructs revealed that adherence was predicted by intention and subjective norm, 
while intention was predicted by attitudes and perceived behavioural control. The 
study supported the use of self-efficacy and Theory of Planned Behaviom· in 
predicting medicine adherence. 
The role of self-efficacy in predicting health behaviour has been revised by 
Rosenstock et al. (1988), whereas self-efficacy always been interpreted as a ban-ier 
to engaging in ｰｯｳｩｴｩｹｾ＠ }lealth behaviours. Therefore, Schwarzer, (1992) has specified 
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self-efficacy as both a mediator of intentions and a direct predictor of action 
(Wallston, 1997). Schwarzer and Renner (2000) specified risk perception, outcomes 
expectancies and action self-efficacy as predictors of intention at wave 1. 
Behavioural intention and coping self-efficacy serves as mediators linking the three 
predictors with low-fat diet and high-fibre dietary intake at 6 months later (wave 2). 
Furthermore, the study also indicated perceived self-efficacy increased with age and 
weight. 
The Transtheoretical Model (Prochaska and DiClemente, 1983; 1984) proposed that 
self-efficacy as one of the key predictors of transition between the stages of change 
and changes itself. The pros and cons and self-efficacy in intetTelated in tnediating an 
individual to move from one stage to another stages of change (Armitage, et al. 
2004). 
Thus, self- efficacy was found significantly correlated with quality of life and also 
counted as one of the key factors that influencing the quality of life of patient with 
chronic illness (Han, eta!. 2003 ). 
2.1.3 Health locus of control 
Most of the research that has been done to examine the linkage between perceived 
control and health behaviour were based on two major social learning theories: locus 
of control (Rotter, 1966) and self-efficacy (Bandura, 1977). The perception of 
control over the behaviour in certain situation does not necessarily can be 
generalized to other behaviours or situation (Wallston, 1997). The individual's 
perception of control is associated with whether or not a person engages in some 
form of health behaviour. Perception of control refers to the subjective detennination 
of the ability to determine or influence behaviour or consequences of the behaviour. 
For example, a person's belief that he or she can choose whether or not to go to 
doctor, and even, select which doctor to got to, or, he or she can improve his or her 
health status by going to the doctor for a check-up. Theoretically, the more people 
perceives control of their behaviour or consequences, the more likely the person is to 
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engage in the behaviour in question all other things being equal, and as a result, they 
will have a better health status(Wallston, 1997; Norman and Bennett, 1995). 
The work related to locus of control can be traced back to Rotter (1954) where 
described it as a generalized expectancy relating to the perceived relationship 
between one's actions and experienced outcomes. Then, he divided locus of control 
into two: internal locus of control related to one.'s own action and under personal 
control, whereas external locus of control are control by factors beyond one's 
personal control (Notman and Bennett, 1995). Such control are learned tlu·ough 
experiences in a variety of situations and thought to be stable over time. Thus, it is 
mostly utilized in many earlier studies (Wallston and Wallston, 1978; Strickland, 
1978; Lavenson, 1973, 1981; Long et al. 1988) as an independent or predictor 
variable. 
The concept of control has widely studied and a few instruments have been 
developed served to measure the patient's level of control of their illness and 
behaviour. It is also important to differentiate between patients' perception of their 
control over their illness to their perception of control that health care provider have 
over their illness. The ability of the patients to take up control over their health 
behaviour is significant in relation to behaviour change (Hirani and Newman, 2008). 
The locus of control, particularly high internal locus of control was associated with 
reduced risk for chronic diseases such as myocardial infarction, seeking more 
information regarding health problems, successful in stop smoking and maintaining 
exercise programme, and compliance (Nagy, et al. 1984; StUnner, et al. 2006). 
Locus of control was first measured using internal-external scale developed by Rotter 
(1966). Reviewing the early work (Strickland, 1978; Wallston and Wallston, 1978) 
using this scale in relation to health behaviour demonstrated that those with high 
internal locus of control is more likely to exert effort to control their environment, to 
take responsibility for their actions, to seek out relevant information, exhibit better 
learning and to show more autonomous decision making (Norman and Bennett, 
1995). 
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Despite of the successful outcome demonstrated by Rotter's Internal-External Scale, 
on the hand, it was found that the variance in health behaviour was typically low 
when using the scale. This situation leads to the needs to develop of situation or 
domain-specific locus of control measures. Argumentation made by Levenson (1974) 
on internal and extetnal locus of control supported the need to develop 
multidimensional locus of control measures. As a result of this criticism, Wallston 
and his associate (1978) has developed health locus of control measure which 
applicable to explain individual differences in health behaviour and health status. 
Early studies (Lau, 1988; Wallston and Wallston, 1981, 1982) utilizing Health Locus 
of Control measure found that those valued health and scored high or low on HLC 
were correlated with various indices ofhealth behaviours (Wallston, 1997). 
The Multidimensional Health Locus of Control (Wallston et al. 1978) measure 
generalized expectancy belief with respect of health across three dimension: first 
dimension measures the extent to which individual believes their health is a result of 
their own action (internal health locus of control); second dhnension measure the 
extent to which individual feel their health is under the control of powerful others 
(powerful other health locus of control), and the third dimension measure the extent 
to which individual believe their health is owing to chance or fate (chance health 
locus of control) (Norman and Bem1ett, 1995). 
The Health Locus of Control theory predicted that internal HLC beliefs should have 
strong association with the performance of preventive health behaviour on a general 
level than with specific behaviours. A mixed of positive and negative result 
discovered from studies on relationship between intetnal HLC beliefs and indices of 
preventive health behaviours. Much literature demonstrated that internality is good 
(Allison, 1990), whilst having strong belief on the role of powerful other HLC would 
be an advantage particularly in acute or chronic illness (Wallston, 1989). Powerful 
others HLC may be predictive of health behaviour if recommended by health 
professional, but powerful others HLC may be unrelated to health behaviour if 
individual choose to advocate self-initiated behaviour change. The Chance HLC, on 
the other hand, provides a minor reflection of the internality dimension where 
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individual with strong chance HLC believed to be less likely to engage in health-
related behaviour (Norman and Bennett, 1995). 
2.1.4 Depression and anxiety state 
Recent works (Jonas et al. 1997; Dimsdale et al. 1997; Barringer et al. 1997; 
Bowman et al. 1997; and Shuster et al. 1997) provided evidence on the prospective 
correlation between negative affect such as anxiety and depression with hypertension 
development. Furthermore, studies on negative affect did show a significant link 
between anxiety and depression with gender and race (Jonas and Lando, 2000; 
Levenstein et al. 2001 ). The prospective association between anxiety and depression 
and Hypertension development was supported by a review of prospective cohort 
studies over 1 year follow-up (Rutledge and Hogan, 2002). 
2.1.5 Demographic variables 
The association of Hypertension prevalence with various demographic variables are 
well established in numerous studies conducted in the west and Malaysia in 
particular. The area of study varied, ranging from epidemiological perspective to the 
treatment and control of Hypertension. Most of these studies pointing out factors that 
associated with low-controlled or non-adherence to treatment for Hypettension. The 
degree of awareness and control appeared to be affected by sociodemographic factors 
(Barker, et al. 1998; Rossum, et al. 2000). On the other hand, little is known on 
demographics variables that able to predict or classify a patient who has controlled 
Hypettension, patticularly among Malaysian hypettensive patients. 
A part from all the psychological factors or predictors of health behaviour that has 
been highlighted in various previous studies, adding to it is the demographic 
characteristics of a patient. This factor has been proven to have a significant impact 
on individual effort to engage in certain health behaviour, for instant physical 
activity. Study on predictors of physical activity among older hypertensive patient 
has indicated the demographic variables that have directly predicted physical activity 
were gender and income, while other factors such self-efficacy, previous exercise 
41 
experience, perceived health status, barrier to physical activity and motivation have 
indirectly predicted physical activity. Hence, the engagement of a patient in regular 
physical activity is affected by these three factors: individual characteristics, 
interpersonal and environmental factor. Including all these three factors and their 
interaction are important in finding ways to intervene and assist hypertensive patient 
in initiation and maintenance of regular exercise (Lee and Laffrey, 2006). 
The following review emphasizing a number of detnographic variables which 
statistically significant associated with either risk of developing hypertension or 
uncontrolled and non-adherence to anti-hypertensive treatment. So, the ability of an 
individual to manage their health problem and thereby control the symptoms is 
proven to be depending on age and type of diseases. No doubt, aged has a significant 
association with the increase risk of developing Hypertension. Study conducted by 
Casson and Godwin (2003) might enlighten the important of including demographic 
variables as one of the predictors to health outcomes. Two epidemiological studies 
using National Health and Nutritional Examination Survey data between 1988 to 
2004 among American hypettensive adults shows that Hypettension control is 
continuously deteriorating especially among non- Hispanic blacks and Mexican 
American, co-morbid medical condition, wotnen, aged 60 years and older was found 
to have significantly low rates of controlled as compared with men, younger 
individual and non-Hispanic whites (Hajjar and Kotchen, 2003; Ostchega, et al. 
2007). Study to determine risk factors among Malaysian hypertensive patients 
conducted by Mohd Yunus, et al. (2004) also pointed out the significant association 
of gender and age with the prevalence of hypertension and obesity. 
Hyman, et al. (200 1) highlighted demographic variables like age, gender, and 
ethnicity as independent predictors of a lack of awareness among hypertensive 
patients, in addition the same variables also associated with poor control among 
those aware of their condition. Study conducted by Hashmi, et al. (2007) suppotted 
that factors (younger age, poor awareness, and symptomatic treatment) associated 
with adherence to anti-hypertensive treatment among Pakistani patients. 
Furthermore, the investigator suggested the finding would be beneficial to cluster 
group who are at risk of low adherence and required intervention to achieve better 
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control and hence prevent complications. Another study associating age and 
education level with the decision to quit smoking following a heart attack. Using 
longitudinal data to track changes and the investigators found that the decision to quit 
smoking among middle-aged adult following the experience of hea11 attack is 
significantly moderated by the level of educational attainment (Wray, et al. 1998). 
Armitage et al. (2004) reported that demographic factor; age in particular, has a 
longitudinal predictive validity in relation to the regression or progression of 
individual from all stage of change of Transtheoretical Model. Older individual is 
likely to progress while the younger individual tend to remain static across the stage 
of change. Study conducted by Steptoe et al. (1996) demonstrated that women and 
married are dominant in the maintenance stage than those in the single or divorce or 
widow category. No association were found among men in term of marital status and 
stage of change, while men are dominant in precontemplation stage. 
On the other hands, study by Maino us et a!. (2004) indicate that locality do play a 
role in determining the intensity that a patient have to control their Hype11ension. 
This study found that the rural African American samples are at increased risk for a 
lack of control of diabetes and Hypel1ension. The outcome of this study was 
consistent with Chang, et al (2003) where Chang and his colleagues found that those 
rural populations has greater difficulty in avoiding risk behaviour and engaging in 
health-related behaviour. King and Crisp (2006) also found that gender and locality 
factor (men and urban locality) are strongly associated with poor blood pressure 
control among outpatients. The investigators suggested that intervention should be 
targeting this group of population. Kramer, et al. (2004) recommended that 
hypertension treatment and control programme should focus and considered patients' 
variations in term of their ethnicity and background. 
To date, there is no definitive exploration been done to predict factors constitute a 
"good" disease management or "good'.' controlled of disease in the general 
population of patients. There is no clear pattern of variables that described a "good" 
disease management is investigated. Review on studies (Clark, et al. 1999; Altobelli, 
et al. 2000; Gregg, et al. 2001) detnonstrated no common features or factor lead to 
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monitoring of chronic illness such as diabetes. However, some studies (Scorpiglione, 
et al. 1996; Karter, et al. 2000) only highlighted statistically significant factors that 
associated with failure to monitoring glucose level atnong diabetic which are: 
patients had been diagnosed for a longer period of time, male, younger age (less than 
50 years old), low income, ethic minority group, complicated regime, difficulty in 
handling insulin and have difficulty to converse in English (Clark, 2003 ). 
Based on the review made above seem that there is limited or none available 
literature discussed demographic variables which possibly predict the initiation of 
any health-related behaviour to Hypeliension. Mostly, factors outline discussed those 
increase risk of developing hypertension or factors affecting low-controlled or non-
adherence to anti-hypettensive drug. Viewing this gap, again this study address the 
need to be conducted which aiming to determine related demographic variables 
which had strong quality of predicting health outcomes among Malaysian 
hypertensive. 
2.2 Psychological aspect of hypertension Intervention 
The review on self regulation, self-efficacy atld health locus of control was 
highlighted to raise questions and suggestion for innovative approaches for 
intervention that will meet the criteria for effectiveness atld efficacy. In other words, 
the intervention which is simple or less complicated, less time consuming and skill 
by practitioner and patients. There is a lot of evidence that support and also had 
doubt as to the feasibility of achieving these two goals: efficiency and effectiveness. 
Webb and Sheeran (2006) suggested that intention and/or plan of action are effective 
for crossing the gap between intention to action for simple and one-time behaviour, 
but ineffective for complex and time consuming behaviour that prevent and chronic 
diseases such as exercise and dietary change. 
Moderate levels of success have also been reported for behavioural intervention for 
control of chronic illnesses that employing social leatning fratnework. But current 
social learning interventions were not adequately considered how patients and their 
medical practitioners represent illnesses and how the treatment experience fit with 
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the patients' representation of their chronic conditions. The success of an 
intervention progrru.nme, for instant, diabetes and hypertension intervention has 
detnonstrated a mixture of negative and positive outcomes. 
The development of behavioural management for particular diseases required the 
addition of concept to self-regulation theory generated from observations in the 
clinics and community. Dunbar (2007) stated that this may entail changes as simple 
as identifying the invalid subjective cues that patients use to guide self-management 
and developing behavioural procedures that teach them to ignore subjective targets 
and use objective indicators e.g. blood pressure to guide self-management. Such 
issues need to be considered in order for effectiveness of the intervention may be 
improved substantially. 
Investigators have recognized the need to improve the effectiveness and efficiency of 
an intervention. Kraemer et al. (2002) has pointed that interventions targeting 
specific subgroup of participants are potentially more effective and efficient than 
intervention using common methods for all participants. 
Other simple procedures may involve reframing the behavioural intervention that is 
implemented to insure that patient able to see their symptoms as part of their chronic 
illness and not as separate and unmanageable illness. 
Self-management education progratnme is relatively providing rather lhnited 
evidence on its benefit to lower blood pressure. Such programme was rarely used 
among elderly patient because the assumption that these group of patients are 
unwilling to engage in health promoting behaviour, though there is no clear 
justification for it. The most challenging issues in health education ru.·e helping 
patients to make a long-term lifestyle changes. Currently, the evidence on the way 
education is implemented is widely discussed because it could be impottant in 
helping patients to engage in a long-term and difficult lifestyle changes. Therefore, a 
comparison study was conducted to determine either patient -empowerment model or 
compliance-based model is most effective in helping patients to change their 
lifestyle. The study result indicated that self-management educational model 
45 
(Patient-empowerment model) was significantly more effective than the compliance-
based n1odel in blood pressure control (Figar et al. 2006). 
Cun·ently, the research on understanding the effect of an intervention designed to 
enhance management by the patient is limited. Some of the studies utilizing a 
randomized controlled trial with a small number of participants (between 20 to 30 
patients); and implementing a short follow-up periods (between 4 months to 6 
months). Such short period of assessment is inadequate given the duration of most 
chronic conditions. A review by Clark (2003) based on thirteen studies and listed out 
three itnportant evidences in relation to the association of interventions and patient 
outcomes. Firstly, a successful programme should be based on a theoretical 
understanding of human behaviow· and mode of changes. The approach used in the 
intervention is self-regulatory, behavioural control techniques and peer group 
influence and reinforcement. Secondly, the review point out that different 
intervention produces different outcomes, although some interventions produced 
desirable outcomes, there was no optimal amount of education that could inferred as 
necessary to produce outcomes. No data available regarding either the needed 
intensity or duration of an intervention. Furthermore, evidence suggested that 
intervention should be conducted as intended rather than be adapted with no further 
evaluation. Thirdly, the potential success of an intervention where emphasis was on 
the process by which patients can develop appropriate strategies based on their 
condition and implemented outside the clinical setting such as community centre or 
at home. But, literature on the evaluation of intervention outside clinical setting is 
small relative to clinical-based intervention. 
The Malaysian intervention programme targeting chronic diseases, specifically 
Hypertension, was formulated on the basis of the need of developing an intervention 
served to decrease the morbidity and mortality due to the disease. The recruitment 
and implementation was conducted based on general referral by various clinical 
disciplines and no proper evaluation to assess the successful of control by the patient 
was conducted on long-term or short-term basis. Theoretical wise, the intervention 
programme does portrays the used of health models such as Proceed-Precede models 
in the developmental stage of the intervention but, nothing much was dictate on how 
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much does the model has successfully assist in the achieving the objectives outline 
before. Furthermore, the content of the intervention was somewhat generic and it is 
more of a one-off kind of activity without considering the patients' actual needs. The 
short-fall of this kind of intervention might be due to the shortage of skilled health 
personnel to conduct the intervention, limitation in time and space and other logistic 
matter which related to the patients themselves does not been addressed clearly. 
This lhnitation leads to the needs of determining ways to improve such standard 
intervention programme through providing suggestion and recommendation 
accordingly. 
Research looking at the psychological determinants of health outcomes of 
Hypertension is widespread. Various health behaviour models such as social 
cognitive model, theory of plan behaviour, theory of reasoned action and health 
belief model has been widely used in the attempt to explain the relationship between 
psychological factors, health and illness behaviours related to Hypettension. The 
predictive utility of these models is supported by many findings in the health 
literature. However, apart of it predictive utility of different health behaviour of 
chronic diseases, most of this models are not exempted from their limitations. The 
models limitation is widely discussed in tnuch literature regarding those models. 
Therefore, model which is tnore versatile in its utilization and placing management 
of the illness by the patient into a conceptual framework is selected and adapted into 
this study. The utilizing of this selected model aims to achieve better understanding 
of different predictors which influences health outcomes and what can be considered 
as better controlled of Hypetiension among Malaysian hypertensive patients. 
Three main theoretical frameworks were adapted into the present study which is 
Leventhal's Self-Regulatory model, Bandura's self-efficacy model and Wallston"s 
health locus of control. These models has received a substantial tribute in respect of 
it efficacy as a fran1ework to understand patients illness and health behaviour and its 
role in the enactment of different health behaviour. 
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The present study acknowledges the importance of including psychological variables 
such as illness perception, health locus of control, self-efficacy and depression and 
anxiety state variables as a predictor in the attempt to predict health behaviours and 
outcomes in relation with Hypertension. However, if any, the limitations mentioned 
above also taken into consideration. Thus, in an attempt to determine the predictors 
of psychological and health outcomes of Malaysian hypertensive patients, this study 
also includes demographic variables found to be significant predictors of 
Hypertension-related outcomes, based on the above literature review. 
In short, illness perception, eating and exercise self-efficacy, health locus of control, 
general depressive and anxiety state and quality of life are predictors of health 
outcomes of Hypertension. Some of these predictors are cognitive in nature, whilst 
others are social or emotional. Some are stable across time and conditions, whilst 
others are situational-specific, fluctuating in frequency and intensity. Several of the 
factors directly influence illness outcomes; others act as mediators. As many studies 
had shown, the predictive and causal patterns of psychological variables on the 
physical, psychological and social functioning are not conclusive. In order to explore 
the predictive power of different psychological variables on the outcomes of 
Hypertension, the following model was developed; incorporating several variables 
used in the model as well as other psychological constructs not included in the model 
but deemed important and applicable to Malaysian context. (see Chapter 3) 
The review based on the available literature on factor and predictors to engagement 
of health behaviour seems to dictate that there is no clear characteristic or factors or 
predictors which deliberately highlighted attributes of a patient do better while other 
do not after attending any intervention, specifically Hypertension. Most of the studies 
discuss factors or predictor associated with the possible initiation of specific health-
related behaviour. Therefore, the gap discovered in this perspective given this study 
the opportunity to explore further the factor that constitute or uncover the reason for 
some patient undergo certain intervention did in some way improve their health 
outcome, while other do not. Moreover, this study also revealed specific quality or 
factor or predictor of health outcome specifically relevant to the Malaysian 
hypertensive context. (see Chapter 4) 
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2.3 Hypothesised psychological predictors of health outcome among Malaysian 
hypertensive patients. 
Based on the review above two research questions were fotmulated for this study. 
The frrst research question was to determine which psychological predictors were 
associated with changes in health outcomes among Malaysian hypet1ension patients 
after attending a standard intervention programme. A set of psychological predictors 
was selected based on previous studies as these were assumed to be associated with 
changes in health outcomes among Malaysian hypertensive patients (see Figure 2.1). 
The psychological predictors were illness perceptions, eating and exercise self-
efficacy, health locus of control, general depressive and anxiety state and patients., 
demographic characteristic. These predictors were hypothesised to be the 
detetminants of changes in health outcomes assessed at Time l, Time 2 (immediately 
after intervention) and Time 3, six months after the intervention. Then, a further 
study was conducted to explore in detail the determinants of successful control of 
hypet1ension among Malaysian hypertensive patients. The results obtained from the 
first study were used to formulate second research question; why do some 
hypet1ensive patients successfully control their Hypet1ension while others do not 
after attending an intervention programme? 
In order to ensure that the overall study objectives were achieved two studies were 
conducted to address the research questions. The methodological description of both 
studies can be reviewed in Chapter 3 and Chapter 4. Data obtained from Study 1 and 
Study 2 are combined, analysed and discussed with a view to getting a more fulsome 
understanding of the ways in which the intervention works. 
Chapter 3 addresses the longitudinal relationships between predictors and health 
outcome variables presented in the model. Research questions derived from the 
model were formulated for this first quantitative study. Finally in Chapter 4, an in-
depth exploration through an interview study approach explored the determinants of 
successful control of hypertension among Malaysian hypet1ensive patients. This was 
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achieved by interviewing both 'successful' and 'unsuccessful' patients and exploring 
their understandings of the intervention. 
Chapter 5 consists of an overall discussion of the finding presented in Chapters 3 and 
4 and discusses the implications for future interventions and future directions for 
research. 
5o 
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t Psychological Predictors 
Illness perception Health locus of control Self-efficacy Depression and anxiety state demographic 
I I I 
Changes in Health outcomes 
Quality of life Cognition (illness perception/ knowledge of condition) Emotion Behaviour Clinical indicators 
Figure 2.1 Hypothesised Model ofPredictors of Health Outcomes among Malaysian Patients Attending Standard Hypertension Intervention Programme 
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CHAPTER3 
STUDYl 
PSYCHOLOGICAL PREDICTORS OF HEALTH OUTCOME AMONG 
MALAYSIAN HYPERTENSIVE PATIENTS: A 
LONGITUDINAL STUDY 
Aim 
The aim of this longitudinal study is to determine psychological predictors of health 
outcomes among hypertensive patients in Malaysia. To date, no psychological study 
of this kind has been conducted in Malaysia. There is no published literature 
available to determine the psychological predictors related to health outcomes and 
identify the factors that motivate or stimulate the control of I-Iypertension and/or 
other related chronic diseases in Malaysia. Much less is known as to whether the 
established psychological predictors found in the Western population studies can be 
replicated among the Malaysian population. 
The focus of tllis chapter is to report the fmdings of Study 1 which looked at the 
association between psychological predictors and health outcomes among Malaysian 
patients across three periods of time: Time 1, Time 2, and Time 3 after co1npleting 
the intervention programme. 
3.0 Research questions 
1. Are there significant different in mean score of physical and medical indices 
between Time 1, Time 2 and Time 3 among intervention group? 
2. Are the mean score of physical and medical indices significantly different between 
intervention and waiting list control group at Time 1 and Time 3? 
3. Are there significant different in mean score of the psychological measures 
between Time 1, Time 2, and Time 3 among intervention group? 
4. Are there significant difference in mean scores on psychological measures 
between intervention group and control waiting list group at Time 1 and Time 3? 
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5. Is there a significant association between changes in patients' physical and 
medical indices and the psychological predictors within intervention group? 
3.1 Methods 
3 .1.1 Pa:tticipants 
The pru.ticipants were a convenience sample recruited from the Outpatient 
Department of two cotnmunity health centres: Mosque Road Cotnmunity Health 
Centre and Tanah Putih Community Health Centre, Malaysia. The patient list and 
contact numbers were made available by the medical assistant in charge of the 
Outpatient Department in each of the two health centres. Eligibility criteria included 
patients with a first diagnosis of essential hypertension, aged 30 years and over, who 
had been prescribed at least one anti-hypertensive drug or non-pharmacological 
treatment, were not suffering from any other physical or mental disability which 
would make it difficult for them to complete questionnaires, had never been referred 
to a hypertension education progratnme and had voluntarily agreed to patticipate. 
3 .1.2 Number of participant 
A review of previous studies that have tried to predict health outcomes after similar 
interventions (Michie & Abraham 2004; Rutledge & Loh 2004; Wallace et al, 2005) 
have tended to find effect sizes of R2s around 0.25 with a range of 0.2 to 0.40. Given 
this, an a priori power calculation suggests that a sample size of 34 should be able to 
detect a similar sized effect (R2=0.20) in the present study with a power of 0.8 (2-
tailed, alpha=0.05). In order to maxhnise the study's power it is anticipated that more 
than 34 people rectuited during the recruitment period. 
3 .1.3 Design and procedure 
Study 1 was a longitudinal study assessing predictors of health outcomes among 
Malaysian hypertensive patients over three occasions: before attending the standard 
intervention programme (Time 1 ), one month after completing the programme (Time 
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2), and six month after the intervention (Time 3 ). All eligible patients were screened 
based on their medical history to exclude patients registered more than six months 
before the study commenced. Infortned consent was obtained from each patient as 
for them to participate in the study. Potential participants were briefed on the aims of 
the study after informed consent was given. Then, the study information pack and 
baseline questionnaires were distributed and had to be completed before attending 
the first session of the intervention programme. Baseline clinical information about 
the blood pressure, weight, height and Body Mass Index (BMI), lipid profile and 
renal function profile were obtained from the patient outpatient card. 
A randon1ized control trial was initially planned to be conducted in for this study as it 
the method of choice for evaluating intervention study. However, due to a lack of 
cooperation from the health personnel at of one of the health centre which limited the 
number of patients recruited, there was a setback in initiating a proper randomized 
control trial. As an altet·native all selected participants recruited were grouped into 
one group and attending the standard patient education programme developed by the 
Malaysian Ministry of Health. Using this standard teaching module, a nurse 
educator, dietician and physiotherapist conducted four hour-long sessions of small-
group intervention for hypertensive patients. The content of the four-sessions 
includes: the nature of hypertension, risk factors and complication, medication, diet 
and the importance of healthy diet and exercise. Patients were assessed after they had 
completed all fom· sessions, approximately at week five. The same set of 
questionnaires was completed where second physical and clinical information was 
gathered. All participants were reassessed at six tnonths after the second evaluation 
was conducted. 
Recruittnent of patients was conducted over two periods: first recruitment conducted 
between November to January 2006 and second recruitment conducted between July 
to August 2007. Among the reason of recruiting another group of patient between 
July to August was the small sample size which could not allow for confident 
statistical analysis. This new group of participants was subjected to the same 
intervention as the initial group. But, due to some logistic problem in getting this 
new group of participants to join the intervention programme, the time gap between 
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the new and initial patient recruitment and time allocated to investigator to be in 
Malaysia again created a setback to the study design. Hence, the new rectuited 
patients did not attend the standard intervention programme and were classified as a 
waiting list control group. 
3 .1.4 Materials 
The study data was collected through a set of tneasures which was originally 
formulated in English. These measures were back-translated by two bilingual 
translators into Bahasa Malaysia and these were the version used in the field study. 
3.1.5 The Questiom1aire: selection and cdteria 
The questionnaire consisted of eight sections: Eating Self-efficacy Scale, Exercise 
Self-Efficacy Scale, and Shott Form Quality of Life Questionnaire for Arterial 
Hypertension, Illness Perception Questionnaire for Hypertension, Multidimensional 
Health Locus of Control, General Health Questionnaire -12, Sociodemographic 
information, and physical and clinical information. (See Appendix 1 for a copy of the 
Study 1 questionnaire). 
The selection of the appropriate measures for assessing the study construct was based 
on the following prerequisites: (1) scales with consistently high reliability and 
validity as assessed in previous studies in the West, with alpha coefficient of .06 or 
more; and (2) scales that have been widely used in general and clinical settings. 
a. Illness Perception Ouestiom1aire for Hypertension 
The Illness Perception Questionnaire (IPQ-R) (Weinman et al., 1996) was developed 
based on Leventhal's Self-Regulatory Model (Leventhal et al., 1984, 1997) to 
provide quantitative assessment of six cotnponent of ilh1ess representation: identity, 
consequences, timeline acute/chronic, timeline cyclical, illness coherence and 
emotional. This scale was widely used in studies of illness adaptation in patients with 
a wide range of conditions: heart disease (Cooper et al., 1999; Petrie et al., 1996; 
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Steed et al., 1996), rheumatoid arthritis (Murphy et al., 1999; Pimm and Weinman, 
1998; Scharloo et al., 1999), psoriasis (Fortune et al., 2000; Scharloo et al., 2000a), 
diabetes (Griva et al., 2000), chronic fatigue syndrome (Heijmans, 1998; Moss-
Morris et al., 1996; Moss-MoiTis et al., 2002). 
The scale was divided into three sections: identity, illness representation and causal 
dimension. The first section consisted of cotnmonly presented symptoms of 
hypertension where patients were required to rate based on their experienced of the 
symptom since being diagnosed with their illness using a yes or no response format. 
Then, patients were asked to rate whether those symptoms were specifically related 
to their illness using the same fonnat. The sum of the "Yes" rated items on the 
second rating section forms the illness identity subscale. This section measured the 
patient's awareness of the link between their symptotns and hypertension by 
tnatching the symptom to an illness label. The following section consisted of six 
dimensions of illness representation: identity, consequences, timeline acute/chronic, 
timeline cyclical, illness coherence and emotional, rated using 5-point Likert scale 
which ranging frotn "strongly disagree" to "strongly agree". Two new items were 
included in this: an emotional representation subscale used to tap six affective 
responses which sensitive to differences in illness perception and predict health-
related responses such as seeking medical care; and secondly, illness coherence items 
assessing patient's awareness of or knowledge about their illnesses. The third section 
of the scale represents the causal dimension of illness perception and it was rated 
using the same Likert scale fonnat (Moss-Morris et al., 2002). 
The scoring of the IPQ-R was: high scores on the identity, timeline, consequences 
and cyclical items represent strong belief about number of sytnptoms attributed to the 
illness, chronicity of the condition, the negative consequences of the illness, and the 
cyclical nature of the condition. On the other hand, higher scores on the personal 
control, treatment control and coherence dimension represent positive beliefs about 
the controllability of the illness and a personal understanding of the condition. 
56 
·.....;._ . 
b. General Health Questionnaire- 12 
General Health Questionnaire 12 (GHQ-12) (Goldberg, 1978) is a commonly used 
instrument to detect . independent verifiable psychiatric morbidity (anxiety and 
depression) that may affect the patients' perceived quality of life (Bowling, 2001, p. 
85). It is widely used in Western countries and has been validated for use an1ong 
patients in Malaysia. The degree of internal consistency was excellent with 
Chronbach's alpha value of .37 to .79 (Quek et al., 2001). 
c. Multidhnensional Health Locus of Control Questionnaire 
The Multidimensional Health Locus of Control scales (MHLC) (Wallston et al. 
1978) are widely used to characterize an individual's belief about control over health 
outcomes (Anderson et al. 1994). MHLC scales consists of 18 items and it measures 
three dimensions: internal health locus of control (six items); powerful other locus of 
control (six items); and chance locus of control (six items). Two sets of MHLC 
scales were distributed and completed by all study patients: Fonn B was used to 
assess patients with chronic illnesses general health locus of controls, while Form C 
was pat1icularized to patients' diagnosis which is hypertension. Generally, MHLC 
was moderately reliable with Cronbach alphas .67 to .77 for all six items of the three 
dimension and two parallel forms. The test-retest coefficients of the scales ranged 
from .60 to .70. For scoring purposes, all items are rated based on five-point Likert 
scales ranging from 'strongly agree' to 'strongly disagree'. Scores for each subscale 
are sum together making total score and higher scores reflect externality (Corcoran 
and Fischer, 2000, p.495). 
d. Eating Self-Efficacy Questionnaire 
The Eating Self-Efficacy (Glynn and Ruderman, 1986) was developed based on 
Bandura's Self-efficacy Model which conceptualizes individual's perceived ability to 
perform a task as a mediator of future task performance. The scale consists of 25 
items that assess an individual's self-efficacy regarding eating or overeating 
behaviour. The scale was divided into two subscales: eating as a function of negative 
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affects (NA 15 iten1s) and eating as a function of socially acceptable circumstances 
(SAC 10 items). The Eating Self-efficacy scale has highly satisfactory internal 
consistency with coefficient alphas .92 for the whole scale; .94 for Negative Affect 
subscale and .85 for Socially Acceptable Circumstances subscale. The scale also has 
very good stability with test-retest reliability of .70 (Glynn and Ruderman, 1986). 
Patients were asked to rate their eating efficacy from 1 to 7 based on the difficulty 
level they faced when controlling eating behaviour under various circumstances 
listed. The rating classification ranged from 1 (No difficulty controlling eating) 
through intermediate degree of difficulty such as 4 (Moderate difficulty controlling 
eating) to complete difficulty in controlling eating at 7 (Most difficulty controlling 
diet). The scale is scored by adding up item scores for subscale scores and summing 
all items for a total score. The mean scores overall Eating Self-efficacy is obtained 
by sumtning all scores and dividing by 25 items. The mean scores for individual 
subscale are obtained by summing item scores and dividing by number of items. The 
interpretation of the scores: the higher the scores, the greater the problem with self-
efficacy for eating (Corcoran and Fischer, 2000, p.273). 
e. Exercise Self-Efficacy Questionnaire 
Exercise self-efficacy scale (Bandura, 1997) consists of 18 items with a unipolar 
scale ranging from 0 percent to a maxitnum strength of 100 percent. Patients were 
rated from 0 to 100 percent based on how confident they were in performing exercise 
routines regularly (three or more tin1es a week) under various circumstances listed. 
The rating classification ranged from 0 (cannot do) through intermediate degree of 
assurance such as 50 (tnoderately certain can do) to complete assurance at 100 
( cettain can do). There are three factors cover by this scale: Situational/interpersonal 
subfactor- factor 1(six items); Competing detnands subfactor- factor 2(five items); 
and Internal feelings subfactor- factor 3(seven items) (Shin eta/. 2001). 
The scale is scored by adding up item scores for subscale scores and summing all 
items for a total score. The mean scores for overall Eating Self-efficacy is obtained 
by summing all scores and dividing by 25 items. The mean scores for individual 
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subscale are obtained by summing up item scores and dividing by number of items. 
The interpretation of the scores: the higher the scores, the greater the problem with 
self-efficacy for eating. 
f. Short form of Quality of Life Questionnaire on High Blood Pressure (MINICHAL) 
The Shott form of Quality of Life Questiom1aire on High Blood Pressure 
(MINICHAL) was used to evaluate quality of life among patients with hypertension. 
The scale encompasses of two dimensions: state of mind (10 items) and somatic 
manifestation (six items). The scale comprises 17 items and patients required to mark 
their response based on the four response options: O=Not at all; 1 =yes, sotnewhat; 
2=yes, quite a lot; 3= yes, a great deal. The score ranges fron1 0 (best health level) to 
30 (worst health level) for State of Mind subscales; and from 0 to 18 for Somatic 
manifestation subscales. The scale has an acceptable reliability score where 
Chronbach alpha for state of mind items is .87 and .80 for somatic manifestation 
items. The test-retest coefficient value is .82 for state of mind items and .75 for 
somatic manifestation (Badia, 2002). The mean scores for both subscale is obtained 
by summing all items and dividing by the number of itetns each subscale. The 
interpretation of the scores: the lower the scores, the better the quality of life. 
g. Socio-demographic information 
This section consists of the patients' personal information which including age, 
gender, ethnicity, education level and occupational status. 
h. Physical and clinical information 
This section of the questionnaire comprises patients' baseline information which 
including weight, height, Body Mass Index (BMI), lipid profiles (Total cholesterol, 
High-density lipoprotein cholesterol, Low-density lipoprotein cholesterol, 
Triglyceride); renal function profiles (Serum creatinine and Serum urea); treatment 
history and types of medication. 
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3.1.6 Translation 
All items were translated by two bilingual translators into Bahasa Malaysia. Only the 
Bahasa Malaysia version was used in this study as it helped most patients to 
complete the whole set of measures. The questionnaires in Bahasa Malaysia were 
pilot-tested among healthy participants who were of Malaysian origin. The purpose 
of the pilot-test was to ensure that the instruction and content of the translated 
questionnaire were clear and understandable. Any confusion encountered during 
pilot-testing was looked into to improve the flow and clarity of the questions. 
3 .1. 7 Ethics approval 
Ethics approval was obtained from the Research Ethics Committee of the Malaysian 
Ministry of Health and the Research Ethics Committee of the University of Surrey. 
Once approval had been given by the ethics committee, the two selected Community 
Health Centres and Sarawak General Hospital were contacted to brief them on the 
proposed study. 
This was followed by the collection and compilation of the name and contact number 
of patients registered with both health centres from the Medical Assistant in-charge. 
Patients meeting the eligibility requirements were approached and given a patient 
information sheet. Upon their agreement to participate all patients were asked to sign 
a consent form. Patients were then given a date for a briefing session which took 
place at the Patient Education Unit, Sarawak General Hospital. This was followed by 
all participants attending four session of standard hypertension intervention 
programme. (See Appendix 2 for correspondence pet1aining to ethics approval) 
3.2 Analyses and Results 
First, the descriptive analysis was conducted on the demographic, physical and 
medical items for Time 1, Time2 and Time3. Then, reliability test were conducted to 
determine the internal reliability of items of different measures used in this study. 
The mean score was obtained by summing up the items and dividing by the number 
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of items in each scale. The mean score and psychometric properties of the constructs 
for Intervention group and Waiting list control group along with their respective 
Cronbach alpha coefficient were computed. 
Next, due to the small sample size and the fact that the data that was not distributed 
in the normal way, non-parametric tests were selected to analyse the survey data. The 
Friedman Test and Wilcoxon Signed-rank Test was performed to examine the 
differences in mean score of the psychological predictors as well as tneans of 
physical and medical indices between Time 1, Time2 and Time3 among patients who 
responded to the follow-up questionnaires and attending intervention. Then, the 
Mann Whitney Test was used to calculate differences in mean score of the 
psychological predictors and tnean of physical and medical indices for both 
intervention and waiting list control group between Time 1 (baseline) and Time 3 
(six month after intervention). The multiple testing corrections (Bonfen-oni 
correction) correcting the p-values of each constructs was performed to protect 
against Type 1 experiment-wise error. Therefore, a correction test was performed 
separately on each constructs. 
The following non-parametric tests were then conducted: Chi Square was performed 
to determine the relationship between physical and medical indices with all 
psychological predictors. Then, Lambda, Spearman's Correlation Coefficient and 
Kendall's tau were calculated to further examine the direction and strength of the 
association of physical and medical indices with the changes in psychological 
predictors across the three periods of thnes. The hnportant issues highlighted in the 
measurement of change literature and taken into consideration in the analysis stage 
of the study included: collecting tnultiwave data for longitudinal measurement of 
change, using change scores instead of residualised scores for analysing change in 
stnall sample, and selecting appropriate' analysis method applied in order to 
adequately distinguish the true change among study participants and to resolve 
Lord's Paradox (Linn and Slinde, 1977; Rogosa and Willett, 1983; Willet, 1989, 
1994; Gottman and Rushe, 1993; Cribbie and Jamieson, 2000; Wainer and Brown, 
2004; Senn, 2006; Wright, 2006). 
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3 .2.1 Demographic characteristics: 
Among the intervention group, about 92 patients who met the inclusion criteria were 
approached and recruited from two Cotnmunity Health Centres. Out of 92 patients, 
76 patients were from Mosque Road Community Health Centre while another 16 
patients were from Tanah Putih Community Health Centre. Of the 92 patients only 
36.9 percent agreed to participate voluntarily in the study. Among the reason for non-
pruticipation were refusal, tin1e constraint, work and transportation problem. 
Of the 34 patients, 15 (44.1%) were male and 19 (55.9%) were female with the age 
range between 29 to 75 years. The mean age of patients was 45.35 years (SD= 8.89). 
Patients belonged to different ethnic groups: 25 (73.5%) were Malays, and remaining 
9 (26.4%) were belonged to other ethnic groups such as Chinese, lban and Melanau. 
Patients' employment status was as follows: 7 (20.6o/o) were government employee, 
13 (38.2%) private sector employee, while the remaining 14 (41.1%) were either 
self-employed or housewife. Patients' education background: 30 (88.2%) has formal 
education while 4 (11.8%) did not have any formal education. 
Among the Waiting list control group, another 69 patients who met the inclusion 
criteria were approached and recruited from both Community Health Centres at Time 
1a. Of 69 patients only 33 patients agreed to participate in the study. This gives a 
grand total of 67 patients participated in this longitudinal study. 
Of the 33 patients, 15 (45.5%) were male and 18 (54.5%) were female with the age 
ranging between 31 to 7 4 years. The mean age of patients was 52.1 years (SD= 9. 78). 
Patients belonged to different ethnic groups: 15 (45.5%) were Malays, and remaining 
18 (54.6%) were belonged to other races such as Chinese, Indian and other ethnic 
group. Patients' employment status was as follows: 12 (36.4%) were government 
employee, 2 (6.1 %) private sector employee, while the remaining 19 (57.6%) were 
either self-employed, pensioner or housewife. Patients' education background: 28 
(84.8%) has formal education while 5 (15.2%) did not have any formal education. 
The demographic characteristics of patients in the intervention group and Waiting list 
control group are summarised in Table 3 .1. 
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Table 3.1 Demogtaphic characteristics of Intervention gtoup and Waiting list 
control group (N=67) 
Demographic Characteristics Mean (SD) or Frequencies (Percent) 
Intervention (n=34) Waiting list control (n=33) 
Age 45.35 years (SD= 8.89) 52.5 years (SD= 9. 78) 
Gender Male 15 (44.1) 15 (45.5) 
Female 19 (55.9) 18 (54.5) 
Ethnic Malay 25 (73.5) 15(45.5) 
Chinese 1 (2.9) 6 (18.2) 
Others 8 (23.5) 12 (36.4) 
Education Primary school 12 (35.3) 8 (24.2) 
Secondary school 18 (52.9) 14 (42.4) 
Tertiary education 6 (18.2) 
No fonnal education 4 (11.8) 5 (15.2) 
Work status Government employee 7 (20.6) 12 (36.4) 
Private sector employee 13 (38.2) 2 (6.1) 
Self-employed 6 (17.6) 2 (6.1) 
Pensioner 6 (18.2) 
Housewife 8 (23.5) 11 (33.3) 
3.2.2 Physical and medical indices: 
The physical indices of study participants were summarised in Table 3 .2. Of 67 
participants, more than 70 percent were found to be overweight (BMI 2: 23 kg/m2) 
and at risk of developing co-morbidities based on the Body Mass Index (BMI) 
classification in adult Asians published by WHOIIASO/IOTF (2000). The mean BMI 
for the intervention group was 29.63 kg/m2 (SD!::: 8.62), while the BMI for the 
waiting list control group was 27.3 kg/m2 (SD= 4.45). The height for both groups 
l'anged between 1.26 tneter and 1.89 meter and weight ranged from 50 to 145 
kilogrrun with a mean of 68.5kg (SD=13.76). 
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Table 3.2 Physical characteristics of study patticipants in Intervention group and 
Waiting list control group (N=67) 
Physical variables 
Physical 
Height (meter) 
Weight (kilogramme) 
BMI 
< 18.5 (Underweight) 
18.5 - 22.9 (Normal) 
2: 23.0 (Overweight) 
Mean (SD) or Frequencies (Percent) 
Intervention (n=34) Waiting list control (n=33) 
1.55m (SD= 0.10) 
70kg (SD= 16.2) 
29.63 kg/m2 (SD= 8.62) 
1 (2.9) 
2 (5.9) 
57 (85.1%) 
1.57m (SD= 0.1 0) 
67kg (SD= 10.76) 
27.3 kg/m2 (SD= 4.45) 
7 (21.2) 
26 (78.8) 
* Class{fication of BMJ is based on WHOIJASO/JOTF (2000) 
The patient's medical characteristics include systolic blood pressure (SBP) and 
diastolic blood pressure (DBP), lipid profile (Total Cholesterol, High-Density 
Lipoprotein Cholesterol, Low-Density Lipoprotein Cholesterol and Triglyceride) and 
renal profile (Serum Urea and Serum Creatinine). 
The mean SBP for Intervention group was 153.5 (SD=16.5) and DBP was 94.4 (SD= 
8.24); while the mean systolic and diastolic blood pressure for Waiting list control 
group was 140.5 Ｈｓｄｾ＠ 13.3) and 87.9 (SD= 6.85). The mean of systolic and diastolic 
blood pressure for both group were cotnparatively high based on Malaysian 
Hypertension Consensus Guideline (1998), where most of the patients fall within the 
range of High Normal to Stage III (SBP) while Normal to Stage IV (DBP). Of 67 
patients, 8 patients fell within high not·mal SBP or DBP and this gt·oup of patients 
was consider at high risk of developing definite Essential Hypertension and would 
usually be prescribed anti-hypertensive dt·ugs. The patient's classification of blood 
pressure is summarized in Table 3.3. 
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Table 3.3 Systolic blood pressm·e and diastolic blood ptessure of study participants 
in Intervention group and Waiting list control group (N=67) 
Blood pressure 
Systolic Blood Pressure (SBP) 
< 130 mmHg (Normal) 
130-139 mmHg (High normal) 
140 - 159 mmHg (Stage 1/Mild) 
160 - 179 mmHg (Stage IT/Moderate) 
180 - 209 mmHg (Stage HI/Severe) 
>210 mmHg (Stage IV/Very severe) 
Diastolic Blood Pressure (DBP) 
<85 mmHg (Normal) 
85 - 89 mmHg (High normal) 
90 - 99 mmHg (Stage I/Mild) 
100 - 109 mmHg (Stage IT/Moderate) 
11 0 - 119 mmHg (Stage III/Severe) 
> 120 mmHg (Stage IV/ Very severe 
Mean (SD) or Frequencies (Percent) 
Intervention group (n=34) Waiting list control (n=33) 
153.5 (SD= 16.5) 140.5 (SD= 13.3) 
5 (14.7) 
13 (38.2) 
13 (38.2) 
3 (8.8) 
94.4 (SO= 8.24) 
2 (5.9) 
19 (55.9) 
10 (29.4) 
2 (5.9) 
1 (2.9) 
10 (30.3) 
2(6.1) 
16 (48.5) 
5 (15.2) 
87.9 (SO= 6.85) 
15 (45.5) 
13 (39.4) 
5 (15.2) 
*Malaysian Hypertension Consensus Guideline, 1998. 
The other medical indices were lipid profile: total cholesterol (TChol), high-density 
lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and 
triglyceride (Tg) and renal profile: serum creatinine and urea. The mean of TChol 
was 6.17 (SD=l.60) where more than 50 percent of participants in Intervention group 
and Waiting list control group falling within the undesired level of total cholestet·ol 
(> 5.2 mmol /1). A similar trend can be observed in HDL-C level of Intervention 
group and Waiting list control group (< 0.9 mmol/1); LDL-C level of Interventioti 
group {< 3.9 mmol/ 1); but, more than 50 percent of participants in Waiting list 
control group had desired LDL-C level ( < 3.9 mmol/ I) and desired Tg level in 
Intervention group and Waiting list control group ( < 2.3 mtnol/1). 
The renal profile t·esult showed that more than 50 percent of the participants had the 
desired level of serum creatinine and urea. The tnean serum creatinine was 86.6 
(SD=29.3) and mean of serum urea was 4.24 ＨｓｄｾＲＮＶＵＩＮ＠ The results are summarised 
in Table 3.4 and Table 3.5. 
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Table 3.4 Lipid Pt•ofile of study participants in Intervention group and Waiting 
list control group (N=67) 
Lipid Profile Mean (SD) or Frequencies (Percent) 
Intervention (n=34) Waiting list control (n=33) 
Total Cholesterol 
< 5.2 mmol/1 (desired level) 
>5.2 mmol/1 (undesired level) 
HDL-C 
> 0.9 mmol/1 (desired level) 
< 0.9 mmol/1 (undesired level) 
LDL-C 
< 3.9 mmol/1 (desired level) 
>3.9 mmol/1 (undesired level) 
Triglyceride 
6.03 (SD= 1.89) 
12 (35.3) 
22 (64.7) 
0.96 (SD= 0.58) 
20 (41.2) 
14 (68.2) 
3.90 (SD= 1.24) 
14 (92.4) 
19 (57.6) 
2.69 (SD= 3 .48) 
< 2.3 tnmol/1) (desired level) 19 (55.9) 
>2.3 mmol/1 (undesired level) 15 (44.1) 
*Classification of lipid and renal is based on Roche Diagnostic Gmbh, 1999 
6.31 (SD= 1.26) 
7 (21.2) 
26 (78.8) 
1.65 (SD= 0.98) 
3 (9.1) 
30 (90.9) 
3.91 (SD= 0.92) 
18 (56.3) 
14 (43.8) 
1.93 (SD= 1.06) 
24 (72.7) 
9 (27.3) 
Table 3.5 Renal profile of study participants in Intervention group and Waiting 
list control group (N=67) 
Renal Profile Mean (SD) or Frequencies (Percent) 
Intervention (n=34) Waiting list control (n=33) 
Serum creatinine 
< 44 mmol/1 (undesired level) 
44-106 mmol/1 (desired level) 
> 106 (undesired level) 
Serum urea 
86.6 (SD= 29 .3) 
3 (9.1) 
23 (69.7) 
7 (21.2) 
4.24 (SD= 2.65) 
< 8.3 mmol/1 (desired level) 31 (96.9) 
>8.3 mmol/1 (undesired level) 1 (3.1) 
*Classification of lipid and renal is based on Roche Diagnostic Gmbh, 1999 
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100.23 (SD= 19.1) 
21 (70.0) 
9 (30.0) 
4.73 (SD= 1.79) 
21 (95.5) 
1 (4.5) 
3.2.3 Treatment: 
The patients' treatment is summarized in Table 3.6. Most of the patients were on 
treatment, 63 (94%) were on medication or other alternative medicine, while 4 (6%) 
patient has stop their medication without consulting their doctors. Out of 63 patients 
who were on medication, 37 (58.7%) patients were on antihypertensive drug, whilst 
24 (38.1 %) were on combination of antihypertensive and cholesterol tablet and the 
retnainders were either on diet control or Chinese medicine. The types of 
antihypertensive drug prescribed for the patients were diuretic, Beta Blocker, Ace 
Inhibitor and Calcium Channel Blocker. 
Table 3.6 Types of medication taken by study participants (N=67) 
Treatment variables 
Types of Treatment On Treatment 
Other or stop treatment 
Types of drug Antihypertensive drug 
Antihypertensive & 
cholesterol tablet 
Alternative therapy 
Frequencies (Percent) 
63 (94%) 
4(9%) 
37 (58.7%) 
24 (38.1%) 
2 (3.2%) 
3 .2.4 Psychometric properties of psychological construct 
The mean scores and standard deviations of psychological measures subscale were 
summarised in Table 3.7. A tnean score was obtained by smnming up the score of 
each items and dividing the sum by the number of items in each subscale. In general, 
the tneans scores of all measures subscale were not normally distributed. 
Cronbach alpha coefficients for all psychological measure constructs administe1·ed on 
the intervention group and waiting list control group were computed. Reliability 
analyses showed that almost all measure constructs of the intervention group had 
acceptable to good internal reliability, ranging from 0.4457 to 0.8925; while 
reliability analyses of waiting list control group demonstrated very low to good 
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internal reliability analyses which ranged from -0.1582 to 0.9951. Among the 
measures of the waiting list control group that obtained a very low internal reliability 
was Multidimensional Health Locus of Control: Intetnal (Form B) = 0.4478; Internal 
(Forn1 C) = -0.1582; Chance (Forn1 C)= 0.0000; other people (Form C) = 0.4018, 
Illness Perception: Timeline Cyclical= 0.2793, and MINICHAL: Somatic 
manifestation= 0.4806. Although some subscales had a very low internal reliability 
score, none of the subscales was removed from the original measures. Table 3.8 list 
all measure subscales and their respective Cronbach alpha coefficients. 
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Table 3.7 Mean scores of psychological measures subscale (N=67) 
Measut·es and subscales Numbe .. 
of items M(SD) S(SE) K(SE) 
Eating Self-efficacy 
Negative Affect (NA) 14 2.60 (0.93) 0.86 (0.29) 0.89 (0.58) 
Socially Acceptable Circumstances 9 2.74 (1.01) 0.70 (0.29) 0.80 (0.58) 
(SAC) 
Exercise Self-efficacy 6 19.1 (21.1) 0.70 (0.29) 0.04 (0.58) 
Situational 5 28.6 (27.8) 0.43 (0.29) -1.00 (0.58) 
Com 7 14.9 (18.1) 1.29 (0.29) 1.13 (0.58) 
Interpersonal 
Illness Pet·ception Questionnaire 
(IPQ-R) 
Identity 19 0.55 (0.55) 0.85 (0.29) -0.04 (0.58) 
Timeline acute/chronic 4 2.71 (0.70) 0.07 (0.29) -0.06 (0.58) 
Timeline cyclical 4 2.97 (0.62) 0.92 (0.29) 0.57 (0.58) 
Consequences 5 2.53 (0.59) 1.52 (0.29) 2.37 (0.58) 
Personal control 4 3.62 (0.44) 0.58 (0.29) 0.20 (0.58) 
Treatment control 3 3.70 (0.67) -0.65 (0.29) 3.13 (0.58) 
Illness control 1 3.81 (0.61) -2.37 (0.29) 7.81 (0.58) 
Emotional representation 5 2.69 (0.86) 0.86 (0.29) ｾＰＮＴＰ＠ (0.58) 
Symptom experience 19 2.74 (1.01) 0.70 (0.29) 0.80 (0.58) 
MINICHAL (QOL) 
State of mind 10 1.52 (0.59) 1.10 (0.29) 0.67 (0.58) 
Somatic manifestation 7 1.40 (0.58) 2.06 (0.29) 5.50 (0.58) 
Multiple Health Locus of Cont .. ol 
(MLHC) 
F onn B Internal 6 4.37 (0.64) 0.79 (0.29) 0.01 (0.58) 
Chance 6 3.30 (0.55) 1.29 (0.29) 1.73 (0.58) 
Powerful others 6 3.88 (0.61) 0.13 (0.29) 0.98 (0.58) 
Form C Internal 6 4.20 (0.52) 0.90 (0.29) 1.31 (0.58) 
Chance 6 3.30 (0.77) 0.76 (0.29) 0.66 (0.58) 
Doctors 3 4.07 (0.54) -0.24 (0.29) 1.57 (0.58) 
Other people 3 3.53 (0.74) 0.27 (0.29) 1.74 (0.58) 
GHQ-12 12 1.67 (0.51) 1.13 (0.58) 4.99 (0.58) 
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Table 3.8 Cronbach alpha coefficients for psychological measures items (N==67) 
Number Cronbach alpha 
Measures and subscales of items Intervention (n=34) Control Waiting List 
(n=33) 
Eating Self-efficacy 
Negative Affect (NA) 14 .8925 .8150 
Socially Acceptable Circumstances 9 .8515 .8166 
(SAC) 
Exercise Self-efficacy 
Situational 6 .8409 .8386 
Com 5 .8704 .9792 
Interpersonal 7 .8399 .7417 
Illness Perception Questimmaire (IPQ-R) 
Identity 19 .7378 .7070 
Timeline acute/chronic 4 .7766 .9046 
Timeline cyclical 4 .6420 .2793 
Consequences 5 .8051 .6681 
Personal control 4 .5138 .7701 
Treatment control 3 .8813 .6608 
Emotional representation 5 .8354 .6960 
MINICHAL (QOL) 
State of mind 11 .7714 .8981 
Somatic manifestation 6 .7645 .4806 
Multiple Health Locus of Control (MLHC) 
FormB 
Internal 6 .8021 .4478 
Chance 6 .4457 .8463 
Powerful others 6 .6786 .5147 
Forme 
Internal 6 .7581 -.1582 
Chance 6 .8753 .0000 
Doctors 3 .6010 .7500 
Other people 3 .6762 .4018 
GHQ-12 12 .7402 .9951 
3.2.5 Distribution properties of physical and 1nedical indices 
Descriptive analyses were conducted to determine the physical and medical indices 
and psychological measures data characteristic over among intervention group at 
three period of time: Tilnel; Time2; and Time3. The mean and standard deviation fot 
both physical and medical indices across these three times showed that tnost of the 
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mean does not represent the data well and the standard deviation was larget relative 
to the mean. Appendix 3 summarized the descriptive analysis of physical and 
medical indices. 
Next, the Friedman Test was conducted to test mean difference of physical and 
medical indices within the intervention group over three period of time: Time 1, 
Time 2, and Time 3. A significant mean different over the tht·ee period of time 
(Timel, Time2 and Time3) was discovered in the patient's weight 
(T(2)=9.3l,p<.05); BMI (T(2)=1l.ll,p<.05); SBP (T(2)=42.66,p<.05); DBP 
(t(2)=29.25,p<.05); Creatinine level (t(2)=9.19,p<.05); and urea level 
(t(2)=19.88,p<.05). Wilcoxon test was used to follow up this finding. A Bonferroni 
correction was applied and all effects were reported to be significant if they exceeded 
p< .0167. It apperu· that weight, BMI, SBP, DBP, Creatinine and urea were found to 
be either significantly increased or decreased over the three periods of times and a 
small to lru·ge change was seen in the six medical indices taken at Time 1 to Time3 
with effect size ranged between -0.41 to -0.85. Appendix 4 summarized the 
differences of physical and medical indices over tht·ee periods of times among 
intervention group. 
Mann-Whitney Tests were conducted to test differences between the intervention and 
waiting list control groups' physical and medical indices before intervention (Timet) 
and six month after intervention (Time3). The test tesults indicated that there were 
significant differences in the following medical indices between two groups. The 
intervention group's SBP (Mdn=150.0mm Hg) is higher than waiting list control 
group (Mdn=140.0mm Hg) during Timet, U=308.000, z=-3.232, p<.05). However, 
the intervention group and waiting list control group SBP apparently the same 
(130mm Hg) at Time3 but counted as non-significant at .05 level of significant. The 
intet·vention group's DBP (Mdn=90.0mm Hg) does not differ than waiting list 
control group's DBP (Mdn=90.0mm Hg) during Tin1el, U=309.000, z=-3.362, 
p<.05) as well as at Time3, but counted as non-significant at .05 level of significant. 
The Waiting list control group's HDL-C (Mdn=l.51mmol/1) appeared to be higher 
than the intervention group (Mdn=0.63mmol/l) at Timet, U=260.500, z=-3.769, 
p<.05, r=-.46, but the HDL-C value was not much different at Time 3. The 
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differences in groups' SBP, DBP and HDL-C were found to be significant before 
intervention as compared to after six month follow-up. Appendix 5 illustrates the 
differences of physical and medical indices between intervention and waiting list 
control group over Time 1 and Time 3. 
In conclusion, there are some significant differences observed between intervention 
and waiting list control group's physical and medical indices over Timel to Time3. 
3.2.6 Distribution properties of psychological measures 
Descriptive analysis was conducted to determine the psychological measures data 
characteristic over the three period of tin1e: Timet; Time2; and Time3. The mean 
and standard deviation for psychological measures subscale act·oss these three times 
showed that most of the mean does represent the data well and the standard deviation 
was smaller relative to the mean. Descriptive analysis of psychological measures 
subscale was summarised in Appendix 6. 
The Friedman Test was conducted to test the differences itt mean score of each 
psychological measures subscale within the intervention group over three period of 
time: Timet, Time2 and Time3. Significant differences in the mean of the 
psychological measures over the three titne periods was found in the following 
subscales: negative affect subscale (t(2)=6.45,p<.05); socially acceptable 
circumstances subscale (f(2)=9.46, p<.OS) and general efficacy subscale 
(X(2)=7 .54, p<.OS) of Eating self-efficacy and situational/interpersonal subscale 
(f(2)=12.4, p<.OS) and internal feeling subscale (f(2)=8.58, p<.OS) of Exercise 
self-efficacy. Table 3.9 illustrated the mean score of Eating self-efficacy and 
Exercise self-efficacy. 
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Table 3.9 Mean score of Eating Self-Efficacy and Exet·cise Self-Efficacy (N=34) 
Measures and subscales Time M(SD) r df p<.05 
Eating Self-efficacy W1 2.82 (1.18) 
:Negative Affect 
W2 2.91 (1.44) 6.45 2 0.039 
W3 2.17 (0.91) 
W1 2.94 (1.25) 
1 Socially Acceptable Circumstances W2 2.8I (1.42) 9.46 i 0.008 
W3 2.19 (0.97) 
W1 2.87 (l.I8) 
1 Efficacy W2 2.87 (1.41) 7.54 2 0.022 
I W3 2.18 (0.92) 
Exercise Self-efficacy WI 28.5 (23.6) 
: Situational/ Interpersonal 
W2 42.6 (24.9) I2.4 2 0.002 
W3 23.5 (20.3) 
Wl 39.1 (29.7) 
I Competing demands W2 45.6 (26.2) 5.49 2 0.063 
W3 30.8 (26.0) 
WI 22.4 (21.2) 
Internal feeling W2 30.2 (21.9) 8.58 2 0.013 
W3 18.4 (17.2) 
In Illness Perception subscales, mean score of three out of eight IPQ subscales was 
found significantly changed across three period of time: identity (t(2)=30.7, p<.05); 
timeline cyclical (t(2)=36.5, p<.05) and follow by etnotional representation 
(t(2)=16.07, p<.OS) . Table 3.10 illustrated the mean score of Illness Perception 
Questionnaire. 
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Table 3.10 Mean score of Illness Perception Questionnaire (N=34) 
IPQ subscales Time M(SD) x- df P<.05 
W1 0.94 (0.48) 
1 Identity W2 0.89 (0.68) 30.67 2 0.000 
I W3 0.25 (0.38) 
W1 2.40 (0.69) 
1 Timeline acute/chronic W2 2.73 (0.82) 1.26 2 0.543 
W3 2.71 (0.85) 
Wl 3.38 (0.60) 
1 Timeline cyclical W2 3.38 (0.60) 36.5 2 0.000 
W3 2.66 (0.54) 
Wl 2.72 (0.75) 
I Consequences W2 2.51 (0.67) 2.85 2 0.246 
W3 2.39 (0.53) 
Wl 3.78 (0.47) 
I Personal control W2 3.82 (0.66) 1.54 2 0.485 
W3 3.90 (0.35) 
Wl 3.86 (0.82) 
1 Treatment control W2 3.83 (0.88) 0.15 2 0.947 
W3 3.85 (0.51) 
WI 3.79 (0.77) I Illness coherence W2 3.68 (1.04) 1.29 2 0.544 
W3 4.00 (0.25) 
W1 3.23 (0.88) 
Emotional representation W2 2.83 (0.93) 16.07 2 0.000 
W3 2.43 (0.69) 
Next, the Multidimensional Health Locus of Contt·ol subscale; the test showed a 
significant different in mean score of both fotm B and C subscales. The three MHLC 
Form B subscale are: Internal ｾＨＲＩ］Ｗ＠ .16, p<.05); chance ｾＨＲＩ］Ｗ＠ .02, p<.05); and 
powerful others (f(2)=6.52, p<.05), while two subscales of MHLC Fotm C are: 
Internal (t(2)=6.12, p<.05) and other people (t(2)=14.47, p<.05). Table 3.11 
illustrated the mean score of Multidimensional Health Locus of Control. 
74 
Table 3.11 Mean score of Multidimensional Health Locus of Control (N=34) 
MHLC subscales Time M(SD) ｾ＠ df p<.05 
FormB WI 4.73 (0.72) 
W2 4.54 (0.79) 7.16 2 0.027 
Internal 
W3 4.25 (0.64) 
Wl 3.56 (0.67) 
Chance W2 3.29 (0.64) 7.02 2 0.029 
W3 3.05 (0.44) 
Wl 4.08 (0.80) 
Powerful others W2 3.7I (0.70) 6.52 2 0.038 
W3 3.73 (0.47) 
Form C WI 4.43 (0.66) 
W2 4.30 (0.69) 6.12 2 0.047 Internal 
W3 4.09 (0.49) 
Wl 3.59 (1.01) 
Chance W2 3.29 (0.75) 5.47 2 0.066 
W3 3.06 (0.48) 
WI 4.I7 (0.75) 
Doctors W2 4.05 (0.87) 0.33 2 0.867 
W3 4.08 (0.55) 
WI 3.81 (0.93) 
Other people W2 3.06 (0.81) I4.47 2 0.000 
W3 3.05 (0.64) 
Finally, the mean score of quality of life subscales and General Health Questionnaire 
scale were tested and all subscale of MINICHAL was found significantly different 
over the three period of times: state of mind (i(2)=31.5, p<.05) and somatic 
manifestation (t(2)=17.6, p<.OS). On the other hands, the mean score for General 
Health Questionnaire-12 was also found significantly different over the three period 
of times (t (2) =53.4, p<.OS). Table 3.12 illustrated the tnean score of MINICHAL 
and GHQ among intervention group. 
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Table 3.12 Mean scote for MINICHAL and GHQ-12 items (N=34) 
Measure subscales Time M(SD) r df p 
MINICHAL (QOL) WI 1.85 (0.55) 
W2 1.74 (0.51) 31.5 2 0.00 
State of mind 
W3 1.23 (0.37) 
WI 1.74 (0.64) 
Somatic manifestation W2 1.73 (0.59) I7.7 2 0.00 
W3 1.23 (0.39) 
GHQ-12 WI 15.7 (4.14) 
W2 15.4 (5.47) 53.4 2 0.00 
W3 1.99 (0.36) 
Next, Wilcoxon tests were conducted to vedfy the finding obtained earlier and a 
Bonfenoni correction was applied such that all effects were reported to be significant 
if they exceeded p<.0167. It appeared that Negative Affect was significantly changed 
from baseline to six n1onths after intervention (z=-2.872), and frotn immediately 
aftet· intervention to six month after intervention (z=-2.663, r===-0.46). The 
differences was not significant from baseline to immediately after intervention (z=-
0.529, p<.05). This follows by other subscales of Eating self-efficacy, Exercise self-
efficacy, Illness Perception, MINICHAL, Multidimensional Health Locus of Control 
and GHQ-12. Appendix 7 illustrates the differences in means score of psychological 
subscales over three periods of time. However, Wilcoxon test did showed significant 
change of the mean score of the subscales and it also demonsttated a tnedium to latge 
change effect. 
Next, Friedman test was conducted to test the diffet·ences of all psychological 
measures between intervention and waiting list control group over Time 1 and Titne3. 
The mean score of the psychological tneasute subscale was found significantly 
difference of the following psychological measures: Negative affect (i (1) =8.963, 
p<.05); Socially acceptable circumstances (t(1)=11.077, p<.05) and general efficacy 
(i(1)=10.667, p<.05) of Exercise Self-Efficacy; three Illness Perception subscale: 
identity (t(1)=13.00, p<.05); consequences (i(l)=5.233) and emotional 
representation (t(1)=7.529, p<.05), MINICHAL quality of life subscale: mind 
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(t(l)=31.84, p<.05) and somatic manifestation (t(1)=16.94, p<.05); GHQ-12 
(t(1)=27.46, p<.05) and two Multidimensional Health Locus of Control (Form B) 
subscale: inte1nal (t(1)=7.714, p<.05) and powerful other (t(l)=3.314, p<.05) and 
one Form C subscale: other people (t(l )=7 .364, p<.05). Then, Mam1 Whitney test 
was conducted to verify the finding and a Bonferroni con·ection was applied and all 
effects were reported to be significant if they exceeded p<.025. It appeared that the 
mean score of the psychological measures has changed over Time3. This can be 
observed in the following psychological measures: the intervention group (M=28.5) 
seems to differ in Situational/interpersonal mean score from the waiting list control 
group (M=11.2) at Timel, U=305.00, r=-0.40. However, after six month, the 
intervention gtoup (M=23 .5) were significantly differ than the waiting list control 
group (M=10.6) at Time3 (U=328.00, p<.025, r=-0.33). This result also can be 
observed in the t•emaining two Eating self-efficacy subscale. Next, three out of eight 
IPQ subscales (tilneline acute/chronic, timeline cyclical, consequences demonstrated 
significant changed in mean score at Time 3, and follow by two subscales of 
MINICHAL (mind and somatic manifestation) respectively, Appendix 8 illustrates 
the differences of mean scote for psychological measw·es subscale for intervention 
and control group over Time 1 and Time3. 
3 .2. 7 Association of physical and medical indices with psychological pt·edictors 
The following non-pat·ametric test was performed to detetmine the relationship 
between physical and n1edical indices with psychological predictors. Among 
physical and medical indices, it was found that BMI change associated with Socially 
Acceptable Circumstances of Eating Self-efficacy (SAC) scale (t =11.54, p= 0.02, 
p<.05). The following physical and medical indices that have significant association 
with psychological predictors are DBP change with Other People subscale of MHLC 
(t =9.90, p= 0.04, p<.05); SBP change with Negative Affect (NA) of Eating Self-
efficacy subscale (t =9.94, p= 0.04, p<.05); Total cholesterol with Chance subscale 
ofMHLC (t =6.39, p=0.04, p<.05); LDL change with Chance ofMHLC (t =7.17, 
p=0.03, p<.05); HDL change with Chance of MHLC (t =8.41, p=0.02, p<.05); 
Creatinine change with Time (acute/chronic) of IPQ (t =6.24, p=0.04, p<.05); and 
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Creatinine change with Chance ofMHLC (t =10.36, p=0.01, p<.05). The significant 
association between the selected physical and medical and related psychological 
predictors were furthet· examine by performing a few tests (Lamda, Spearman and 
Kendall's Tau) serve to examine the strength and direction of the association. A 
strong positive relationship was found between BMI changes with SAC Ｈｴ ｾ ＮＲＲＬ＠
p<.05), SBP change with NA (r-.18,p<.05), Total cholesterol change with Chance 
of MHLC Form C (t=.19,p<.05), HDL change with Chance of MHLC Form C 
(r-.25,p<.05), Creatinine change with Chance of MHLC Fotm C (r-.31,p<.05). 
Appendix 9 illustrated the analysis of association between physical and medical 
change with psychological predictor. 
3.3 Summary 
The result obtained from this longitudinal study provided answer to all research 
questions outline earlier. It was found that there is a somewhat difference or changes 
in the patients' physical and medical indices as well as the psychological predictors 
assessed at Tin1e 1, Time2, and Time3. The changes across these three periods of 
time ate expected since most of the participants were on treatment prior to 
cotmnencement of the study. 
The physical and medical indices of intervention group (weight, BMI, SBP, DBP, 
serum creatinine and urea) seemed to decrease significantly over three time periods 
and represent a small to large sized effect (r=-0.11-1.54). The changes in all indices 
were further examined and the changes can be observed from baseline (Time 1) to 
immediately after intervention (Thne2) or between baseline (Time 1) to six months 
after intervention (Tinle3) or from immediately after intervention (Titne2) to six 
month after intervention (Time3). 
The physical and n1edical indices differences wete further examined between 
intervention and waiting list control group. The test results did detnonstrate 
differences between these two groups. Although the intervention group had 
undergone an intervention progran1me it appeared that the clinical outcomes 
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collected at Time3 did not showed tnuch difference between the two groups. This 
raises a question of why there is no different between the groups? 
Next, all the psychologicaltneasures subscales were tested for differences or changes 
either within intervention group or between waiting list control group over tlu·ee 
periods of time. Some changes can be seen in most of the subscales and it also 
demonstrated a medium to large sized effect (r=-.38 to -.87). 
Finally, the last research question of Study 1 addresses the question of which 
psychological predictors were associated with the clinical outcomes among 
intervention group. A number of non-pru·ametric tests wete conducted to determine 
the association and the strength and direction of the relation between psychological 
predictots and clinical outcome. The ru1alysis presented a positive relationship 
between the following psychological predictors: socially acceptable circumstances of 
Eating self-efficacy with changes in BMI (p<.05); SBP with Negative Affect of 
Eating self-efficacy (p<.05); Total cholesterol and HDL-C associated with Chance 
subscales ofMHLC Fotm C (p<.05); and cteatinine change with Chance subscales of 
MHLC Form C (p<.05). 
However, these results were unable to show a great difference either in term of the 
physical and medical indices tests result or psychological predictors of the study 
participant. Therefore, the question of why some patients undetgo an intervention 
and do well while others do not still remain a question. Thus, this leads to the 
formulation of Study 2 which attempts to address this ｲ･ｳ･｡ｴ｣ｾ＠ question; why do 
some patients that undergo an intervention does well while others do not. 
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CHAPTER4 
STUDY2 
DETERMINANTS OF SUCCESSFUL CONTROL OF HYPERTENSION 
AMONG MALAYSIAN HYPERTENSION PATIENTS: AN INTERVIEW 
STUDY 
Aim 
The aim of Study 2 is to explore the determinants of successful control of 
Hypertension among Malaysian patients. This was done by exploring patients' 
personal experiences of their knowledge and understanding of their condition and 
disease; followed by factors that facilitate or stimulate patients to change their 
behaviour and barriers to change; finally, patients' views of current intervention. An 
interview study method was used to explore these three issues which subsequently 
provided answers to the research question of why some patients who undergo 
intervention do well while others do not. 
The focus of this chapter is to report the finding of Study 2 and acts as an impetus for 
future studies in this area. Knowledge on patients' understanding of their condition 
and illness, control and behaviour change factors was helpful for understanding the 
dete1minant of successful control of Hypertension. Furthermore, the infonnation will 
also help in forwarding suggestion to improve the present standard hypertension 
intervention programme. 
3.0 Rationale and choice of interview as a study approach 
Kvale ( 1996) has defined interview as a means to learn others' experiences about 
their world in their own words and understand the meaning (i.e. interpretation) of 
what the participants say and their experiences (p.5-6). Mason (2007) has pointed out 
that this approach was the most co1ninonly used 1nethod in qualitative research and 
there are many reasons why this method was chosen by the investigator. Among the 
reasons was that; it is an appropriate approach to use to generate meaningful 
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knowledge and address the research question. Moreover, this approach yields tnore 
personal and details information than a questionnaire and, it gives investigator a 
chance to explore the participant's answers with them. The results of Study 1 did not 
identify any significant factor which determinate successful control of hypertension 
among the study participants. Therefore, the second research question was 
formulated for this interview study with aims to explore, learn and understand what 
factors determine a successful control of hypettension from the patients' own 
perspectives. 
Hence, this interview study only emerged after the survey data (Study 1) has been 
completely analysed. The selection of the participants for this study has been fi·otn 
the pool of those surveyed earlier (Study 1). The planning to the final repol1 stages of 
the interview study is following that recommendation by Kvale (1996) as to provide 
some methodological structure to the study. The operational definition of the 
interview study is discussed explicitly in the following paragraph. 
3.1 Design and procedure 
3.1.1 Participants 
A small number of patiicipants were recruited for this study based on 
recomn1endation by Kavle (1996) where the nwnber of subjects necessary depends 
on a study's pw-pose. Six pruticipants were selected though purposive sampling as to 
find a closely defined group for whom the research question will be significru1t. This 
small number of pruticipants was intended to examine the differences and sitnilarities 
between pruticipants and it was able to serve the aitns ru1d resow·ces available for the 
study. 
This study selected six participants from the pool of patticipants of the initial study 
(Study 1 ). The selection criterion for the pruticipants are based on the findings of 
Study 1, previous hypertension literatw·e which signify that this category of patients 
is suitable to further explore the studies phenomenon and also the inclusion criteria 
outline below. The inclusion criteria were: participants who had pat1icipated in Study 
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1; who had been classified as having successfully or unsuccessfully controlled their 
hypertension based on overall clinical indicator outcomes which include systolic 
blood pressure of less than 140mm Hg and diastolic blood pressure of less or equal to 
90 nun Hg; lipid profile ( cholesterol <5.2mmol/l, Triglyceride<2.3mmol/l, Hdl-C 
>0.9mmol/l, Ldl-C <3.9) and renal profile (serum urea 1.7-8.3 mmol/1, creatinine 44-
1 06mmol/l). Those patients categories as successful control of hypertension if patient 
was able to sustain at least two out of three clinical indicators (blood pressure or lipid 
profile or renal function) at the desired level of controlled and those grouped as 
unsuccessful controlled of hypertension are those who unable to sustain at least two 
out of three clinical indicators. Other inclusion ctiteria were that they had attended 
the intervention programme earlier, who had given their consent to pat1icipate in 
Study 2 and that they were staying within the reach and accessible for the 
investigators to visit. 
3 .1.2 Data collection procedure 
It is very important for the investigator to maintain the link of each section of the 
interview study with the research question. Thus, for that purpose an interview 
schedule was drawn up covering three main issues and it is described in this section. 
This interview study aims was to explore the hypet1ensive patients' experiences with 
their illness from their own perspective, therefore, a standard open-ended interview 
schedule was developed as to guide the interviewer asking the same question to all 
participants. 
The outline of the interview question is designed based on recommendation by Kvale 
(1996) where it started with an introductory question and was then follow by more 
probing questions. A few probing questions posted where it is necessary to 
encourage participants to deliver more information on topic discussed and/or any 
relevant point or opinion raised by the pat1icipant. The interview schedule is 
structured using open-ended question which then minimize biases occurred during 
interview session and also following the study protocol. Each interview is recorded 
using ordinary handy audiotape-recorder and supplemented by notes taken during the 
interviewing session. 
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All participants were briefed and infotmed about the purpose and procedure of the 
interview. Informed consent was obtained from all participants before interviewing 
and recording proceed. The interview is estimated to last between one hour to one 
hour and half depending on the participants. See Appendix 2 of the interview 
schedule for Study 2. 
The interview took place at a location chosen by the pat1icipants that was conducive 
to them speaking freely and was easily accessible by the investigator. The rationale 
for asking the pat1icipant to select location for the interview was that this might 
affect the way pat1icipant responded to the interview questions, it minimized time 
taken by the interviewee in travelling and it created a familiru· situation and friendly 
atmosphere. The investigator role is to play a less dominant figure towards the 
research where the participants feel less intimidated and more willing to disclose 
information. It was also hoped that by taking the action of coming out to the 
interviewees rather than asking them to come for the interview indirectly give the 
oppot1unity for the investigator to understand even more the participants from their 
geographical and physical structure background and demonstrate investigator 
passionate towards the issue. 
3 .1.3 Analysis 
The interview study findings are part of a broader multi-method study and it is 
presented in a question and answer format. The data obtained from this interview 
study were analysed by using a content analysis method. This mode of analysis was 
used to achieve the aims of this interview study which was to explore in detail the 
individual patients' personal life experience and how patients are making sense of 
their personal life experiences in controlling Hypertension. 
3.2 Results 
All transcripts were read a number of times until sin1ilarities and differences in terms 
of participants' interpretation were drawn fi·om the six pat1icipants. 
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3 .2.1 Background of study participants: 
There were six participants selected from a pool of patticipants of Study 1 and they 
were selected based on the inclusion criteria above. Then, they were classified into 
two groups; successful or unsuccessful controllers of hypertension based on their 
clinical outcomes. Table 3.1 summarized the background of Study 2 participants and 
Table 3.2 summarized the clinical outcon1es of the participants. 
Table 4.1 The background of six participants of Study 2 
Participant grouping 
Background Successful controlled Unsuccessful controlled 
hypertension hypertension 
Gender Male 2 1 
Female 1 2 
Age 29 years old and below - -
30 years old and above 3 3 
Race Malay 3 2 
Other ethnic 
- 1 
Education level No formal education 1 
-
Primary school - 1 
Secondary school 2 2 
Tettiary - -
Occupation Government/private employee 2 1 
Self-employed 1 
-
Housewife - 2 
3.2.2 Participants' responses to the questions posed during the interview: 
The pruticipants' responses were organized and reported according to the 
classification of the participru1t as either successful or unsuccessful at controlling 
hypertension. The following were the participants' responses: 
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i. Successful control of hypertension: 
Part 1: Knowledge of condition and disease: 
The first question of part 1 exploring participants' way of describing their condition. 
Mot participant described their condition by referring to their feeling and/or present 
of previous symptoms. The following is the participant response: 
Q 1.1 Interviewer: How do you find your condition at the moment? 
P 1 : At the moment I'm feeling OK, just that I'm constantly had headache, maybe 
due to side-effect of my medication, especially this month, and previously I 
never had this feeling. But within this month, I did had headache, 
maybe[pause] I'm not that sure, maybe it's my medication, apart from that 
reason, I'm not sure, that's all, 
P1: I felt OK; I'm feeling OK, because previously before I'm starting taking my 
medication, I felt like floating, felt nausea, 
Pl: But when I started taking my medication, everything seems OK, no problem 
at all, 
P 1: What ... like ... a ... just 0 K ever since I'm taking my medicine, I did not feel 
anymore pain, I did not feel fatigue, everything I felt before had gone and I'm 
feeling OK, 
P2: Err ... currently I'mfeeling OK than before, 
P2: Previously I constantly had headache, in pain, but now, ever since I'm 
following your programme, I'm started to feel OK, 
P2: Yes, !feeling much better and hardly had headache, 
P3: Well ... I'm feeling just fine, just fine and nothing wrong with me, 
P3: I'm feeling like I'm used to; usual state. 
The following question explored pru.iicipants' ability to access or identify whether 
their condition was controlled. Participants referred to their feelings and/or the 
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symptom that they had experienced before and doctor's report as to indicate that their 
condition was controlled. The following are the patients' feedback: 
Q 1.2 Interviewer: How do you know that your condition had change and/or 
controlled? 
P 1 : Yes, there is some changed as far as I can feel, 
P 1: Because such changes err ... how can I say? 
Pl: Its [pause] I'mfeelingfresh and healthy, 
PI: Feeling fresh, before this /felt different, I constantly felt dizzy, tired, and then 
felt lazy, 
PI: After I took my medication, I did not feel anything, feel just fine. 
Pl: I came to know it from, err ... feelingfit, I'm feeling fit, before this I'm usually 
feeling lazy, nausea, but when there is some changed on my blood pressure 
level, I did felt different, there is some effect, I felt like normal people without 
Hypertension. 
P 1: I do go and check my blood pressure monthly with my brother-in-law who is 
a homeopathy doctor. So, I usually went to see him, "em ... it is normal, your 
blood pressure is OK, it is not high, it is coming down, and just hy to 
maintain it to stay at this level", he said to me. 
P2: I usually go and see my doctor during follow-up clinic, so, during that time I 
got to know my condition or illness is OK 
P2: I, myself can feel it as well, previously I constantly had headache, pain at the 
back of my head, but now the pain and headache is reducing. 
P3: Fine, because I can feel that my body fee/light. 
All participants' understandings of their condition and illness were further examined 
by exploring other ways that participants might assess their condition. The 
pru.1icipants had referred to their doctor report as a meant to monitor their condition. 
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Q 1.3 Interviewer: Have you any other ways to assess your condition at the 
motnent? 
Pl: Yes when I went to the private clinic, I did check-up, sometime every month, 
apart from going to the private clinic, I regularly attending my follow-up 
clinic once in three month, 
Pl: I usually do my own monthly check-up with my brother-in-law, he is a 
homeopathy practitioner, so, I regularly went to see him to check my blood 
pressure, and he sometime, err ... told me that my blood pressure is normal, 
"your blood pressure is OK", he said; it does not high, its coming down, and 
he did advice me to maintain my blood pressure as it is now. 
P3: Yes, the doctor did record my examination result into my patient card, 
P3: He [doctor] usually says my condition is fine. 
Next, patients were asked about their interest in seeking infonnation pertaining to 
their illness. The pru1icipants had pointed out that they never asked for more 
infonnation of their illness. Among the reasons for not seeking more information is 
that they felt satisfied with their current condition, were currently taking medication 
and had regulru·ly been informed that their condition is fine by their doctor. The 
participru1ts' responses are as follows: 
Q 1.4 Interviewer: Did you ever try to seru·ch information on your illness? 
P1: Yes, I did went and my brother-in-law, asked him what and how to deal my 
illness, my doctor did inform me not to take this and that, for instant do not 
take too much salt, just like that. 
P2: I'm constantly wanted to know how to get rid this illness, 
P2: I'm never know anything about my illness before, I never know how to 
prevent it, but ever since I'm attending your [investigator] programme; more 
or less I get to know it, for example reducing intake of salty food, do exercise 
regularly. 
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P2: When I know that I had high blood pressure; I'm started reading a book and 
trying to find out information in the book, how to control high blood pressure. 
P3: I never asked more information on my condition, 
P3: This is because I'm just feeling better. 
P3: He [doctor] said I'm fine, he did record it, 
P3: He [doctor] said, "You are fine". 
Then, the participants were asked about their level of knowledge of their illness. 
Most of the participants had superficial knowledge of there illness [i.e. causes, risk 
factor and symptom related to high blood pressure]. The participants relate whatever 
feeling or symptom they had experienced before to represent their level of 
knowledge of high blood pressure. 
Q 1.5 Interviewer: What aspect of high blood pressure (knowledge) that you 
currently have? 
Pl: What I understand about my high blood pressure is; normally those who get 
high blood pressure because they took too much salty food, 
P 1: Eat a lot of high fatty food, that all I know at the moment, 
P2: High blood pressure is caused by unhealthy eating; like before, I'm can eat 
medium size salty fish [laughing] and one salty egg, 
P2: That all I know; other thing is eating red meat and liver. 
P3: But, I felt, I felt like not having high blood pressure, I did feel nothing at all, 
I'm just feel healthy. 
P3: Before this my constantly had body aching, the whole body [patient pointing 
to every part of his body that aching] 
P3: Especially in the evening, fee/like been cut with a knife. 
Next, participants were asked about their source of information on high blood 
pressure. Most of them obtain infonnation of their illness from their immediate 
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relative, friend or medical personal. Apart fi·om that most of them find it is difficult 
to search information on high blood pressure. The following are participants' source 
of information: 
Ql.6 Interviewer: How do you obtain information on high blood presstu·e? 
Pl: Do you mean where I gain knowledge on my illness? [Pause] Sometime I 
asked other people, because I myself is working at the library, so I usually try 
to search relevant book on high blood pressure, before that I usually asked 
my mother because she also had high blood pressure, and others as well, 
Pl: Others are my office-mate, and my close relative. 
P 1: Eh .. . It is difficult to search information on high blood pressure, especially 
books; it's really hard to search about high blood pressure, because our book 
at this library is not up-to-date, so I usually asked from my office-mate who 
had similar health problem. 
P3: He [doctor] said I'm fine; he [doctor] did record it, 
P3: He [doctor] said, "You are fine ". 
Part 2: Factors that motivate lifestyle change and barrier to change: 
The second patt of the interview explored patticipants view on lifestyle change and 
barrier encountered pertaining changing and sustaining lifestyle change. The first 
question of this interview asking participatlts view about ways to control their high 
blood pressure and their cun-ent practice of control measures. 
Q2.1 Interviewer: Have you ever try to search ways to control your high blood 
pressure? 
Pl: Yes, 
Pl: Ways to control, sometime, it from my diet, other people told me that, "this 
kind offood can lower your blood pressure, and this herb helped lower blood 
pressure". I did take whatever herb that's helps lower my blood pressure, I 
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drunk sour sop fruit juices to lower my blood pressure, beside taking my 
medication, I did try something else just to help lower my blood pressure. 
P2: Like what I said before, I never know ways to control my illness, I did search 
ways to come about doing it, ever since I was told by you [investigator] how 
can I do it, I did follow your [advice]. 
P3: I just eat a little, not too much, 
P3: Do a bit of work, 
P3: Do cycling, a bit of work around my house. 
In term of seeking ways to control high blood pressure, most pat1icipants did practice 
any one of recommended control measure (i.e. control diet) or seeking information 
ways to control their illness. Following this question, pat1icipants were asked about 
any changes (if any) after they practicing any one of the recommended control 
measures. Participants did find some changes after they practiced control measure 
though there is some kind of "withdrawal symptom" i.e. feeling dizzy occw·s after 
practising diet control. One pat1icipant mentioning that the changes he discovered 
after practising control measure was the symptom which he usually experienced 
before had stopped while another pat1icipant did not any changes at all. 
Q2.2 Interviewer: How did you find changes (if any) after practising control 
measure? 
Pl: Changes, yes, definitely there is some changes, but sometime I still 
experiencing dizziness, to me, such changes that I had experienced; when I 
try to reduce my salt intake, I usually had high salt intake but when I tried to 
reduce it, I tend to feel dizzy. 
P 1: I felt dizzy, I had already controlled my diet, I felt dizzy and had headache, 
because I think it is due; I constantly had high consumption of salt in my 
food, but when it was reduced, I had headache, I'm feeling fatigue, that sort 
of changes that I had experienced. 
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P2: I can see the changes, before I'm following the programme; I constantly had 
headache, pain at the back of my neck, I find it weird; I never did any 
exercise, if I wanted to eat, most of the time I'm having salty fish, another 
salty fish, meat and especially liver [laughing] wow! That is the most 
delicious one. After I join in the programme; I really feel good and did not 
find any problem controlling my diet. 
P2: It is effective if we're constantly controlling our diet, and do a bit of exercise, 
P2: I think it should be practiced i.e. diet control and regular exercise. 
P3: I did not feel any changes, not at all. 
Next, all participants were asked whether they felt satisfied with the result obtained 
after practicing any one of the recommended control measures. The participants did 
express their dissatisfaction towards the outcomes of their control. One of participant 
find that her overweight problem still persist though her blood pressure tutn out to be 
OK. Another participant claitned he satisfied with his control but another participant 
did not find any change at all. The following is the responses given by the participant 
pettaining to this question. 
Q2.3 Interviewer: How satisfy are you with your control at the moment? 
Pl: At the moment, I'm not that satisfY because I'm still facing overweight 
problem, it's not coming down, I'm not satisfy with my overweight, so, my 
impression is that my blood pressure is high. I'm not that satisfy although my 
doctor says that my blood pressure is normal; but my blood pressure keep on 
going up and my weight as well, keep going up, 
P 1: I'm worry that my weight is not coming down, I have tried so many ways but 
still it is not coming down, 
Pl: To me, it is important to bring down my weight, my weight and height is not 
balanced, and for that reason my weight is not coming down. 
P2: I did see its effectiveness, 
P2: Because for me; I'm really want to be normal like before, that's all. 
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P3: I did not feel any changes, not at all. 
Two participants give their views on factors that helped them control their illness. 
External factor facilitate the participants with their control was family members and 
the investigator. The role of both external factors boosts participant's spirit to control 
their illness. 
Q2.4 Interviewer: What factors that help you to control your illness? 
P 1 : Help me, [pause] beside of assisting me, I think my family did a lot, they try 
to prevent me from taking food which I should avoid, they said "Stop! Stop! 
Stop! You cannot take this food". Apart from that my office mate did help me 
a lot with my control, 
P 1: To me their support boost up my spirit to control my illness. 
P2: It was YOU [participant referring to investigator], 
P2: YOU did advice me, if I practise this, control diet, regularly exercise, 
Insyallah we can manage to control my illness, so, I just do whatever YOU 
advice to do like what explain in the program before, 
P2: I did try to motivate myself to change, 
P2: Before this I have zero idea about ways to control my illness, like what I said 
earlier, I did try to find ways to prevent the illness, ever since YOU advice 
me, I just follow what YOU had advice me. 
The participants were fuliher probed about problem to sustain the changes which 
resulting after practicing any one of the recommended control n1easures. Some 
participants did say that they would not have any problems sustaining the changes 
although one of then1 did experience some "withdrawal symptoms" which she 
assumed might be due to her diet control. 
Q2.5 Interviewer: Do you have problems sustaining the changes? 
P1: Not at all, [firm tone], not at all, 
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P 1: I will try, to me such "withdrawal symptom" is temporary, once I manage to 
control it, it will go away, and I believe that "withdrawal symptom is 
temporary. 
P2: But for me, what I have said before about lowering my blood pressure; I did 
want it to lower my blood pressure as much as possible, so I can maintain on 
just two tablets. I don 't want to end up with taking more tablets than what I 
had now [laughing], 
P2: I will try my best. 
The pruticipants' experiences of lifestyle change were further explored: Firstly, in 
exploring participants' experiences, it was found that they had a positive perception 
towards lifestyle change. Those participants that perceived lifestyle change as 
positive thought such change was very impot1ant, a must to be practiced by the 
participants and associated it with positive health outcome. On the other hand, some 
participants seem to have doubt about lifestyle change. The pat1icipant felt that she 
did not feel the necessity to uptake lifestyle change while the other pruticipants 
claimed that there was no changed after taking the recommended measure. Following 
are the responses given by the particular patients: 
Q2.6 Interviewer: How do you find lifestyle change? 
P 1 : I think lifestyle change is very important, 
P 1: I feel like so because, apart from making us feel healthy, it also encourage us 
to control my diet, prevent myself from taking high salt kind of food, drink a 
lot of water, that how I see it as beneficial to me. 
P2: Yes, definitely, it is a must, 
P2: We need to change our lifestyle, for instant our diet, previously we eat a lot, 
now, we try to reduce some bad food, do exercise, 
P2: It is beneficial; if possible those with high blood pressure should change their 
diet, exercise regularly, although it is just light exercise, 
P2: Continuous practising diet control and exercise, 
93 
P2: Take medication, but just taking medication without doing exercise would not 
mean anything, 
P3: I did not feel any change, I did not feel anything. 
Apat1 from getting the pal1icipants' perceptions of lifestyle changes, they were 
probed further about the importance of lifestyle change in relation to the control of 
their illness. The participants stated they learned the importance of lifestyle change 
based on their own personal experiences as well fi·om other immediate relative 
experiences. 
Q2. 7 Interviewer: Where do you leru·n the hnpot1ant of lifestyle change to the 
control of your disease? 
Pl: I learned it by observing my mother, 
P 1: I take it from my mother, previously she never look after her diet, she eat a 
lot, now she 's currently having a number of related diseases, when I saw her 
agony or trauma having all those diseases, it came to my mind, I definitely 
will have similar condition if I don't act now, 
Pl: When I constantly watch her agony fighting her illness, suddenly I thought I 
should go and have a check, just to ensure myself, like people use to say, 
prevention is better than curing, 
P 1: When other says that you are having this problem, at least we already have 
some bit of idea to react towards it. 
P2: I think lifestyle change does not prevent me from doing what I usually do 
before, even more it does make my feel much better than before, 
Next, participants indicated they did not find that lifestyle change prevent them fi·om 
continuing their usual routine. In fact, some of these participru1ts' pointed out such 
difficulties as something temporary and will go off once they manage to control it. 
Furthermore, their interest or intention seen1s to suppress the negative feeling and 
subsequently make the sustaining of change possible. The participants also 
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highlighted the important of others support (i.e. family member and investigator) 
droved them to practiced lifestyle change. These factors (i.e. immediate relatives and 
investigator) played an importance role in relation to motivating them continuing 
practicing lifestyle change. 
Q2. 8 Interviewer: Did the difficulty faced during change period prevent you to 
continue or/and sustained particular change? 
Pl: Not at all, 
P 1: I will try my best to eliminate such negative feeling, to me it is not permanent, 
and it is something temporary in nature, once I manage to control it, it will 
go off, and to me it's only temporary. 
P2: I did not had any problem with it, 
P2: Because for me, I'm really want to be normal like before, that's all. 
Q2.9 Interviewer: What factors that suppo11 or drive you to practice lifestyle 
change? 
Pl: My father and my entire immediate family members, 
P 1: My mother helps me a lot in terms of giving me support to change my 
lifestyle. 
P2: It was YOU [referring to investigator], 
P2: YOU did advise me, if I practise this (i.e. diet control and exercise, insyallah 
I can manage to control my illness, so, I just do whatever YOU advise me to 
do, like what YOU had explained in the programme before, 
P2: I did try to motivate myself to change, 
P2: Before this, I have zero idea about ways to control my illness, like what I said 
earlier, I did try to find ways to prevent the illness, ever since YOU advised 
me, I just follow what YOU had advised 
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The pru1icipants did mention they did practice any one of the recommended lifestyle 
change activity (i.e. diet control and exercise). Then, participants were again proved 
about problems or bru1·ier that they might encountered during the practice of lifestyle 
change activity. The pru.1icipru1ts seem to perceived the barrier or problem faced as a 
motivator or challenger which droved them to stick with whatever change they had 
done with their lifestyle. Furthermore, they felt comfortable and fine with the 
change; and indirectly such attitude help participants achieved their own goal. 
Q2.1 0 Interviewer: What types of healthy lifestyle activity are you currently 
practising? 
Pl At the moment I'm only doing exercise, 
P2: At the moment I'm taking a lot of water, 
P2: Regularly do a bit of exercise, not that much, then my diet, I try to avoid 
taking salted fish, red meat, liver, at the moment I never take red meat at all, 
P2: !felt afraid of taking it, 
P3: Yes, I did some work, 
P3: Yes, I did cycling and do a bit of work around my house, 
P3: Yes, did control a bit of my diet. 
Q2.11 Interviewer: Have you encounter any barrier or problem to change your 
lifestyle? 
Pl: I did not see or perceived lifestyle change prevent me from continuing doing 
whatever that I'm currently do in my life, 
P 1: I did not see it as a burden for me. 
Pl: I do feel sometime there is some barrier for me to continue practising lifestyle 
change, this especially relating to my diet control, once I know that I'm 
having high blood pressure, I try to change my diet habit, from taldng high 
fatty food to, now taking food which are cook through steaming or simmer 
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methods, so sometime when I saw my sister preparing meal, those curry, 
dhal, my appetite increased, oh ... I'm started to eat a lot, 
PI: That's sort of barrier, I'm struggling to maintain my afford, sometime, once 
I'mfull, I'm started to feel lazy to go exercise, 
PI: Apart from that, my laziness, 
P2: I did not feel practising ltfestyle change affecting my usual daily lifestyle, 
P2: I did not feel it as a burden or barrier, 
P2: Not at all, I feel comfortable with it, 
P2: I didn't feel force to change; because L myself wanted to change my diet, 
P2: So, Iwouldfeel comfortable. 
P2: I think it is an effective ways to control my high blood pressure, 
P2: I wanted to feel normal again, 
P3: No problem, no problem at all, 
P3: Because I just ate a little, not much, 
P3: I'mfeelingfine. 
Q2.12 Interviewer: Although you have try to eliminate some barrier for you to 
change, but that barrier still persist, would you continue you're afford to 
change or revert to old lifestyle? 
PI: I'll try to change, to me, I don not want to be like my mother, she had whole 
range of related disease to high blood pressure, I aiming for maintaining only 
one disease i.e. high blood pressure, I do not want to have diabetes, heart 
disease, just high blood pressure alone, I'll try to prevent myself from getting 
those diseases, 
PI: I already have seen enough and have example, so I definitely don not want it 
to happen to me, 
P 1: sometime, I do feel like just forget about lifestyle change, I just do what I 
want to do, I don 't care, I usually do not like stay at home, because I 
definitely will constantly walk into the kitchen, find something to eat, 
sometime I eat food which I should avoid, 
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P1: after that I felt regret with what I have done, it make me think that my action 
will increase my blood pressure, 
P 1: After that I regret with my action, 
Part 3: Views of current health intervention programme: 
The last section of the interview explores participants' opinion on the ongoing 
standard intervention programme. It sought to determine participants' view of any 
intervention programme they had attended before, the knowledge gain fron1 the 
programme and their interest to attend such programme in future. Most of the patient 
found that the standard intervention programme. These are the participants' 
responses following from these three questions: 
Q3 .1. Interviewer: Have you ever attended any ldnd of standard intervention 
programme before? 
P1: I never attend any other programme apart from the one that you 
[Investigator] had organized. Following that I try some herbal medicine 
which I was informed by few friends that, it is not advisable to take herbal 
medicine without cautious, it might do harm our health instead. 
P2: I never attend any programme before, 
P2: After I was diagnosed with high blood pressure and also been invited to 
attend your [programme], I just immediately follow the programme. 
P3: This matter is far too long, I couldn 't remember it anymore. 
Q3 .2 Interviewer: What do you of think of the standaTd intervention programme 
that you had attended before? 
P1: Not at all, because if I were call, I think it was brilliant, very good, because 
out of all those high blood pressure patients, I was selected although a few 
turn- up to the programme, 
P1: !feel honour and sincerely willing to come, 
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P2: I'm not just interested to follow the programme but also wanted to know ways 
to change my lifestyle when already had high blood pressure, 
P2: After attending your [investigator] programme than I realized about the 
important to control my illness, 
P2: Before this I never bother about my illness; I did not know anything about it, 
P2: What is the cause? 
P2: I'm satisfied when the doctor always informed that my blood pressure is OK 
P3: I was selected and I thought it was brilliant, 
P3: I did not feel force to come to the programme, 
Q3 .3 Intervention: What have you learned or gained from the standard 
intervention programme? 
P 1: A lot of things that I learn from the program, it is about diet, exercise, ways 
to control my diet, about my high blood pressure, and medication, that's it. 
P 1 : A ... about diet, previously I just eat whatever I want to eat, never care about it 
at all. But after following this programme I learned that those with high 
blood pressure should not take too much meat, high fatty food, have to take 
proper meal, that all I know about diet. 
P2: A lot of things that I learned from the programme, 
P2: Firstly, I learned about diet, medication, and ways to do exercise. 
P3: This is advice by the doctor to me, take care my diet, do not take too much 
high fatty food, I need to take care my diet, 
Q3 .4 Interviewer: Which infonnation on high blood pressure that is impoliant for 
you to know? 
P 1 : I think diet is ve1y important, because if we did not control our diet, other 
disease will not come to us, and then about exercise, 
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P 1 : If we only take medication, but never try to control diet, definitely our blood 
pressure rise, that's why I think it is important to control diet as well, 
P 1: Because by controlling our diet, we can lower our blood pressure, that's my 
opinion. 
P1: I thought information on the disease itself also important, it will make us 
aware about the complication if having uncontrolled high blood pressure, 
foremost all the information on high blood pressure is important because it is 
related to one another. Most of these topics need to be stress and explain 
clearly. If we know about the disease but we did not control our diet, it would 
not work perfectly. This also the same if we controlled our diet but does not 
take medication, it would not give good outcomes. 
P2: !want to know more about the causes ofhigh blood pressure, ways to prevent 
it, other related disease to high blood pressure, 
P3: I haven 't thought of anything pertaining to my high blood pressure, 
P3: Because I, I did not feel my blood pressure is high, I'm just feeling like 
normal, 
Q3 .5 Interviewer: Would you interested to attend health education or 
intervention programme in future? 
P1: I'll come to the programme, although my high blood pressure already 
controlled or not, but still I'm interested to attend the programme. It was 
hard to predict what would happen next when you have high blood pressure. 
I'll attend the programme and furthermore I'll bring others together with me. 
P2: lnsyallah I definitely wanted to go again [laughing]. 
P3: Yes, I'm interested to come, 
P3: I'll come if! am not busy, 
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ii. Unsuccessful controlled of hypertension: 
Part 1: Knowledge of condition and disease: 
The first question of pal1 I exploring participant's way of describing their condition. 
Mot participant described their condition by refening either to their feeling and/or 
present of previous symptoms. Some refers to their ability to sense whether their 
blood pressure is high or low, and they also refening to changes that they themselves 
realized after some time taking medication as well as pointing the factor that cause 
them getting high blood pressure. The following is the participant response: 
Q 1.1 Interviewer: How do you find your condition at the moment? 
P4: !feel a little bit better than before, 
P4: It's much better, I didn't had severe headache, pain at the back of my neck, 
all has reducing a bit than before, 
P5: At this point, sometime I felt my blood pressure is going up, sometime its 
coming down, because if I don't take my medication, I do felt like so, 
P5: If I don 't eat anything, my blood goes up, I felt dizzy, its feel like my head is 
going to explored, I couldn't get up, then I started taking my medication 
[show her medication], it turn up to be OK, 
P6: Ah ... my condition, more or less as usual, there is some changes, as I thought 
of My body felt just fine, not like before, 
P6: I'mfeeling better, for instant my sleeping pattern and my appetite, before this 
I'm usually had less appetite and unable to sleep well, 
P6: Sometime only at 1 am than I can sleep, but now, you can ask my children, 
before past 8 pm, I'm already fall asleep, like what I told you just now, this 
medicine, to me it is really fairly good, l didn't say it is bad or even too good, 
but I can feel the changes, 
P6: A ... it is a big change, 
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P6: Well, apart from my appetite and sleep; maybe I 'm not having that much 
stress of thinking about my problems; that might be the cause [laughing]; 
before this I do feel the pain, and currently I can still feel the pain, but not 
that painful which make me take paracetamol; it doesn 't goes off, but 
currently, if there is the pain, I try not to take paracetamol, and sometime I 
do take it, but there is some changes; this is maybe due to my control over my 
illness ever since you [investigator] asked me to come and listen to the talk, 
there is some changes. 
The following question explored participants' ability to access or identify whether 
their condition was controlled. Pruticipants referred to their feelings and/or the 
symptom that they had experienced before and doctor's report as to indicate that their 
condition was controlled. The following are the patients' feedback: 
Q 1.2 Interviewer: How do you know that your condition had change and/or 
controlled? 
P4: It is based on my own instinct or feeling that my blood pressure is coming 
down or otherwise there are some other reason which I myself not that sure. 
P5: Well, for instant my eating pattern, I had to controlled whatever the things 
that I eat, for example red meat; I had to controlled my meat intake, 
sometime for week I did not take any meat, chicken or even seldom take fish. 
Sometime only just take a bit, or sometime I just take rice porridge if I don 't 
have any appetite, just plain rice porridge with black soy ketchup, I'll eat, 
then I feel like eating, what a weird feeling that we can experienced when 
fall sick. 
P5: I did also go to the clinic and asked them about my blood pressure. 
P6: I'm judging it based on my condition; previously when I walk under very hot 
weather, I feel like fainting, but now Insyallah, I can proved that before this if 
I was on field work, if that feeling hit me I'm easily falling down, but now I 
can managed it, before this even an hour I already couldn 't stand ｩｴｾ＠
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P6: You can see from my current physical appearance, it is far diffirent than 
before, when I listen to your [investigator 1 advice asking me to control my 
diet, I can see the differences, 
P6: Yes, I'm feeling healthy, my sleeping and eating pattern is OK just that I have 
problem with my bladder, 
All participants' understanding of their condition and illness were further examining 
by exploring other ways that participants might used to assess their condition. The 
participants had referred to their doctor repo11 as a meant to monitor their condition. 
Some based their assessment to their own feeling and then making their own 
interpretation and another participant reminding himself to monitor his condition 
based on what he learned from other experience and listening to advices. The 
following is their responses: 
Q 1.3 Interviewer: Have you any other ways to assess your condition at the 
mon1ent? 
P4: I sense it not that bad like before, I did not worried, and I felt calm after 
taking my medication, 
P5: At the moment I only know about my condition from my doctor. 
P6: Every month I did went for my follow-up clinic, why don't you have a look of 
my clinic card, I remember your [investigator 1 advice reminding me to check 
my blood pressure, I did follow that advice, than I realized if we listen to our 
doctor advice, we can get better; if we ignore their advice meaning that we 
want to get even sick. I learned the lesson from what happen to my brother-
In-law, he had high blood pressure, on medication but his condition is worse, 
he ignored his doctor advice to take his medication. That make me feel 
anxious and remember your [investigator 1 advised me not to leave my 
medication. And that incident also makes me not to forget taking my 
medication. I always carry my medication with me. 
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Next, patients were asked about their interest towards seeking information pel1aining 
to their illness. The pal1icipants had pointed that they never asked more information 
of their illness. Among the reason for not seeking more information is: they felt 
satisfied with their current condition; currently taking tnedication and constantly 
been informed that their condition is fine by their doctor. Some get to know about 
their illness after been reminded by their doctor the risk factor which causes their 
problem. Then they reflect it on their own personal experience. The pal1icipants' 
responses are as follows: 
Q 1.4 Interviewer: Did you ever try to search information on your illness? 
P4: At the moment I did not feel there any necessity to ask more information on 
my high blood pressure, 
P4: I did not requesting any further information on high blood pressure because 
I'm pretty much satisfied with my blood pressure level at the moment, I 
already taldng my medication, and my blood pressure is coming down. 
PS: Yes, what we call, black-out, as if you are looldng at the twinkling stars, then 
I asked my friend, is that how you all felt if you are known to have high blood 
pressure? My friend reply, HYes, that's how we feel", I thought, I'm felt 
afraid because I do have family history of high blood pressure. 
P6: From my own point of view, I didn't get the information from other source, its 
from myself, because when my doctor remaining me about my drinking habit, 
I assume that I get this illness because of my drinking habit, I drink a lot .... 
P6: I always sleep late night, once you drink definitely you tend to sleep late 
night, that's cause me getting this health problem, moreover, I didn't control 
my diet, eat a lot of oily food, and high in cholesterol, that why I get this 
illness. 
P6: The doctor always says, " by any mean try not to take this type of food, don't 
consume too much of meat, fish, he did also reminding me to take a lot of 
vegetable. 
P6: 0 ... yes, my friends, he did take three tablets for his high blood pressure, he 
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did advised me, "if possible please try to prevent yourselves from been like 
me" ...... 
P6: I never search information from the book, my daughter is a nurse, then she 
always reminding and advising me, "Dad, try not to take too much, try to be 
moderate, not too full, that's why my smoking habit, if possible she wanted 
me to stop it, but (laughing) it's very hard to throw away my dearest friend 
Then, the participants were asked about their level of knowledge of their illness. 
Most of the participants had superficial knowledge of there illness [i.e. causes, risk 
factor and symptom related to high blood pressure]. The participants relate whatever 
feeling or symptom they had experienced before to represent their level of 
knowledge of high blood pressure. 
Q 1.5 Interviewer: What aspect of high blood presstu·e (knowledge) that you 
cunently have? 
P4: I'm not really sure about that, 
P4: I'm only have a little information on high blood pressure, 
P4: What I know is that high blood pressure can be inherit from our family 
member, for instant I got it because my mother have high blood pressure, 
P4: Apart from that I'm not that sure. 
PS: Currently, I'm feeling good, because I already know, I did went for check up, 
then I know, I had high blood pressure or diabetes, because I knew by 
reviewing my test result, the doctor did inform me, I had high blood pressure 
and I must controlled it, controlled my diet, 
PS: Yes, there is some sign, feeling dizzy, nausea, and feel like vomiting, from 
there I know that I had high blood pressure, moreover, my husband also had 
high blood pressure, both of us similar disease, but we are taking different 
medication 
P6: There is a number of causes of high blood pressure, firstly, heavy drinking 
alcohol, like myself before, I did told you before, I'm a heavy drinker, ever 
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since I went for pilgrimage, I already stop drinking alcohol, next, if we eat 
too much we can get high blood pressure, oily food and egg. If I took egg, I 
can get dizzy for hours, 
P6: Apart from that, do a lot of thinking, when I cannot sleep, eat a lot, think a 
lot, definitely can cause someone get high blood pressure, that just what I 
thought of, 
P6: Worry a lot, if we cannot sleep well for more than 24 hour, sometime eat 
unhealthy food, 
P6: Ah .. . like so, if we eat a lot, I think it will cause someone getting high blood 
pressure, mainly alcohol, apart form that I'm not sure, 
Next, participants were asked about their source of information on high blood 
pressure. Most of them obtain infonnation of their illness frotn their immediate 
relative, friend or medical personal. Apart frotn that most of them find it is difficult 
to search infotmation on high blood pressure. The following are source of 
information to the patient: 
Q 1.6 Interviewer: How do you obtain information on high blood pressure? 
P4: I came to know that family history is one of high blood pressure risk factor; 
when my grandmother got it then my mother had it until she pass away, she 
did took high blood pressure tablet. She suddenly passes away because of her 
blood pressure. Just after a few months after my mother pass away, I 
suddenly had this dizziness feeling, so I went to policlinics and then they 
confirmed that I had high blood pressure. 
P4: I'm not sure; I think it is very hard to obtain information on high blood 
pressure, 
P4: I usually been informed by the clinic personal about my blood pressure, 
P4: They only advised me just take my medication, and come back in three month 
to see whether any changes, that's all, 
P4: They did also advise me to reduce salt intake, high fatty food, reduce oil 
intake, just that they told me. 
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P5: That's all; I'm only gaining it from my doctor. 
P6: I did not get information from other mean than my doctor; he constantly 
remind me about my drinking habit, and I thought I get high blood pressure 
because of my drinking habit, My doctor did asked me what time I went to 
bed? And I usually sleep late, if I drink usually I'll stay up late, that cause me 
get high blood pressure, because I did not control my diet, regularly taking 
oily and high cholesterol kind of food, that make me get high blood pressure. 
P6: My doctor always remind me to avoid certain food, you can eat this but 
reduce my meat intake. Not to take too much fish, but he constantly advice me 
to take more vegetable. 
Part 2: Factors that motivate lifestyle change and barrier to change: 
The second part of the interview explored participants view on lifestyle change and 
ban-ier encountered pel1aining changing and sustaining lifestyle change. The first 
question of this interview asking participants view about ways to control their high 
blood pressure and their current practice of control measures. Pa11icipants did 
practice some control measure either through diet control or taking alternative 
medicine. Some did asked fi·om friends about ways to control high blood pressure 
and some did stal1ed to practised it based on their knowledge that such practiced 
would help them controlled their high blood pressure. 
Q2.1 Interviewer: Have you ever try to search ways to control your high blood 
pressure? 
P4: I did thought of it, I did want to control my diet, for instant my diet, I've to 
take care it, 
P4: About my diet, I try to reduce oily and high fat kind of food, 
P4: Nothing else. 
P5: For example, my diet, I have to control my food, such as meat, have to be 
taken a bit only, sometime, for week I didn't take meat at all, same with 
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chicken, fish, but even hardly taking fish. Sometime I just prepared rice 
porridge if I don 't feel like eating, I did prepare plain rice porridge and take 
it with black soya sauce, then I had my appitite back, a lot of feeling when we 
start having some illness. 
P6: 0 ... yes, I did asked my friend, he took three types of medication and he did 
advised me to control my illness so that I'll not end up like him. Everywhere 
painful, pain on the hand, headache, blurring eyes, and he is right, I did had 
some problem with my eye-sight, maybe due to my age. He also reminds me 
to take bitter herbs to lower my blood pressure, which currently been 
practiced. I did take one kind of root called "akar mali" to supplement my 
medication. My wife do have high blood pressure and she did take it and she 
cured. I'm taking this "akar mali" root and nake it as daily supplement 
which I regularly took at night before going to sleep. That's all ... 
P6: Some friends did mention about sea-cucumber gel, 
P6: I had already started taking that supplement; I took it because I'm not 
satisfied with the treatment that I had currently. I did ask my doctor about the 
supplement with my doctor. He did ask me why I need that supplement while 
he already prescribed with some medication. But I'm not going to leave my 
medication, but I wanted to supplement my current control so that my 
condition can be much better. 
In term of seeking ways to control high blood pressure, the participants did 
somewhat have thought of finding ways to control his/her high blood pressure or just 
initiate some kind of control measure which he/she thought best for them. They did 
practice any one of recommended control measure or seeking information ways to 
control their illness. Following this question, participants were asked about any 
changes (if any) after they practicing any one of the recommended control measures. 
Participants referred the changes based on either describing their feeling before and 
after practicing some control measure, referring to medical check-up report and the 
absent of some previous habit such as taking "panadol" or "cap kapak oilment". 
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Q2.2 Interviewer: How do you find changes (if any) after practising control 
measure? 
P4: !find some changes, 
P4: I felt that my condition is not that bad like before, I didn't feel worried 
anymore, my mind felt settle, after taking my prescription. 
P5: Yes, 
P5: I can see its effectiveness, because I, myself already know, because I already 
did some check-up, I realized it, I know I'm having high blood pressure, 
because I can see from my medical record, where my doctor did inform me 
about my condition, I need to uptake some control measure, controlling my 
diet, 
P5: There's a lot of change that I experience ever since I'm attending your 
[investigator] programme. The change is from the aspect of diet control and 
doing exercise. 
P6: Before this you can smell my oilmen!, that is the main changes happen to me, 
I, I feel that ever since I'm following this programme, this are the changes 
that obviously happen to me, I used carry with me "cap kapak oilment" or " 
panadol" in my pocket, but now, it's all gone, I'm not bluffing but that's the 
truth. 
Next, all participants were asked whether they feel satisfy with the result obtain after 
practicing any one of the recommended control measure. The participants did 
express their satisfaction of their present control but, one did state his dissatisfaction 
towards the outcomes of their control. The dissatisfaction branching from his feeling 
of anxiety that previous syn1ptoms will attack again and though he did try to control 
his cholesterol level but still it maintain at undesired level. The following is the 
responses given by the participant petiaining to this question. 
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Q2.3 Interviewer: How satisfy are you with your control at the moment? 
P4: I'm pretty much satisfied with my control, I did take my medication, and my 
blood pressure seems to come down. 
P5: Yes, I'm satisfied with my current control. 
P6: I'm not satisfy with it, not yet, 
P6: What make me feel like so because I'm afraid it will come again, my doctor 
did told me "your blood pressure is OK; so, I can reduce the doses", but I 
told him, "I'm still had my previous symptom", so you just take this 
medication for three to four month than. Lucky my medication last for three 
month, if I stop, I'm remember what you have said before, if I do not take my 
medication, my blood pressure can goes up, that's what I'm afraid of, if 
talking about satisfaction, I currently not satisfy yet with my condition. 
P6: I also find it weird; I usually control my diet but my cholesterol level still 
high. I did inform my doctor about it and asked him, ucan you prescribe me 
some cholesterol tablet?" but he said, ''You don't need that tablet yet 
because your condition is still much better than other patient". So, I'm not 
that satisfied with that decision. 
The patticipants view on their control was further explored by looking into factors 
that help them controlling their illness. Factor that facilitates the patiicipants with 
their control derived from the patticipant own willingness to control their health 
problem, feeling anxiety and their goal or desired to live longer. The following is 
participant responses: 
Q.2.4 Interviewer: What factors that help you to control your illness? 
P4: My factor, em ... for instant, I control my diet, I'm afraid my blood goes up 
than what it should be, it will cause me a problem, I'm afraid that I have to in 
and out of hospital due to my illness , 
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P5: L myself wanted to do it, 
P6: Yes, the main factor that helps me to control my illness is my aim to live even 
longer, that's why I want to control my illness. Those who do not want to 
control his illness meaning that he or she want to die [laughing]; that person 
really want to get sick and die. For that reason I put my aim as to keep on 
taking my medication, have to control because I want to live even longer. 
The patticipants were further proved about sustaining the changes which they had 
achieved after practicing any one of the recommended control measures. Some 
patticipants did stated that they do not have any problems sustaining the changes. 
They presumed it as something should be done and some participant did admitted 
faced difficulties in sustaining the control. But, some try to motivate themselves and 
try to accept the fact that with their current health problem no choice they have to 
control it as to get better. 
Q2.5 Interviewer: Do you have any problem sustaining the control? 
P4: There's no problem, no problem at all, 
P4: For me, I will always look after my diet, although my condition is already 
OK, but I'm afraid it might turn worse if I stop, 
P4: So, for the time been /just continue controlling my diet. 
P5: We must try to sustain it, we have to look after our diet, we gradually control 
our diet, in order to be fit, we don 't want, err ... if we look at that food, we just 
take it, look such food so delicious, we just go ahead We have to control our 
urge a hi, 
P5: It is a must, as much as possible control it. 
P5: I do faced some difficulties to control, since I already have high blood 
pressure, I thought, I have to look after my diet. 
P6: 0 ... I don't have that's problem, because, I did told you before, when people 
advice us to look after our health, if we do not want to listen to it, meaning 
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that we want to get sick or even worse, but for me, I don't want that I'll 
follow the advice given to me, I'll and it is not a problem, like what you said, 
though you far younger than me, but I can take your advice, 100% I grateful 
with you, I listen to your advice and that is the best thing to do (laughing) 
P6: A .... sometime I do felt some difficulty to ward certain extent, 
P6: So, sometime, err ... I have to be selective with the food, because I want to get 
better, I want to get rid the problem, I did take such difficulty as a barrier for 
me to control and sustain such control, but 20-30% I do faced some difficult. 
P6: I would say and not going to hide it, the fact is that I do faced some barrier, 
but I try as much as possible not to surrender to it, if I can 't help it, my wife 
always remind me about the important for me to sustain my level of control, I 
treat it as something light and it would not be the end of the world if I don 't 
take avoidable type of food, but foremost I want to get better. 
The participants' experiences of lifestyle change were finiher explored; it was found 
that participants perceived lifestyle change as something positive and did have some 
thought that such changes very important for them to ensure their illness is control. 
On the other hand, another pruiicipant felt she did not feel it is necessary for her 
uptake lifestyle change due to lack of knowledge on how to come about changing her 
lifestyle. While another participant claimed changing his lifestyle i.e. smoking habit 
and unhealthy diet, after sometitne he did observed sotne positive outcome where he 
did not taking "panadol" or "cap kapak oilment" with him. Following are the 
responses given by the particular patients: 
Q2.6 Interviewer: How do you find lifestyle change? 
P4: Yes, I did thought about lifestyle change, but at the moment, I did not think of 
initiating any lifestyle change, 
P4: I did thought about it, but just I did not how to come about doing it, 
P4: In what we can change our lifestyle after or once been told that I'm having 
it, 
P4: I'm, not really sure how to come about changing my lifestyle. 
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PS: Making a change, if it gives positive effect definitely we go for it, 
PS: Definitely I want to search how I can change my lifestyle so that I can get 
better. 
P6: Definitely I'm trying to change, firstly about my smoking habit, I usually have 
two pack of cigarettes, now, with one pack and last for two days, for me I 
definitely wanted to change, I want to live longer, firstly, I need to listen to 
my doctor advice, your [investigator 1 advice and I told my wife, I really 
appreciate what you have done to me, I tell you, I'm a stubborn person, but 
when you [investigator 1 and other doctor advice me about my high blood 
pressure, so, I listen to my doctor advice. Before this, I hardly go to the clinic 
requesting some medication but now, I did use the privilege; I'm really 
stubborn [laughing]. 
P6: Moreover, I want to stop taldng unhealthy food, 
P6: Even now I do not want to take to much shrimp paste because I'm afraid my 
blood pressure will goes up. Before I met you [investigator 1, I usually have 
watery eyes; carry "Cap Kapak" oilmen with me. 
P6: Previously you can smell my "Cap Kapak" oilmen, but that is the biggest 
changes that I ever experience after I'm following this programme. I did not 
carry that oilmen and paracetamol anymore with me. 
Apart from getting the pmticipants' perceptions of lifestyle change, they were probed 
further about the importance of lifestyle change in relation to the control of their 
illness. The participants stated they learned the impoliance of lifestyle change based 
on their friend's experiences as well fi·om medical personal. One of the participants 
did thought about it but lack of knowledge on lifestyle change limit her from 
pursuing it. 
Q2. 7 Interviewer: Where do you learn the important of lifestyle change to the 
control of your disease? 
P4: I did thought about it, but just I did not how to come about doing it, 
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P5: I did ask about it from the clinic personal. 
P6: Yes, it is true, if, because my friends, when he fall sick, he can get better, but 
why I can't be the same? I can't get better, so, I asked him how or what he 
did to get better? So he told me ... "we have to listen to our doctor advice, we 
have to avoid some of the food, " he said. We can get better. 
Next, participants were probed fwther on whether they have any difficulty to 
continue or sustaining lifestyle change. Participants did faced some difficulties to 
sustain changes that they had made to their present lifestyle despite they already did 
the lifestyle change or have some thought of it. Among reason contributing toward 
this difficulties are lack of knowledge on lifestyle change, personally they 
thetnselves feel it is hard to change and sustain the changes especially at their age. 
However, sotne did try to fotm positive thinking towards lifestyle change and 
rationalize the impotiant and its implication upon their illness control. 
Q2.8 Interviewer: Did the difficulty faced during change period prevent you to 
continue or/and sustained particular change? 
P4: Not a problem, 
P4: If I were informed how to do it, definitely I'll try it slowly. 
P5: Definitely there is some dffficulty that !faced during initiating change, 
P5: Yes, it is difficult to sustain it, but I know that I'm having this high blood 
pressure, I said to myself, I ought to initiate such control. 
P5: We have to sustain it, we have to take care our diet, we control our diet so 
that we can be fit, we don 't want .... err ... after we view the food and 
immediate we have it, look some irresistible food, we just have some, we need 
to control out desire. 
P6: I would not say or hide it, the fact is that I do faced some barrier, but I try as 
much as possible not to surrender to it, if I can't help it, my wife always 
remind me about the important for me to sustain my level of control, I treat it 
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as something light and it would not be the end of the world if I don't take 
avoidable type of food, but foremost !want to get better. 
Following from that question, participants were asked about factors support or drive 
them to practice lifestyle change. The participants stated it should be from 
themselves because although others might facilitate or enhance the drive to change 
but, if they themselves have no interest it will be a failure. So, to these participants 
aprut of interest and support of other i.e. family member or friend, they themselves 
should play an important role and no doubt providing sufficient knowledge will 
enhance confidence to initiate lifestyle change. 
Q2.9 Interviewer: What factors that support or drive you to practice lifestyle 
chru1ge? 
P4: I did thought about it, but just I did not how to come about doing it, 
P5: lt'sfrom me, 
P5: Yes, I'm interested to do it. 
P6: It should start from our self, if we do not want to change, even our family 
could not do anything, and it should be on our own self. 
P6: The truth is, whatever it is, illness or other things, if we our self do not want 
to change, you definitely would not change, frankly speaking, like myself, I 
have to make myself strong, because I did told you before, my daughter 
always advice and remind me about my illness, at least we should put up 
some interest on it. 
P6: I did learn about this fi·om my fellow friend, when I fall sick, he managed to 
control his illness, why I cannot do the same? We have to question our self, 
how to come about doing it, "0 ... you have to listen to your doctor advice, 
whatever they advice you to avoid, best try to avoid it; so if we feel sick, we 
definitely wanted to get well", he said That why I thought if there are 100 
good doctor to give good advice to their patient, that would be brilliant 
[laughing], 
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P6: Main factor that make me think about changing my lifestyle is: to me those 
who do not want to change, meaning that he or she wanted to die fast, when 
we want to find ways to cure our self meaning that we set our gold as wanted 
to live much longer, therefore those who do not want to watch out their 
illness meaning they want to die [laughing], 
A few participants did mention currently, they do practiced one of the recommended 
lifestyle change activity (i.e. diet control and exercise, reducing smoking habit). 
Subsequently, participants were proved about problems or barrier that they might 
encountered during the practice of lifestyle change activity. 
Q2.1 0 Interviewer: What types of healthy lifestyle activity that you currently 
practising? 
P4: Ah ... I reduce salty food, I will reduce adding salt when preparing meal, 
avoid eating meat and liver, seldom eating chicken, regularly eat vegetable, 
that all, 
P5: I just do exercise, 
P6: Yes, I do want change my lifestyle, firstly my smoking ｨ｡｢ｩｴｾ＠ I usually have 
two packs a day, but for now I try to reduce to one pack for two days ... 
P6: Moreover, I want to reduce taking avoidable type of food, I don't want it 
anymore, all those nonsense, 
P6: Currently I do not want to take too much prawn paste, because of my anxiety, 
I really afraid that my blood pressure goes up, it's really painful having high 
blood pressure, before I met you, I used to have watery eyes, and only depend 
on this "cap kapak" ailment, I never treat my problem. 
The participants do not have any problem or facing any barrier toward initiation 
lifestyle change. They did realize they should change their way of lifestyle for they 
own good. However, some did feel it is not necessary to change her lifestyle at the 
moment because it would not affect her daily living. Some did felt some difficulties 
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but they manage to find out ways to compensate such barrier such as take lifestyle 
change slow and easy, or take it as a challenge which they have to con1plete and 
rewarded if have done well. 
Q2.11 Interviewer: Have you encounter any barrier or problem to change your 
lifestyle? 
P4: I did not feel it as barrier or problem; I do not feel any problem with it, 
P4: !feel force to do it because I'm having high blood pressure, 
P4: At the moment I do not feel like changing my lifestyle, 
P4: It does not affect my daily lifestyle; just do not feel like doing it at the 
moment, 
PS: I did feel difficult to maintain control of my illness, because I had high blood 
pressure, I thought, I definitely need to control whatever things I eat, 
PS: Yes, I just take it easy, go for a walk, talk to my friend, share my problem with 
them, let everything out of my chest, then !feel better. 
P6: Yes, I did.find it is hard to change, but if we wanted to change, so we need to 
face all the hardship, that's how the game was played, for example if I'm now 
at stage 1, so definitely I want to move to the next level, another example, if 
our working performance is good so I definitely wanted to make my 
performance much better, so this is applicable to my fight to control my 
illness, I definitely wanted to lower my blood pressure up to the best level as 
much as possible, 
P6: 0 ... if that matter, that is not a problem, because like what I said before, if 
people give us good advice pertaining to our health, if we do not want to 
listen meaning that we want to sick, but I definitely do not want to be like so, I 
will try to follow the advice, that's not a problem, like your [investigator 1 
give advice, although I'm pretty older than you but I do not bother, thank you 
very much for your [investigator 1 advice, the best part of it is that if other 
advice us meaning that they try to educate us about our illness. 
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Finally, participants were probe whether they still continuing with their current 
lifestyle although the barriers faced has been sort out but still persist. One of the 
participant still highlighting that there is no need for her to change but the other two 
pointing out the important to sustain the changes as to ensure their quality of life and 
illness is within control. 
Q2.12 Interviewer: Although you have try to eliminate some barrier for you to 
change, but that barrier still persist, would you continue you're afford to 
change or revert to old lifestyle? 
P4: I did not feel it as barrier or problem; I do not feel any problem with it, 
P4: !feel force to do it because I'm having high blood pressure, 
P4: At the moment I do not feel/ike changing my lifestyle, 
P4: It does not affect my daily lifestyle; just do not feel like doing it at the 
moment, 
PS: We have to sustain ｩｴｾ＠ we have to take care our diet, we control our diet so 
that we can be fit, we don 't want .... err ... after we view the food and 
immediate we have it, look some irresistible food, we just have some, we need 
to control out desire. 
P6: I would not say or hide it, the fact is that I do faced some barrier, but I try as 
much as possible not to surrender to it, if I can 't help it, my wife always 
remind me about the important for me to sustain my level of control, I treat it 
as something light and it would not be the end of the world if I don 't take 
avoidable type of food, but foremost I want to get better. 
3.2.3 Views of current health intervention programme: 
The last section of the interview explores participants' opinion of the ongoing 
standard intervention programme. It sought to determine participants' view of any 
intervention programtne they ever attended before, the knowledge gained fron1 the 
programme and their interest to attend such programme in future. 
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Most of the patient never attend any kind of intervention progranune apart from the 
one organized by investigators. They find the standard intervention progranune 
informative where they had gained and learned a lot of things about their illness, to 
control and prevention methods till the important of controlling and sustaining 
lifestyle change. Despite been informative, some did feel that they are forced o attend 
the progranune. Most did mention their willingness to come to future intervention 
programme. The following are responses peltaining to participants' view on cunent 
intervention: 
Q3 .1. Interviewer: Have you ever attend any kind of standard intervention 
programme before? 
P4: Never, 
P4: Never at all except the programme you [investigator] held at the hospital. 
PS: Yes, I did attend that programme, 
PS: I never attend other programme than that. 
P6: A ... after you [investigator] went back to England, those people from the Red-
Crescent did organized similar programme at Gedung. Whatever given in 
that programme already heard when I'm attending your [investigator] at the 
hospital. 
Q3.2 Interviewer: What do you of think of the standard intervention progranune 
that you attended? 
P4: I think it is good; it is good I went to that programme, 
P4: I thought it is good; I create my interest to learn about my illness. It is good 
for me as patient and been invited to come. It's really good programme. 
PS: I was force to come, I was contacted; and I feel, I should attend the 
programme, 
119 
P6: Err ... if other says that this programme does not bring any benefit; I can says 
that person is totally stupid, I think it is a good activity, for me is like a blind 
person been given back his eye-sight; those without any knowledge will then 
gain some knowledge; bad person becoming good person; you [investigator 1 
understand what I'm saying. If possible this kind of activity is good, after I'm 
following this programme what I'm find most impressive that I manage to 
stop carrying "Cap Kapak" oilmen with me and able to sleep well at night. 
Q3 .3 Intervention: What have you learn or gain from the standard intervention 
programme? 
P4: A lot of things that I learn from that programme, like, so, we need to exercise 
everyday, when we have time, we try to allocate time for exercising, it is 
definitely good, 
P5: 0 ... at that programme, I learn about exercise; we have to take our 
medication as prescribed; what else, I could not remember. 
P6: Err ... a lot of things that I learn from that programme, but I did not know 
about other people, 
P6: A lot of things that I learn, firstly, about diet control, working, about exercise 
I did regularly went for jogging, until now I'm still doing it, 
P6: I definitely did it, you [investigator 1 do not have to ask from others, I'm 
already admit that I regularly do exercise starting the day I'm joining your 
[investigator 1 programme. At first, I never heard talk on diet, undergo blood 
test but after I did change after attending that programme. 
P6: A lot things to see and learn, 
P6: Previously, I did not know anything about my illness; I'm really stubborn like 
I said before. Once I, myself got it than I realized that I need to listen 
[laughing]. 
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Q3 .4 Interviewer: Which information on high blood presstu·e that is important for 
you to know? 
P4: I'm interested to know ways to lower high blood pressure, what should I do to 
control my blood pressure, 
PS: I would to know more about high blood pressure and diabetes, 
PS: I would like to know more about ways to control high blood pressure, 
PS: Yes, diet control, exercise, what are the things that we can do on daily basis, 
P6: If possible I want to know more about medication which is good and other 
educational programme which can help us {patient] get better quality of life. 
P6: I want ways or methods, 
P6: likewise, ways to healthy eating, like when we control our high blood 
pressure, what cause it to rise or going down, ways to get rid of high blood 
pressure, you [investigator] did gives us some leaflet, I still kept it with me. 
Q3 .5 Interviewer: Would you interested to attend health education or 
intervention programme in future? 
P4: Yes, I definitely interested to attend this kind o.fprogramme again in future, 
PS: I would like to come, we need to know how our conditions like is, they will 
teach us this and that, except if it is not far away. 
P6: Sure, I definitely wanted to come to this sort of programme again, if it related 
to my illness, I'll make time for it, Insyallah either it was organized by you 
[investigator] or other doctors. 
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3.3 Similarities and differences of Malaysian participants' views on determinant of 
successful control of hypertension: 
The analysis made on the six interviews derived the following fmding which 
representing the determinant of successful control of hypet1ension from Malaysian 
patient perspective: 
i. Similarities between groups: 
Part 1 of the interview focused the participants' knowledge of their condition and 
diseases. It was found that both groups share similar ways of describing their 
condition and illness. Both groups (successful and unsuccessful control of 
hypertension) referred to their feeling or previous symptotns experienced 
(P1/P2/P3/P4); or changes after taking medicine (P6) and ability to sense that her 
blood pressure increase or decrease :fi·on1 desired value (P5) to define the state of 
their condition. 
Both groups also define their state of condition is controlled by referring either at 
their feeling or previous symptoms experienced (P 1 to P6). This question is proved 
further by exploring other ways than what has been stated before to justify whether 
their condition is controlled or not. Both groups did refetred to their doctor's report 
while some based it on pat1icipant' s feeling and making sense or interpretation such 
feeling as to verify the level of control of her condition (P5) and son1e (P6) used to 
recall information gained fi·om others experienced or doctor's advice as a 
benchmru·k. 
Next, both groups were asking about their interest of seeking knowledge or 
information on their illness. Most participants obtained the knowledge of high blood 
pressure either from their family member with similar illness (P1/P4/P5/P6) or 
fl-iends (Pl/P2/P5/P6) or medical personal (P6). One of the participants never asked 
for more information and among the reasons are: he's satisfied with his current 
condition; he's on medication and constantly been infotmed that his condition is 
good by the respective medical personal (P6). Then, participants' level of knowledge 
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was probe further to explore the types of information they have in relation to their 
illness. Most patticipants had superficial or basic knowledge of their illness such as 
risk factors, cause or sign and symptoms. Although one patticipant did states never 
seek information about their illness but he able to define his level of knowledge 
based on the symptoms which previously appear (P3). 
Lastly, both groups were probed about source of information of their illness; some of 
the participant stated it was hard for them to search infonnation on high blood 
pressm·e (Pl/P4/P6). So, basically their main source of information is either from 
their family metnber or friends with high blood pressw·e or medical personal 
(Pl/P2/P4/P5/P6). 
The second part of the interview concentrating on exploring both group views on 
factors motivated them to practice lifestyle change and barrier. The exploration of 
participants' views started at seeking participants' ways of controlling high blood 
pressure. Most participants did mention they did practise atly one of the control 
measures (i.e. diet control, exercise or reducing smoking habit) (Pl to P6). They 
started to uptake any one of the control measw·es based on others advice such family 
members, friends, and medical personal. Following this question, participants were 
ask to state changes (if any) in any fotm noticed after practicing respective control 
measw·es. The participants able to identify or notify some changes to them following 
fron1 initiation of any control measure such as: some mentioned experiencing some 
kind of "withdrawal symptom" (i.e. feeling dizzy) after statted practicing diet control 
(Pl); some realized the symptoms which constantly present before has gone off 
(P2/P4/P5/P6); and some did mentioned haven't see any changes following the 
initiation of controltneasures. 
Next, patticipants were asked whether they feel satisfied with the state of their 
cm·rent control. Most of them expressed their dissatisfaction of the outcome of their 
control. Some realized following from the practiced of any control measures; they 
still faced with some health problem related to high blood pressure (i.e. overweight, 
high cholesterol level) and some felt anxious of the relapse of previous symptoms 
(Pl/P6). 
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Following this question, participants were asked to state factors that help them to 
controlling their illness. Both groups did mention factors facilitate them with the 
control of their illness. Alnong the factors are: family members (Pl); investigator 
(P2); own self willingness (P5/P6), feeling anxiety of the illness will turn worse (P4) 
and the goal or desired to live longer (P6). All this factors had plays it own role in 
facilitating pruticipant with their control. 
Finally, participants were asked if they have difficulties in sustaining the changes 
following from the practised of control measure. Patticipants (successful control of 
hypettension) did state that they had no problems of sustaining the changes. 
Although some (Pl) did faced some kind of "withdrawal symptom" and it doesn't 
stopped participant continuing control sustaining the change. On the other hands, 
those pmticipants (unsuccessful control ofhypettension) did adn1it that they do faced 
difficulties in sustaining the changes. But they resolve the difficulties by developing 
positive perception such as: viewing control as something should be done, try to 
motivate themselves and accept the fact that they have no choice but to control there 
illness as to get better. 
Aprut from explodng participants view on practice of control measure and it 
implication to the control of illness; participants were probe further on aspect of 
lifestyle change. Both group perceived lifestyle change as something positive, 
important and must be continuously practiced as to obtain better outcomes. On the 
other hands, participant of each group (P3/P4) gives a negative feedback on lifestyle 
change and among the reason are: did not see any changes after initiating lifestyle 
change and always in a state of "OK" as what was constantly told by his doctor or 
not ready to initiate any lifestyle change due to lack of idea or knowledge on lifestyle 
change. 
The participants of both groups (Pl/P5/P6) lem·ned about lifestyle change either from 
their family tnetnber with similru· problem or friends which also suffering from 
similar health problem or came to realize the impo1tant of lifestyle change after they 
had practising it (P2). Both groups did indicate faced some difficulties or barrier 
through out the process of sustaining changes after trying to change their lifestyle. 
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However, most of them try to look at such banier as either something temporary in 
nature, or grounding for setting positive goal, or understand its important and 
implication in relation to the outcome of control. Among the reason lead to the 
existent of barrier to sustain change is: lack of knowledge how to initiate proper 
lifestyle change, personally they feel it is hard to sustain the changes and age factor. 
Both groups (Pl/P2/P4/P5) stated family metnber or friends or investigator does play 
an important role in providing support or drive for the participant to practice lifestyle 
change. But some of the unsuccessful controls of hypertension did highlight the role 
of "themselves" (P6) and the others act as enhancer to that support system. Both 
groups practiced diet control or exercise or reduce smoking. 
Both groups take barrier as something positive which they find comfortable with and 
they see it as something they should do for their own good. But some (unsuccessful 
control of hypertension) did feel it is not necessary to change his/her lifestyle at the 
moment because it would not affect her daily living. 
Both groups did state the important to sustain change because it is for their own good 
and some perceived it as prevention for them from end up having complication due 
to hypertension. 
Last part of the interview focus on the participant views of the standard intervention 
programme. The question covers their experiences on attending any kind intervention 
programme, knowledge gain :fi.·om the progra1nme, types of infonnation on 
hypertension which vital to the participant and lastly they interest to attend similar 
programme in future. 
Most participants never attended any intervention programme before apart :fi.·om 
what has been organized by the investigators. (Ql) Most of them did view that they 
did benefited from such intervention programme where it did started to trigger one of 
the participant (P2) interest to learn more about their illness and some did feel like 
they have to come since been contacted (QS). 
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Most patients did have some basic knowledge on hypettension i.e. risk factor, cause 
or sign and symptom. Most of them thought the important information for patient to 
know are: how to control or prevention of hypertension; other disease related to 
hypettension and way to control blood pressure from going up and overall control 
measures. Most of them interested to attend the programme in future. 
n. Differences between groups: 
It is very hard to identify the differences between successful and unsuccessful control 
of hypettension view on determinant of successful control of hypettension. It seems 
that both group share similar opinion about control of hypertension; but what make 
some of their view slightly different from other participant is either they do not have 
sufficient knowledge of the aspect discuss during interview (P4) or some participant 
felt satisfied with their condition and that is sufficient for them to ensure that they are 
cure (PS) or some did find they are not ready to commit to any change (P4 ). Another 
possible reason for this two participant's (P4/P3) view differed from other may be 
because they just had been a few months diagnosed with hypettension as compare to 
the rest of the patticipants. 
3.4 Summary 
The participants of successful and unsuccessful controlled of hypertension group 
have similar view on aspect discussed within interview and some did differ to certain 
extent. Although some of the participants did differ in their view of cettain aspect of 
lifestyle change and practice of control measure; but this difference doesn't mean 
that such participant against it or unwilling to change at all. 
The contributing factors to this gap may be due to lack of knowledge or patient's 
condition constantly been informed as good by their doctor rather than truly 
discussed with the patient the actual fact of their condition. This scenario can limit 
the patient with whatever knowledge they have on their illness; for instance by taking 
medication should be sufficient enough to ensure that their condition is controlled 
whereby they should look at the practice of control in an overall manner. In other 
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words, all the control measures (i.e. compliance to medication, controlling diet, and 
regular exercising) should be perceived as inter-related and not to be selected based 
on any preference as to ensure positive health outcome. 
In conclusion, whether controlled or uncontrolled hypertension was not the main 
issue why some patients' undergo similar intervention would not present expected 
health outco1nes. There are various things contribute to the detenninant of successful 
control of hypertension which ranged from the patient to health care provider to the 
sunounding or environment which support the changes do plays an important role as 
to ensure that the expected outcomes is achieved at the end of an intervention. 
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Table 4.2 The clinical outcomes of six participants of Study 2 
Participant ｾｲｯｵｰｩｮｾ＠
Clinical indicators Successful controlled hypertension Unsuccessful controlled hypertension 
T1 T2 T3 T1 T2 T3 
P1 P2 P3 P1 P2 P3 P1 P2 P3 P4 P5 P6 P4 P5 P6 P4 P5 P6 
Systolic blood pressure 140 150 130 140 130 130 120 120 130 180 150 160 140 130 150 140 130 160 
(<140mmHg) 
Diastolic blood pressure 90 90 100 90 90 90 70 80 80 100 80 90 90 80 100 70 70 90 
(<90mmHg) 
Lipid profile 
Cholesterol ( <5.2mmolll) 3.74 5.98 3.15 4.71 4.85 5.42 4.84 4.94 5.26 6.4 7.96 6.07 5.98 4.79 6.65 5.82 6.18 6.63 
Triglyceride ( <2.3 mmol/1) 2.43 0.91 0.63 2.54 1.03 1.09 1.83 1.43 0.68 3.71 0.96 2.44 2.04 1.27 1.51 1.27 0.6 1.76 
Hdi-C (>0.9mmolll) 0.35 1.38 0.31 0.52 1.11 1.39 0.83 1.19 1.17 0.63 1.13 0.58 1.49 0.89 1.69 1.06 1.39 0.97 
Ldi-C _(_ <3.9mmolll) 2.29 4.18 2.5 3.04 3.27 3.54 3.18 3.10 3.78 4.4 6.39 4.3 3.56 3.33 4.27 4.18 4.52 4.96 
Renal profile 
Serum urea (1.7-8.3 mmol/1) 2.8 3.8 1.8 2.8 7.2 2.1 4.0 5.5 3.6 3.2 5.5 5.3 2.7 4.3 4.8 3.8 5.1 5.7 
Creatinine (44-106 mmol/1) 82 94 42 89 119 57 102 118 79 58 92 121 52 64 114 62 59 135 
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CHAPTERS 
GENERAL DISCUSSION 
Aims and Overview 
The aim of this chapter is to discuss the principal findings of Study 1 and Study 2 and 
then draw together the implications across these two studies on predictors of health 
outcmnes among hypettensive patients in Malaysia. The chapter is divided into three 
sections: (1) summary of principal findings; (2) implications of main findings and (3) 
recommendation and suggestion. 
5.1 Discussion of principal fmdings 
The study conducted in the course of this research project revealed several interesting 
findings that may be beneficial to researchers interested in further exploring hypertension 
psychology in Malaysia. The findings highlight the potential of conducting more studies 
focusing on the psychological aspect of hypettension and development of intervention in 
the Malaysian context. 
5 .1.1 Principal findings of Study 1 : 
There is significant difference or change in tenns of patients' physical and medical 
indices across three times period and it represent a medium to large sized effects (r=-.41 
to -.85). But there was not much difference or change observed between the intervention 
group and the waiting list control group over three times period. The changes across this 
three times period are expected since most of the participants were on treatment prior to 
the commencement of the study. 
Next, the result showed some changes in 1nost psychological subscales either within 
intervention or between intervention and waiting list control group over three times 
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period. These changes has detnonstrated a medium to large sized effect (r=-.38 to -.87). 
The differences in mean score between groups over Time 1 and Thne3 was examine and 
test result showed significant differences in mean score of Eating self-efficacy; IPQ; 
MINICHAL; MHLC and GHQ-12 subscales (p<.05). Mann Whitney test was conducted 
and it appeared that the mean score of the psychological measures has found changed 
over Time3 {P<.OS). Then, the result also presented significant association between few 
psychological subscales and changes in few of the medical indices: Eating self-efficacy 
with changes in body mass index (BMI), p<.05; negative affect with changes in systolic 
blood pressure, p<.05; Chance of Multidimensional Health Locus of Control (Form C) 
associated with total cholesterol change, HDL-C change, and serum creatinine change 
(p<.05). 
In conclusion, the test results did show changes or differences within intervention group 
or between intervention and waiting list control group on aspect tested in this study. 
However, these results unable to represent or provide answer to the research question of 
why some patients undergone an intervention programme does well while others do not. 
5 .1.2 Principal finding of Study 2: 
The findings of the Study 2 highlight the similarities and differences of successful and 
unsuccessful control of hypettension patticipant's view on the determinant of successful 
controlled of hypertension from Malaysian patients perspective. The content analysis 
conducted on the six interviews revealed both successful and unsuccessful control of 
hypertension participants shared similar views on the three aspects (i.e. knowledge of 
condition; factors motivate lifestyle change or barrier to change; and view on current 
intervention programme) covered during interview. 
Both pruticipants' responses on knowledge of their condition and illness issue: most 
participants somewhat do have basic knowledge of their illness (i.e. risk factors or causes 
or symptoms) which they gained mostly from either family member or friend with similar 
health problem and medical personal. Participants able to assess their level of control 
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with the knowledge they had gained before. The participants interpreted the absent of 
previous sytnptoms or feeling as indicator or benchtnark for their condition is controlled. 
However, participants did find hard for them to gain information of their illness from 
other sources and some participants felt that it is not necessary for them to learn tnore 
about their illness since their condition always "OK:' as commented by their doctors. 
Those participants who practiced control measures (i.e. dirt control, exercise or reduce 
smoking) or has taken an attempt to change their lifestyle did find somewhat difficulties 
either changing their lifestyle or sustaining the changes. They resolved the difficulties by 
interpreting it as something temporary and will go off once controlled or perceived it as a 
challenge which they had to uptake in order to achieved desired outcome. The family 
metnber or friend with similar illness are the main factors support or drive pat1icipants to 
uptake control measures or change their lifestyle. Foremost, individual participants plays 
an itnpot1ant role in ensuring they are practicing control measures or lifestyle change 
while others (i.e. family member or friend or medical personal) become enhancer or 
support system. However, the participants did feel unsatisfied with the outcome observed 
after practicing control measures; where the problems (i.e. overweight or high level of 
cholesterol) still persist and some participant did not intend to change their lifestyle due 
to lack of knowledge on the impot1ance of lifestyle change and its implication to the 
control of hypertension or very much satisfied with their condition as constantly informed 
that their condition is .,OK" by their doctor. 
As far as the standard intervention programme is concern; both groups never attended 
any intervention programme before. They did benefit frmn the standard intervention 
programme and it triggered the participant's interest to learn more about their illness; but 
some did feel force to attend the intervention programme. 
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5.2 Implications of the principal findings of Study 1 and Study 2 
5 .2.1 Implications on intervention programme in Malaysia: 
The outcome of this study highlighted a few importance points which might improve the 
planning and implementation of an intervention programme available in Malaysia: 
i. Understanding what patient knows about their illness will indirectly help 
improve patient care. Each patient has his/her own interpretation of their 
illness as well as ways to control or prevent them from getting any 
complication later. Patient form their illness interpretation based on whatever 
information they gained from various sources especially those close to thetn 
(i.e. family member or friend with similar health problem). Knowing patient's 
illness perception or interpretation will help health-care provider correct any 
possible misconception or misunderstanding experienced by the patient. Thus, 
it will also provide health-care provider some background on which aspect to 
be concentrated when planning appropriate intervention for each patient. 
ii. It is importance to the patient to know the actual outcome of each assessment 
done during follow-up. Providing the patient with actual fact of their 
assessment outcome will help patient realize the importance of controlling 
their illness which subsequently avoid miss-interpretation of infortnation 
given by health-care provider. In other words, miss-interpretation of 
information might lead patient decide to ignore the needs to control their 
illness and practicing any recommended control measures or lifestyle change. 
iii. It is importance to be specific and clear with the patient especially in 
delivering information pertaining to the treatment and other control measures 
which they need to follow. Providing clear and precise information to the 
needs of each patient willtnake the patient clear what they need to do in order 
to achieve certain desired level, for instant, diet control, and patient should be 
thought the impot1ant of diet control and ways to implement it based on the 
patient capability. The specific desired goal should be discussed and planned 
ｬｬｾ＠
. . , 
with the patient as to ensure at the end of the intervention somewhat changes 
can be presented, and this will enhanced the patient confidence and see the 
benefit of it. 
tv. Proper planning an intervention programme will enhance the patient care; 
therefore, it is advisable to discuss the content of each intervention with 
particular group of patients. This will avoid delivering information which not 
that useful for the patient and which then failed the programme from 
achieving it initial objectives. 
5 .2.2 Implications on future research: 
The outcome of this study shed some light on the importance to futther study the factors 
contribute to the effectiveness of any intervention programme from Malaysian context. 
Although there are wide range of intervention programme implemented in Malaysia, but 
few study was done to assess the actual implication or the effect of such intervention on 
the patient's psychosocial status and quality of life. Future studies should also take into 
account cultural-specific factors such as the quality of support received in the attempts to 
predict psychological and functional outcomes of having a chronic disease, hypertension 
in patticular. 
5.3 Recommendation and suggestion: 
In conclusion, it is recommended that further study or assessment should be done to 
evaluate and verify the effect of an intervention programme implemented in Malaysia. 
The proper evaluation of an intervention will provide some background or guideline 
which will assist in the plam1ing of future intervention programme either for 
communicable or non-communicable diseases. Furthermore, it is important to plan an 
intervention goal consistent with the expected outcomes (i.e. laboratory test or physical 
assessment) for each patient which then help patient realized its importance and its 
implication to their control. 
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DEPARTMENT OF PSYCHOLOGY 
UNIVERSITY OF SURREY, UNITED KINGDOM 
Kajian Berl{aitan Penentu-Penentu Tahap Kesihatan Di Kalangan Pesakit Yang Mengkuti 
Pt·ogram Intervensi Penyakit 
Telcanan Darah Tinggi Di Malaysia 
Saya, RASIDAH ABD WAHAB, seorang penuntut di University of Surrey akan melakukan kajian 
tersebut diatas. Tujuan kajian tersebut adalah menilai penentu-penentu tahap kesihatan dan perubahan 
pada tahap kognisi, emosi, tiugkahlaku dan kesihatan pesakit Tekanan Darah Tinggi selepas 
mengikuti program intervensi penyakit Tekanan Darah Tinggi. 
Berikut adalah siri borang soal selidik yang perlu anda lengkapkan. Soalselidik ini mengandungi 
LAP AN bahagian. Setiap bahagian mengandungi araban tersendiri dan anda dikehendaki memberi 
maklumbalas mengikut araban pada borang tersebut. Bahagian A: Eating Self-efficacy Scale; 
Bahagian B: Exercise Self-efficacy Scale; Bahagian C: Illness Perception Questionnaire for 
Hypertension; Babagian D: Quality of Life Questionnaire on High Blood Pressure (MINICHAL ); 
Bahagian E: Multidimentional Health Locus of Control Questionnaire; Babagian F: General Health 
Questionnaire; Bahagian G: Maklumat Pesakit; Bahagian H: Maklumat Klinikal Pesakit. Borang 
yang telah dileugkapkan hendaklah dikembalikan kepada penyelidik. Kami akan mempastikan setiap 
maklumat yang diperolehi akan dirahsiakan. 
Tarikh: 
Nombor Siri: 
UNIS/2007 I T ( ) 
Bahagian A:Eating Self-efficacy Scale 
Soalan 1-23 sepatutnya dinilai berdasarkan kemungkinan anda akan mengalami masalah mengawal pemakanan 
anda pada setiap situasi berik:ut mengik:ut skala: 
A rail all: Sila BULATKAN jawapan anda pada nombor berkenaan: 
Sejauh manakah kesukaran anda alami ketika mengawal pemakanan anda sepanjang EMPAT minggu yang 
lepas .•• 
2 3 4 1 
Tiada kesukaran 
mengawal 
Mengalami sedikit 
kesukaran mengawal 
pem ak an an k pema anan 
1. selepas bekerja 
2. bila anda keletihan 
3. bila anda merasa sedih 
4. hila tertekan 
5. bersama kawan-kawan 
6. hila menyediakan makanan 
7. bila rasa kurang selesa 
8. bila berada di restoran atau jamuan 
9. hila bersama ahli keluarga 
10. hila diusik 
11 . hila marah 
12. bila anda marah pada diri sendiri 
13. hila murung 
14. hila anda merasa tidak sabar 
15. selepas suatu pertengkaran 
16. bila anda merasa kecewa 
17. bila makanan menyelerakan dihadapan anda 
18. hila anda ingin menyenangkan hati 
19. hila terdapat hanyak makanan didalam peti sejuk 
20. hila anda merasa terlalu sensitif 
21. hila merasa takut 
22. hila lapar 
23. hila resah atau bimhang 
5 6 7 
Sentiasa mengalami kesukaran mengawal 
pemakanan 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
- 1 -
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Bahaian B: Exercise Self-efficacy Scale 
Bagi soalan 1-18 anda sepatutnya menilai sejauh mana keyakinan anda untuk kerap melakukan rutin 
senaman (tiga atau lehih dalam seminggu) pada setiap situasi herikut. 
Aralla11: Sila nilaikan keyakinan anda untuk melakukan rutin senaman pada setiap situasi herikut 
berdasarkan simla nomhor 0 hingga 100 ini: 
0 50 
Tidak yakin dapat melakukan Dapat melakukan secara seder·hana 
SITU ASI 
1) hila saya merasa penat 
2) hila saya merasa tertekan disehahkan ketja 
3) ketika cuaca hw·uk 
4) hila semhuh daripada kecederaan yang menyehabkan saya berhenti bersenam 
5) ketika atau selepas menghadapi masalah peribadi 
6) hila saya merasa mw·ung 
7) hila saya merasa resah 
8) selepas sembuh daripada penyakit yang menyehabkan saya berhenti hersenam 
9) hila saya merasa kurang selesa secara fizikal ketika bersenam 
1 0) selepas bercuti 
11) hila saya mempunyai ban yak tugasan dirwnah 
12) hila ada pelawat 
13) hila terdapat aktiviti yang lehih menarik untuk dilakukan 
14) hila saya tidak mencapai matlamat untuk melakukan senaman 
15) tanpa sokongan daripada keluarga dan kawan-kawan 
16) ketika bercuti 
17) hila saya ada masa terluang 
18) setelah mengalami masalah keluarga 
100 
Yaldn boleh 
melakukan 
KEYAKINAN 
-2-
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Bahagian C: Persepsi Penyakit Bagi Penyakit Tekanan Darab Tinggi 
Pandangan anda berkenaan penyakit Tekanan Darah Tinggi; 
• Kami berminat dengan pandangan anda berkenaan penyakit Tekanan Darah Tinggi. 
• Berikut keyataan yang dibuat oleh individu lain berkenaan penyakit Tekanan Darah Tinggi 
Araltall: Sila nyatakan sejauh mana anda BERSETUJU atau TIDAK BERSETUJU dengan setiap kenyataan 
berikut dengan menandakan (X) pada kotak berkenaan. 
Pandangan anda berkenaan penyakit Tekanan Sangat Tidak Tidak Setuju Sangat 
Darah Tinggi Tidak Setuju Pasti Setuju 
Setuju 
er5 Menghidapi penyakit Tekanan Darah Tinggi membuat 
saya berasa resah 
ti5 Saya akan menghidapi penyakit Tekanan Darah Tinggi 
seumur hidup 
erl Saya menjadi murung apabila memikir tentang 
penyakit Tekanan Darah Tinggi saya 
cy4 Saya telah mengharungi tahap baik dan teruk penyakit 
Tekanan Darah Tinggi saya 
cq6 Penyakit Tekanan Darah Tinggi saya menyukarkan 
sesiapa yang rapat dengan saya 
cq5 Penyakit Tekanan Darah Tinggi saya mempunyai 
implikasi kewangan yang serius 
cp5 Saya mempunyai kekuatan untuk mempengaruhi 
tekanan darah tinggi 
cql Penyakit Tekanan Darah Tinggi saya adalah serius 
cp3 Keadaan penyakit Tekanan Darah Tinggi saya 
bergantung pada saya sendiri 
ti2 Penyakit Tekanan Darah Tinggi saya adalah kekal dan 
bukan sementara 
cy3 Tekanan Darah Tinggi saya sukar dijangka 
er6 Tekanan Darah Tinggi menakutkan saya 
er3 Penyakit Tekanan Darah Tinggi menyebab saya 
merasa marah 
cq4 Penyakit Tekanan Darah Tinggi sangat mempengaruhi 
bagaimana orang lain melihat saya 
ti6 Penyakit Tekanan Darah Tinggi saya akan sembuh 
cq2 Penyakit Tekanan Darah Tinggi saya mempengaruhi 
kehidupan harian saya 
cp2 Sebarang tindakan saya menentukan tahap tekanan 
darah saya terkawal atau menjadi tetuk 
ti3 Penyakit Tekanan Darah Tinggi saya akan kekal untuk 
selama-lamanya 
ct4 Rawatan saya ikuti boleh mengawal penyakit Tekanan 
Darah Tinggi saya 
ct2 Rawatan yang dikuti berkesan mengawal penyakit 
Tekanan Darah Tinggi saya 
er2 Saya merasa sedih apabila memikirkan tentang 
. penyakit Tekanan Darah Tinggi saya 
ch5 Saya memahami kedudukan penyakit Tekanan Darah 
Tinggi saya 
ct3 Rawatan yang saya diikuti boleh mencegah kesan 
buruk penyakit Tekanan Darah Tinggi 
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Pandanganl pendapat anda berkenaan simptom/ yang pernah anda alami; 
• Kami benninat mengetahui tentang SIMPTOM yang anda alami setelah disahkan menghidapi penyakit Tekanan 
Darah Tinggi 
• Sesetangah individu mengalami atau tidak mengalami simtom penyakit Tekanan Darah Tinggi 
• Seumpamanya, sesetengah individu mengalami atau tidak mengalami simtom berkaitan dengan rawatan yang 
diikuti 
• Berikut adalah senarai simtom lazim bagi penyakit Tekanan Darah Tinggi 
• Aralla11: Sila nyatakan sekira anda pernah mengalami simtom berikut dengan membulatkan sama ada Y A atau 
TIDAK. Sekira anda pernah mengalami simtom berikut, sila nyatakan sama ada ia berkaitan dengan 
TEKANAN DARAH TINGGI atau RA WATAN bagi penyakit Tekanan Darah Tinggi anda. Sekira anda 
tidak pasti sama ada simtom berikut berkaitan dengan TEKANAN DARAH TINGGI atau RA WATAN, sila 
bulatkan TIDAK T AHU 
SIMPT Sayaada Sekira Simtom ini berkaitan dengan Simtom ini berkaitan dengan 
OM mengalami jawapan TEKANAN DARAH RA WA TAN penyakit 
simtom berikut YA TINGGI Tekanan Darah Tinggi saya 
iel Rasa TIDAK YA Sekira YA ril YA TIDAK TIDAK rml YA TIDAK TIDAK 
sakit TAHU TAHU 
ie2 Sakit TIDAK YA SekiraYA ri2 YA TIDAK TIDAK rm2 YA TIDAK TIDAK 
tekak TAHU TAHU 
ie3 Mual TIDAK YA Sekira VA ri3 YA TIDAK TIDAK rm3 VA TIDAK TIDAK 
TAHU TAHU 
ie4 Sukar TIDAK VA Sekira YA ri4 VA TIDAK TIDAK nn4 YA TIDAK TIDAK 
bernafas TAHU TAHU 
ie5 Kurang TIDAK YA Sekira YA ri5 YA TIDAK TIDAK rm5 YA TIDAK TIDAK 
berat TAHU TAHU 
bad an 
ie6 Lesu TIDAK YA Sekira YA ri6 YA TIDAK TIDAK rm6 VA TIDAK TIDAK 
TAHU TAHU 
ie7 Kejang TIDAK YA Sekira YA ri7 YA TIDAK TIDAK rm7 YA TIDAK TIDAK 
sendi TAHU TAHU 
ie8 Mata TIDAK YA Sekira VA ri8 YA TIDAK TIDAK rm8 VA TIDAK TIDAK 
bengkak TAHU TAHU 
ie9 Wheezin TIDAK YA Sekira YA ri9 YA TIDAK TIDAK rm9 YA TIDAK TIDAK 
ess TAHU TAHU 
ielO sakit TIDAK YA Sekira YA rilO YA TIDAK TIDAK nnl VA TIDAl( TIDAK 
kepala TAHU 0 TAHU 
iell Sakit TIDAK YA Sekira VA rill YA TIDAK TIDAK rml YA TIDAK TIDAK 
perut TAHU 1 TABU 
iel2 Sukar TIDAK YA Sekira YA ri12 YA TIDAK TIDAK rml YA TIDAK TIDAK 
tidur TABU 2 TAHU 
ie13 pening TIDAK YA Sekira YA ri13 YA TIDAK TIDAK rml VA TIDAK TIDAK 
TAHU 3 TAHU 
ie14 Lemah TIDAK YA Sekira YA ri14 YA TIDAK TIDAK rml YA TIDAK TIDAK 
TAHU 4 TAHU 
ie15 Hilang TIDAK YA Sekira YA ri15 YA TIDAK TIDAK rml YA TIDAK TIDAK 
nafsu TAHU 5 TAHU 
seks 
iel6 Mati TIDAK YA Sekira YA ri16 YA TIDAK TIDAK rml YA TIDAK TIDAK 
pucuk TAHU 6 TAHU 
ie17 Muka TIDAK VA Sekira YA ril7 YA TIDAK TIDAK nnl YA TIDAK TIDAK 
merah TABU 7 TAHU 
ie18 Degupan TIDAK YA Sekira YA ri18 YA TIDAK TIDAK rml YA TIDAK TIDAK 
jan tung TAHU 8 TAHU 
kuat 
ie19 Ngilu I TIDAK VA Sekira YA ril9 YA TIDAK TIDAK rml YA TIDAK TIDAK 
tajam TAHU 9 TAHU 
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Pandangan berkenaan simptom yang pernah anda alami; (bersambung) 
• Sekira anda pemah mengalami simtom selain daripada diatas dan ia mungkin berkaitan dengan TEKANAN 
DARAH TINGGI atau RAW AT AN bagi penyakit Tekanan Darah Tinggi, sila nyatakan pada ruangan 
dibawah. 
Arallam Sila nyatakan sama ada ia berkaitan dengan TEKANAN DARAH TINGGI atau RA WATAN bagi 
penyakit Tekanan Darah Tinggi dengan membulatkan VA, TIDAK atau TIDAK T AHU 
Simptom Simtom ini berkaitan dengan Simtom ini berkaitan dengan 
tekanan darah tinggi rawatan bagi tekanan darah 
tinggi 
ie20 ri20 VA TIDAK TIDAK rm20 VA TIDAK TIDAK 
TAHU TAHU 
ie21 ri21 YA TIDAK TIDAK rm21 VA TIDAK TIDAK 
TAHU TAHU 
ie22 ri22 VA TIDAK TIDAK rm22 YA TIDAK TIDAK 
TAHU TAHU 
Sekira anda ada mengalami simtom yang berkaitan dengan tekanan darah tinggi, sila jawab soalan berikut. 
Sekira TIADA, sila ke muka surat sebelah. 
• Kami berminat dengan pandangan anda berkaitan simtom penyakit Tekanan Darah Tinggi 
anda. 
• Berikut adalah kenyataan yang dibuat oleh individu lain tentang simtom yang mereka alami. 
Aralran: Sila nyatakan sejauh mana anda BERSETUJU atau TIDAK BERSETUJU pada petak 
berkenaan. 
San gat Tidk Tidak Setuju San gat 
Pandangan anda berkenaan simtom berkaitan Tidak Setuju Pasti Setuju 
tekanan darah tinggi Setuju 
cpl Banyak usaha boleh dilakukan untuk mengawal simtom 
penyakit Tekanan Darah Tinggi saya 
Simtom saya datang dan pergi tidak menentu I tidak 
cy2 tetap 
Simtom penyakit Tekanan Darah Tinggi saya bersilih-
cyl ganti dari hari ke sehari 
Pandangan berkenaan penyebab penyakit Tekanan Darah Tinggi anda; 
• Kami berminat dengan pandangan anda berkenaan penyebab penyakit Tekanan Darah Tinggi 
• Berikut adalah senarai penyebab-penyebab penyakit Tekanan Darah Tinggi 
• Setiap orang mempunyai penyebab yang berbeza, oleh itu, tiadajawapan betul untuk soalan berikut 
Aral1an: Sila nyatakan sama ada anda SETUJU atau TIDAK SETUJU tentang penyebab penyakit 
Tekanan Darah Tinggi anda dengan menandakan setiap satu penyebab berikut 
San gat Tidak Tidak Setuju San gat 
Kemungkinan Penyebab Penyakit Tekanan Darah Tidak Setuju Pasti Setuju 
ｔｩｮｾｾｩ＠ Setuju 
CAl Tekanan atau bingung 
CA2 Ketmunan 
CA3 Kuman atau virus 
CA4 Pemakanan atau tabiat pemakanan 
CA5 Takdir atau nasib tidak baik 
CA6 Penjagaan kesihatan yang tidak memuas 
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CA7 Pencemaran persekitaran 
CAS Tingkahlaku saya 
CA9 Berfikiran negatif tentang kehidupan 
CAlO Masalah keluarga dan bingung 
CAll Terlalu banyak kerja 
CA12 Status emosi saya sepe11i sedih, kesunyian, takut, 
resah 
CA13 Proses penuan 
CA14 Alkohol 
CA15 Merokok 
CA16 Kemalangan atau kecerderaan 
CA17 Peribadi saya 
CA18 Sistem daya tahan yang tidak memuaskan 
• Di dalamjadual berikut, sila senaraikan TIGA penyebab utama Penyakit Tekanan Darah Tinggi anda. 
• Anda boleh menyenaraikan penyebab seperti yang dinyatakan diatas, atau pandangan anda tersendiri. 
• Sekira anda tidak dapat menyenaraikan TIGA penyebab penyakit Tekanan Darah Tinggi, sila tulis satu atau dua 
yang anda pasti. 
Penyebab utama Penyakit Tekanan Darah Tinggi saya adalab: 
IMI 
1M2 
1M3 
Babagian D: Kualiti Hidup Bagi Penyaldt Tekanan Da•·ah Tinggi (MINICHAL) 
Soalan-soalan berikut adalah berkaitan dengan keadaan anda 7 hari lepas. Sila baca setiap soalan dan tandakan jawapan 
yang terbaik menggambarkan keadaan anda. Sila pilih satu jawapan bagi setiap soalan, pangkah (X) jawapan anda pada 
kotak berkenaan. 
Sepanjang 7 bari yang Jepas ••••••• 
Jarang Kadang- Agak Ke•·ap 
lea dang kerap 
1. Adakah anda mengalami masalah untuk tidur? 
2. Adakah anda mengalami masalah untuk mengekalkan hubungan 
sosial seperti biasa? 
3. Adakah anda mengalami masalah untuk bergaul dengan 
masyarakat sekeliling? 
4. Adakah and a merasakan tidak berupaya menjalankan 
tanggungjawab kehidupan harian? 
5. Adakah anda merasa sukar untuk membuat keputusan dan 
melakukan perkara baru? 
6. Adakah anda sentiasa merasa tertekan dan sangat gelisah? 
7. Adakah and a merasakan kehidupan merupakan satu us aha 
berterusan? 
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8. Adakah anda merasa sukar untuk mengikuti akitiviti harian seperti 
bias a? 
9. Adakah anda merasa keletihan dan lemah? 
10. Adakah anda merasakan diri anda berp_enyakit? 
11. Adakah anda sedar anda mengalami masalah untuk bernafas atau 
sukar bernafas tanpa sebarang sebab yang nyata? 
12. Adakah anda mengalami bengkakpada pergelangan kaki? 
13. Adakah anda sedar bahawa anda kerap kencing? 
14. Adakah anda sedar bahawa anda merasakan mulut kering? 
15. Adakah anda mengalami sakit pada bahagian dada walaupun 
tidak beketja? 
16. Adakah anda merasakan kekejangan atau ngilu pada mana-mana 
bahagian badan anda? 
17. Adakah Anda merasakan penyakit Tekanan Darah Tinggi dan 
rawatannya mengganggu kualiti hidup anda? 
Bahagian E: Multidimentional Health Locus of Control 
MHLC Borang B 
Arahan: Kenyataan berikut berkaitan sejauh mana anda BERSETUJU atau TIDAK BERSETUJU dengan· 
keadaan kesiahatan anda. Setiap kenyataan berikut diwakili oleh satu skala di antara SANG AT -SAN GAT 
TIDAK SETUJU (1) hingga SANGAT-SANGAT SETUJU (6). Kami menghendaki anda menandakan 
jawapan pada skala bagi setiap kenyataan tersebut. Semakin tinggi tahap persetujuan anda pada kenyataan 
tersebut maka semakin besar nombor yang akan anda bulatkan. Manakala, semakin kecil nombor yang akan anda 
bulat bagi menunujuk tahap tidak bersetuju anda bagi setiap kenyataan tersebut. Sila pastikan anda menjawab 
SEMUA kenyataan berikut dan BULATKAN hanya SATU nombor bagi setiap kenyataan. Soal selidik ini ingin 
mengukur tahap kepercayaan anda dan teryata tiada jawapan betul atau salah bagi setiap kenyataan. 
Sangat-Sangat 
Tidak Setuju 
(SSTS) 
2 
Sangat Tidak 
Setuju (STS) 
3 
Tidak Setuju 
(TS) 
4 
Setuju 
(S) 
5 
Sangat Setuju 
(SS) 
SSTS STS TS S 
1. Sekiranya saya jatuh sakit, saya berupaya memulihkan keadaan 2 3 4 
kesihatan saya semula. 
2. Selalunya saya merasakan walau apa pun saya lakukan, sekira 
saya akanjatuh sakit, saya akan sakit. 
3. Sekiranya saya sentiasa berjumpa doktor yang cekap, 
kemungkinan saya jatuh sakit adalah tipis. 
4. Adalah lumrah tahap kesihatan saya banyak dipengaruhi oleh 
sesuatu perkara yang berlaku secara kebetulan. 
---=--· 
1 
1 
2 3 4 
2 3 4 
2 3 4 
6 
Sangat-Sangat 
Setuju (SSS) 
ss sss 
5 6 
5 6 
5 6 
5 6 
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5. Saya cuma berupaya mengekalkan tahap kesihatan saya dengan 
betjumpa anggota kesihatan. 
6. Saya bertanggungjawab secat·a langsung ke atas tahap kesihatan 
say a. 
7. Orang lain memainkan peranan utama sama ada saya kekal 
sihat atau jatuh sakit. 
8. Sekiranya berlaku sebarang masalah terhadap kesihatan saya ia 
berpunca daripada diri saya sendiri. 
9 . Apabila saya sakit, saya akan membiarkan ia sembuh secm·a 
semulajadi. 
10. Anggota kesihatan memastikan saya sentiasa sihat. 
11. Apabila saya kekal sihat, saya cuma bemasib baik. 
12. Kesejahteraan fizika1 saya bergantung kepada bagaimana saya 
menjaga diri saya sendiri. 
13. Apabila sayajatuh sakit, saya sedar bahawa saya telah 
mengabaikan penjagaan kesihatan saya. 
14. Sejauh mana saya akan sembuh daripada sesuatu penyakit 
bergantung denganjenis rawatan yang saya terima daripada orang 
lain. 
15. Walaupun saya menjaga kesihatan, saya mudahjatuh sakit. 
16. Apabila saya jatuh sakit, ianya telah ditakdirkan. 
17. Saya akan sentiasa sihat apabila saya menjaga diri saya 
sendiri. 
18. Mengikuti nasihat doktor secara bertulis merupakan langkah 
terbaik untuk memastikan saya sentiasa sihat. 
MHLC Borang C 
2 
2 
2 
2 
2 
2 
2 
2 
2 
1 2 
2 
1 2 
2 
2 
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3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
Araban: Kenyataan berikut berkaitan sejauh mana anda BERSETUJU atau TIDAK BERSETUJU dengan 
keadaan kesiahatan anda. Setiap kenyataan berikut diwakili oleh satu skala di antara SANG AT -SANG AT 
TIDAK SETUJU (1) hingga SANG AT -SAN GAT SETUJU (6). Kami menghendaki anda menandakan jawapan 
pada skala bagi setiap kenyataan tersebut. Semakin tinggi tahap persetujuan anda pada kenyataan tersebut maka 
semakin besar nombor yang akan anda bulatkan. Manakala, semakin kecil nombor yang akan anda bulat bagi 
menunujuk tahap tidak bersetuju anda bagi setiap kenyataan tersebut. Sila pastikan anda menjawab SEMUA 
kenyataan berikut dan BULA TKAN hanya SATU nombor bagi setiap kenyataan. Soal selidik ini ingin mengukur 
tahap kepercayaan anda dan teryata tiada jawapan betul atau salah bagi setiap kenyataan. 
l 
Sangat-Sangat 
Tidak Setuju 
(SSTS) 
2 
Sangat Tidak 
Setuj u (STS) 
3 
Tidal<. 
Setuju (TS) 
4 
Setuju 
(S) 
5 
San gat 
Setuju (SS) 
6 
Sangat-Sangat 
Setuju (SSS) 
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SSTS STS TS s ss sss 
1. Sekiranya kesihatan saya semakin tenlk, tingkahlaku saya akan 1 2 3 4 5 6 
menentukan secepat mana saya pulih. 
2. Berdasarkan kesihatan saya, apa yang akan jadi, akan jadi. 1 2 3 4 5 6 
3. Sekira saya sentiasa berjumpa doktor saya, kemungkinan saya 1 2 3 4 5 6 
mengalami masalah dengan kesihatan saya adalah tipis. 
4. Kebanyakan perkara yang mempengaruhi kesihatan saya 1 2 3 4 5 6 
berlaku secm·a kebetulan. 
5. Setiap kali kesihatan saya menjadi teruk, saya sepatutnya 1 2 3 4 5 6 
betjumpa anggota kesihatan terlatih. 
6. Saya bertanggungjawab secm·a Iangsung sama ada kesihatan 1 2 3 4 5 6 
saya bertambah baik atau teruk 
7. Orang lain memainkan peranan penting sama ada kesihatan 1 2 3 4 5 6 
saya bertambah baik, kekal sedia kala atau menjadi tenlk. 
8. Sekira berlaku sebarang masalah ke atas kesihatan saya, ia 1 2 3 4 5 6 
berpunca daripada diri saya sendiri. 
9. Nasib memainkan peranan penting di dalam menentukan 1 2 3 4 5 6 
sejauhmana kesihatan saya pulih. 
10. Untuk memastikan kesihatan saya pulih, ia bergantung kepada 1 2 3 4 5 6 
bagaimana orang lain memastikan perkara yang betul dilakukan. 
11. Walaupw1 kesihatan saya pulih, ia merupakan satu takdir. l 2 3 4 5 6 
12. Perkara utama yang mempengaruhi kesihatan saya bergantung 1 2 3 4 5 6 
kepada apa yang saya lakukan. 
13. Saya patut menerima pujiaan sekira kesihatan saya bertambah 1 2 3 4 5 6 
baik atau teguran sekira ia menjadi teruk. 
14. Mengikuti araban bertulis daripada doktor merupakan cara 1 2 3 4 5 6 
terbaik untuk mengilakkan kesihatan saya bertambah teruk. 
15. Sekira kesihatan saya semakin teruk, ia adalah disebabkau 1 2 3 4 5 6 
takdir. 
16. Sekira saya bemasib baik, kesihatan saya akan bertambah 1 2 3 4 5 6 
baik. 
17. Sekira kesihatan saya semakin teruk, ia disebabkan saya tidak 1 2 3 4 5 6 
mengambil perhatian ke atas penjagaan kesihatan saya. 
18. Jenis rawatan yang saya terima daripada orang lain 1 2 3 4 5 6 
menentukan secepat mana saya akan pulih. 
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Bahagian F: General Health Questionnaire (GHQ-12) 
Sila baca dengan teliti: 
Kami ingin mengetahui sama ada anda mengadu sakit, dan bagaimana keadaan tahap kesihatan anda secara umum, 
bagi sepanjang beberapa minggu lepas. Sila jawab SEMUA soalan-soalan berikut dengan menanda pada petak 
berkenaan. Sila ingat bahawa kami ingin mengetahui aduan semasa kesihatan anda, dan bukan yang lepas. Adalah 
penting anda cuba menjawab SEMUA soalan-soalan berikut. 
Terima kasih atas ketjasama yang anda berikan. 
ADAKAH ANDA: 
1. berupaya untuk memberi tumpuan 
sepenuhnya kepada perkara yang dilakukan? 
2. kurang masa tidur disebabkan bingung? 
3. merasakan anda memainkan peranan 
didalam segala hal? 
4. berupaya membuat keputusan terhadap 
sesuatu perkara? 
5. senantiasa merasa tertekan? 
6. merasakan tidak dapat menyelesai 
permasalahan? 
7. berupaya menikmati aktiviti harian sepe1ti 
biasa? 
8. berupaya berdepan dengan masalah anda? 
9. merasa susah hati dan murung? 
10. hilang keyakinan terhadap diri sendiri? 
11. merasa diri sendiri tidak berguna? 
12. merasa senang hati dan berupaya berflkir 
secm·a waras? 
Lebih bail{ 
daripada biasa 
D 
0 
0 
0 
0 
0 
D 
D 
0 
D 
D 
0 
Seperti 
biasa 
D 
0 
0 
0 
0 
D 
D 
D 
0 
0 
0 
0 
Kut·ang 
daripada biasa 
0 
0 
D 
D 
0 
0 
D 
D 
0 
D 
D 
0 
Lebih kurang 
da1·ipada biasa 
0 
0 
0 
0 
0 
0 
D 
0 
0 
D 
0 
0 
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BAHAGIAN G: Latarbelalmng Responden 
Aralzan: Sila tandakan jawapan anda pada kotak berkenaan: 
1. Status pekerjaan: njawat kerajaan D 
Penjawat sektor swasta D 
Beketja sendiri D 
Penganggur D 
Pesara D 
2. Tahap pendidikan: Tiada pendidikan formal D 
Sekolah rendah D 
Sekolah menengah D 
Kolejluniverisiti D 
3. Jan tina: Lelaki 0 Perempuan D 
4. Keturunan: Melayu D 
India 0 
Cina D 
Lain-lain 0 
5. Umur: I Tahun 
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BAHAGIAN H: Relmd Klinil{al dan Pemeriksaan Fizikal: 
Aralla11: (Untuk dilengkapkan oleh penyelidik) 
I. Ketinggian: ___ meter 
2. Berat: ____ kilogram 
3. Beart badan unggul (BMI): ____ kg/m2 
5. Tekanan darah: Sistolik Distolik 
6. Profil Lipid: Jumlah kolesterol: __ _ 
HDL-C: ___ mmol/1 
LDL-C: mmol/1 
Triglyceride: mmol/1 
7. Fungsi renal: Serum creatinine __ _ 
Serum urea __ _ 
Udc Acid ___ _ 
8. Fasting Blood Glucose: ___ _ 
9. Jenis rawatan: 1. UbatO 
(Sila nyatakan nama ubat: _____________ __./ 
2. Rawatan selain daripada ubat 0 
(Sila nyatakan: 
3. Tiada menerima sebarang rawatanO 
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Study 2: Interview Schedule 
138 
ｾ Ｍ
The interview schedule: 
No. Items Question Prove question. 
'\i 1. Knowledge of disease • What do you know about your current Q- If patient says: States I'm suffering from 
status I condition condition? Hypertension, And I'm in a Great condition OR Good. 
Q- Let patient express more on great condition to assess 
patient understanding of their condition. 
• Do you feel that your current If patient says "YES" or ''NO", Q- ask patient to 
condition has improved? express in what way and why their condition improved 
or not improved? 
• How do you know that your current ｐｯｳｳｩ｢ｬｾ＠ answer; from my doctors, Q- ｾｫ＠ patient what 
condition has improved? information given to them which explain their condition 
by the doctor,· OR from my outpatient cards, ask patient 
further what information give hint that their condition is 
-..:..:: 
improved.· 
Ask patient further- Q- if they are the one that take the 
first initiative. to ask about their condition or leave it to 
the doctors or health personnel to deliver whatever 
outcome of the assessment. Q- Do at most time they 
feel satisfy with the explanation given to them about 
their condition. 
2. Knowledge of disease • What do you know about your Q- Let the patient express clearly what their 
disease? understanding of their disease. i.e. sign and symptom, 
causes, complication, blood pressure, medication, 
ｾｾｾｾｾ＠ ｾＢＢＧＭＭＭＭＭＮＴｬｬｩｬｬＧ ﾷ＠
------------------- ·--- ---··--- --
2. Change factors 
• How did you first learn about your 
disease? 
• Do you ever think of finding ways to 
improve your current condition after 
you have been confirmed having 
hypertension? 
• How did you first learn about ways to 
improve your condition? 
• What are the things that you think 
might help you· to improve your 
condition? 
control and prevention measure etc. 
Q- Let the patient express clearly what resource or 
information available to them on their disease. Q- How 
does the patient find the resources or information that 
they had excess with? Q- Do the patient find easy to 
gain excess to the relevant resources or information on 
their disease? 
If patient states "YES" or "NO"- Q- Do the patient feel 
that their lifestyle changed after been confirmed having 
hypertension? Q- Ask patient in what ways patient can 
improve their current condition. 
Q- Why patient think it is important to improve their 
current condition? Q- Do patient think that improving 
current condition will enhance their quality of life, or by 
having the disease affect their quality of life? 
Q- Ask the patient whether they are the one who take 
the first step to learn ways to improve their condition 
OR they are been advised to do so. Q- Do patient feel 
that they able to incorporate new ways to improve their 
condition into their current lifestyle or feel it as a 
burden or ignore it. 
ｾ＠
Q- Let the patient list out resources or information they 
obtain to improved their condition. Q- Ask the patient-
which information or ways they think would be helpful 
in improving their condition. Q- Do patient satisfy or 
"'· 
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-.:.:,. 3. Barrier to change 
• What factors motivate you to improve 
your current condition? 
• How far will these factors help you 
improving your condition? 
• Do you think that you will continue 
sustaining your current condition? 
• Will there any problems changing 
your old lifestyle and practicing new 
lifestyle? 
• What sort of problems that you faced? 
• Would you ever try to sort out such 
problems and how? 
happy with information they have. 
Q- Let patient list out possible factors motivate them to 
improve themselves? Possible answer- self- or others. 
Q-. Why it is this factor vital in helping them to 
. ? nnprove .. 
Q- .Could patient improve by their own or totally 
depending on others I factors? 
If Yes or No, Why you need to continue sustain your 
current condition? Q- Ask further if there any 
underlying factors/ reasons that make patient uptake or 
not interested to sustain the current condition? 
Q- Ask ｰ｡ｾ･ｮｴ＠ to elevate the problems faced. 
Q- What patient feeling/thought when been ask to 
change lifestyle? 
Q- Who responsible to ask or persuade them to change? 
Q- Do patient think it is important to change their 
current lifestyle? 
. Q- How or in what ways that patient feels at ease to 
change their lifestyle. 
ｩｯｲｾＭｾｴ＠ ｩｩ ｾ ｗＺＺＮＮＮｾ＠ • - · · ... ｦＮﾫｕｬｬｴｲＢｾＢＢｶＭＮＭＭＭＮｾ Ｍ ｭｾｾＢＢＢﾷＭＭ ﾷＭﾷ＠ ＭＭＭＭＭＭＮＬＮＮｾ＠
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4. Knowledge of 
intervention 
• Do you ever attend any kind of 
intervention programme after you 
have been diagnosed with 
hypertension? If ｹ･ｳｾ＠ could you 
describe types of intervention and 
what information did you gain or learn 
from that intervention? If no, why? 
• Do you face any problem attending 
the intervention programme? If no, 
what and who motivate you to come to 
the session? If yes, could you explain 
what your problem is? 
-- - ----- - - -- - -- -·· - - --- - ＭＭＭ ＭＭＭＭＭ ｾ＠
Q- If patient asked to change, what come to they mind? 
And how they dealt with it i.e. do they immediately take 
the advice or think about it and act accordingly or forget 
about it? 
Q- Prove patient type of intervention that they ever 
attend beside the programme? Q- Who motivate them to 
attend such intervention/programme? Q- What 
information they gain from such intervention? Q- Do 
patient feel the learn something from such intervention? 
Q- If patient list out info or they have learn from the 
intervention, asked them to elaborate in detail what they 
have learn, to ensure that they understand whatever info 
given during intervention. 
Q- What and who make them come to the intervention? 
Q- If patient does not learn anything at all, asked them 
to describe why they felt that way? 
Q- Prove further whatever answer patient given relating 
to the problem they faced when attendingintervention? 
Q- Asked patient whether they try to sort out ways to 
solve problem face when attending the intervention? 
Q- Asked patient if they are given option to either 
ＭＭﾷＭ Ｍ ＭＭ ﾷ ＭＭ Ｍ Ｍ ＭｾＭ Ｍ Ｍ ＭＭＭＭＭ ＭＭ __ ,_ ... ·- . - - . ' .... .... . __ - _.....__ ____ _________ . _____  - ------- ------· ＭｾＭ ·-· ···-· · - - ·· ·-- .. 
ＭＭＭＭＭＭＭＭＭＭＭ ｾＭＭｾＭＭ ｾ＠
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• Apart from your current knowledge of 
your health problem, do you ever try 
to search out more information about 
it from other sources? If yes, what sort 
of additional information that you are 
interested in and from where or whom 
you are seeking suph additional 
information? If no, why? 
Q- Prove patient to assess their initiative to search 
additional information on their disease? Q- What 
make them take the step to search more info? Q-
Does anybody motivate or persuade them to do so? 
Q- Prove patient to list out resources of additional 
information. 
Q- If patient did not search other info, question why 
they had taken such action? 
ｾ＠
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5. Benefit of intervention 
Ｇ［ｺｾＧｕｩｴＧＧＭｲ＠ - - - -- · 
• Do you find that intervention helps 
you improved your condition? If yes, 
in what ways does it helps you 
improved your condition? If no, why? 
• Apart form all information that you 
have gain from the intervention 
programme, which one do you think 
would works effectively with your 
intention to improved your condition 
and why? 
attend the intervention, would them take it positively 
and come by themselves or need persuasion most of the 
time or not coming at all. 
Q- Asked patient to elaborate in detail if they find the 
intervention help them improving or not? Why they feel 
such a viay? 
Q- If they feel it does not help, in what way it does not 
helping and how do they think or what would help them 
improve their condition? 
Q- Ifthey felt it helping them improving, in :what way 
and how? Preferably patient try to explain in more 
explicit manner by giving some example and prove in 
their own word that such intervention do help. 
Q .. If them say "YES", would they ever thought of 
taking further step ahead from whatever action or 
practice they think help them, let the patient to explain 
by providing some example or prove . 
Q- Prove patient to list out information and asked them 
to how selected information help improve their 
condition. Then Q- asked why they think the selected 
information is important than others? 
-- -- ••• •• •- ,_ ﾷ•ｾ＠ - --·--••W 
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THil . QUEEN'S 
.NNIVERSAII.Y PRIZES 
20_Q2 
Divisional Health Officer 
Kuching Divisional Health Office 
J alan Tun Ahmad Zaidi Adruce 
93586 Kuching, Sarawak 
MALAYSIA 
UniS 
University 
of Surrey 
Guildford 
Surrey GU2 7XH, UK ' 
Telephone 
+44 (0)1483 300800 
Facsimile /:. 
+44 (0)1483 300803 
www.surrey.ac.uk 
(Att: Medical Officer In-charge of Polyclinic Tanah Puti ) 
15 October 2006 
Dear Sir/Madam, 
School of 
Human 
Sciences 
Department of 
Psychology 
Facsimile 
+44 (0)1483 689553 
Study on Predictors of Health Outcomes in Patients Attending Hypertension 
Intervention Programme in Malaysia 
Please kindly refer to the above matter. 
I, ｾ｡ｳｩ､｡ｨ＠ bt Abd W aha]?, a research student in ｈｾ｡ｬｴｨ＠ Psychology at University of 
Surrey, United Kingdom would like to conduct an academic research at ｐｯｾｹ｣ｬｩｮｩ｣＠
Tanah Putih. I am ·planning to conduct the research commencing in November 2006 
until July 2007 at your out-patient department. 
The objectives of the research include the following: 
1. · To determine changes in cognitions, emotions, behaviours and health of 
hypertension patients attending Hypertension Intervention Programme. 
2. To determine predictors of health outcomes in hypertension patients after 
attending Hypertension Intervyntion Programme. 
For your information, I have received ethical approval from the Ethics Committee of 
Ministry of Health Malaysia allowing me to conduct tins study in your polyclinic. 
Therefore, I would greatly appreciate it if my · application for access to the 
Hypertension patient and patient's record at the polyclinic be granted. I am also would 
like to invite the staff of out-patient to involve in this study. Their involvement is very 
much appreciated because I believe they will greatly benefit fi.·om this study as the 
findings will be helpful in providing essential information on predictors, changes and 
outcomes of the patient attending the intervention programme. This in tum will assist 
in improving the current intervention programme that tailor to the needs of 
Hypertension patients. 
. 1:. 
Enclosed please find a letter of support from my academic supervisor, Dr Chris Fife-
, 
Schaw regarding the research. Please find also a copy of approval letter from the 
Ethics Committee, the research proposal as submitted earlier to the Department of 
Psychology, University of Surrey and research schedule. Please do contact me or Dr 
Chris Fife-Schaw at the following address for any further enquiries. 
Thank you for your attention and cooperation. I look forward to your response. 
Yours sincerely, 
.Department of Psychology 
University of Surrey 
Guild(ord 
GU2 7XH Surrey 
United Kingdom 
Tel: 0044 (0) 1483 876939 
Fax: 0044 (0) 1483 689553 
En1ail: rasidah2004@yahoo.com 
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THB QUJUiN'S 
NIVBRSAilY l'IUZil5 
2002 
Director of Health 
Sarawak State Health Department 
Jalan Tun Abang Haji Openg 
93590 Kuching, Sarawak, 
.MALAYSIA 
28 March 2006 
Dear Sir/Madam, 
UniS 
University 
of Surrey 
Guild ford 
Surrey GU2 7XH, UK 
Telephone 
+44 (0)1483 300800 
Facsimile /:. 
+44 (0)1483 300803 
www.surrey.ac.uk 
Proposed Study: Predictors of Health Outcomes in Patients Attending 
Hypertension Intervention Programme in Malaysia 
Please kindly refer to the above matter. 
School of 
Human 
Sciences 
Department of 
Psychology 
Facsimile 
+44 (0) 1483 689553 
I, Rasidah bt Abd Wahab, an MPhill PhD student in Health Psychology at University 
of Surrey, United Kingdom would like to seek permission to conduct academic 
research at Sarawak General Hospital and Policlinic Mosque Road and Tanah Putih. 
The objectives of proposed research include the following: 
1. To determine changes in cognitions, emotions, behaviours and health of 
hypertension patients attending Hypertension Intervention Programme. 
2. To detennine predictors of health 'outcomes in hypertension patients after 
attending Hypertension Intervention Progratrtme. 
The academic research will be conducted in the middle of 2006. Therefore, I would 
greatly appreciate it if my application for access to the Patient Education Unit at 
Sarawak General Hospital and patients at Polyclinics Mosque Road and Tanah Putih 
... 
.... ·i. 
Herewith I attached a letter of support from my academic supervisor, Dr Chris Fife-
Schaw regarding the proposed research. Please find FIVE copies of my application 
forms together with relevant documents required by the Research Committee, 
Ministry of Health Malaysia. Please do contact me at the following address for any 
further enquiries. 
Thank you for your attention and cooperation. 
Yours sincerely, 
ｒａｾｄｗａｈａｂ＠
Department of Psychology 
University of Surrey 
Guildford 
GU2 7XH Surrey 
United Kingdom 
Tel: 0044 (0) 1483 876939 
Fax: 0044 (0) 1483 6895.53 
Email: rasidah2004@yahoo.com 
/:. 
03 November 2006 
Mrs Rasidah Abd Wahab 
Department of Psychology 
School of Human Sciences 
Dear Mrs Abd Wahab 
UniS 
Ethics Committee 
Prediction of Health Outcomes in Patient Attending Hypertension Intervention Programme in 
Malaysia (EC/2006/97/PSYCHl 
On behalf of the Ethics Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the submitted protocol and supporting documentation. 
Date of confirmation of ethical opinion: 3 November 2006 
The final list of documents reviewed by the Committee is as follows: 
ｾｽ＠ ... Ｌｩｩ［ｾｲｴＭﾷｾｾ＠ ｾﾷ＠ • -" r Ｎｾｾｾ＠ • • • .,., ... ［ｾＮ＠ ... ｾ＠ , - - ｾ＠ ""':t't'..t." ·' ;.,.., ·- "; .. ｾＢ｜Ｎ＠ .... '. ... Ｎｾ＠ "'"' 
Application : 26/09/06 
Insurance proforma 26/09/06 
Research proposal 26/09/06 
Participant information sheet 26/09/06 
Consent form 26/09/06 
Questionnaires 26/09/06 
Patient profile 26/09/06 
Email from Malaysian Ministry of Health 20/10/05 
Your response to the Committee's comments 16/10/06 
Copies of letters fro'm participating clinics/hospital 02/11/06 
This op1n1on is given on the understanding that you will comply with the University's Ethical 
Guidelines for Teaching and Research. 
The Committee should be notified of any amendments to the protocol, any adverse reactions 
suffered by research participants, and if the study is terminated earlier than expected with reasons. 
You are asked to note that a further submission to the Ethics Committee will be required in the event 
that the study is not completed within five years of the above date. 
Please inform me when the research has been completed. 
Yours sincerely 
ｾＯＳｾ＠
Catherine Ashbee (Mrs} 
Secretary, University Ethics Committee 
Registry 
cc: Professor T Desombre, Chairman, Ethics Committee 
Dr Chris Fife-Schaw, Department of Psychology 
PEJABAT TIMBALAN KETUA PENGARAH KESIHATAN 
OFFICE OF THE DEPUTY DIRECTOR-GENERAL OF HEALTH 
(PENYELIDIKAN & SOKONGAN TEKNIKAL) 
(RESEARCH & TECHNICAL SUPPORT) 
KEMENTERIAN KESIHATAN MALAYSIA 
MINISTRY OF HEALTH MALAYSIA 
Aras 12, Blok E7, Parsel E, Presint 1 
Leve/12, Block E7, Parcel E, Precinct 1 
Pusat Pentadbiran Kerajaan Persekutuan 
Federal Government Administrative Centre 
62590 PUTRAJA YA 
Tel : 03 88832543 
Faks: 03 88895184 
MEDICAL RESEARCH & ETHICS COMMITTEE 
MINISTRY OF HEALTH MALAYSIA 
Ruj. Kami : (5) KKM/NIHSEC!/08/0804/POS-73 
C/o Institute for Medical Research 
Jalan Pahang 
50588 Kuala Lumpur 
Puan Rasidah Abd Wahab 
Psychology Department 
University of Surrey 
United Kingdom 
Puan, 
Tarikh : 31 Julai 2006 
Predictors of Health Outcome in patients attending hypertension intervention programme in 
Malaysia 
Lokasi projek : Hospital Umum Sarawak, Poliklinik Mosque Road dan Tanah Putih 
Dengan hormatnya perkara di atas adalah dirujuk. 
2. Jawatankuasa Etika & Penyelidikan Perubatan (JEPP), Kementerian Kesihatan Malaysia (KKM) 
mengambil maklum bahawa projek te(sebut merupakan syarat keperluan kurusus MPhii/Phd ､ｾｮ＠ telah 
diluluskan oleh pihak University of Surrey. 
3. Sehupungan demgan ini, dimaklumkan juga bahaw.a .Piba_k.JEPP KKM ｴｩｾ､｡＠ halangan,. dari segi 
etika, ke atas ｰ･ｬ｡ｾｳ｡ｮ｡｡ｮ＠ projek puan dengan syarat kebenaran diperolehi daripada Pengarah I 
Pegawai Perubatan Kanan di hospital dan poliklinik yang terlibat di dalam kajian puan. 
4. · Puan adalah dikehendaki mengemukakan laporan tamat kajian kepada Jawatankuasa Etika & 
Penyelidikan- Perubatan selepas tamatnya projek ini. · 
Sekian terima kasih. 
NTUKNEGARA 
ut perintah, 
(DATO' DR ZAKI MORAD MOHO ZAHER) 
Pengarah Rangkaian Pusat Penyelidikan Klinikal 
lnstitut Kesihatan Negara (NIH) 
Kementerian Kesihatan Malaysia 
Dan Pengerusi 
Jawatankuasa Etika & Penyelidikan Perubatan 
Kementerian Kesihatan Malaysia 
. . 
s.k. Pengarah Jabatan Kesihatan Negeri Sarawak 
Urusetia NIH, KKM 
PEJABAT KESIHATAN BAHAGIAN, 
BAHAGIAN KUCHING, 
JALAN TUN AHMAD ZAIDI ADRUCE 
93150, KUCHING, SARAWAK, 
MALAYSIA. 
Cik Rasidah Bt Abdul Wahap 
Department of Psychology 
University of Surrey, Gulldfor, UK 
Dear Cik Rasidah, 
Fax: 082-41.4542 
Telefon: 082-238635 I 
082-236454 /082-257867 
{:, 
Ruj kami : PKBK/014/005 
Tarikh : 2 November 2006 
"STUDY ON PREDICTORS OF HEALTH OUTCOMES INPATIENTS AlTENDING HYPERTENSION 
INTERVENTION PROGRAMME IN MALAYSIA" 
I refer to the above matter. 
I am grateful to Inform you that we bave no objection to your request. You are most welcome to carry 
out the study in our clinics as been requested. I hope the findings of your study can be shared and 
hopefully It will provide essential information that will help us in Improving our services.· 
Thank you. 
Your sincerely, 
(DR. HJ. JAMAIL BIN HJ. MUHI) 
Divisional Health Officer 
Kuchlng Divisional Health Office 
jbm/ .... 2-Nov-06 
.HOSPITAL UMUM SARAWAK 
JALAN HOSPITAL . 
93586 KUCHING 
Ruj. Tuan: 
Ruj. Kami: HU6/01.24/099/A/V5(14) 
Tarikh: 
19 Oktober 2006 
Department of Psychology 
University of Survey 
Guilford 
GU2 7XH Surrey 
United Kingdom 
(Att: Dr Chris Fife-Schaw) 
Dear Dr, 
Tel 
Faks 
Email 
{l, 
STUDY OF PREDICTORS OF HEALTH OUTCOMES IN PATIENTS 
AlTENDING A HYPERTENSION INTERVENTION PROGRAMME IN 
MALAYSIA 
With reference to your letter dated 15 October 2006, our hospital has no 
objection regarding the study. 
082-276666 
082-242751 
sgh@ ｨ･｡ｬｴｨＮｧｯｶＮｭｾ＠
2. .. However further detail of the study is required to be discussed later. 
Thank you 
ＢｐｅｎｙａｙＮｾｎｇＬｋｅｒｊａ＠ BERPASUKAN It PROFESIONALISME ADALAH 
. : ·.· BUDAY A KERJA KITA" . 
Yours sincerely, 
ＨｄｒＮｬｾａｎｇｋａｓＩ＠
Deputy Director 
Hospital Umum Sarawak 
Kuch1ng 
c.c Rasidah Abd Wahab 
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Mean and SD of Physical and Medical Indices among Intervention Group (N=34) 
Clinical Wl W2 W3 
items M(SD) Mdn S(SE) K(SE) M(SD) Mdn S(SE) K(SE) M(SD) Mdn S(SE) K(SE) 
Wei2ht 70.0 (16.2) 65.7 3.12 (0.40) 13.7 (0.79) 68.9 (16.3) 66.5 3.09 (0.40) 13.9 (0.79) 69.3 (16.9) 66.7 2.78 (0.40) 11.5 (0.79) 
BMI 29.6 (8.62) 28.3 2.82 (0.40) 10.7 (0.79) 29.2 (8.63) 27.4 2.91 (0.40) 11.1 (0.79) 29.3 (8.73) 27.4 2.77 (0.40) 10.2 (0.79) 
SBP 153.5 (16.5) 150.0 0.73 (0.40) 1.03 (0.79) 139.1 (15.0) 140.0 0.89 (0.40) 1.96 (0.79) 132.7 (15.2) 130.0 0.67 (0.40) 1.92 (0.79) 
DBP 94.4 (8.24) 90.0 1.06 (0.40) 1.84 (0.79) 90.9 (10.8) 90.0 0.42 (0.40) -0.57 (0.79) 82.7 (10.2) 80.0 0.69 (0.40) 0.21 (0.79) 
TChol 6.03 (1.89) 6.0 0.80 (0.40) 1.66 (0.79) 5.43 (1.26) 5.25 0.76 (0.40) 0.77 (0.79) 5.51 (1.19) 5.26 1.17 (0.40) 1.33 (0.79) 
HDL-C 0.96 (0.58) 0.63 0.62 (0.40) -1.09 (0.79) 1.08 (0.46) 0.97 0.53 (0.40) -0.68 (0.79) 1.04 (0.27) 1.03 0.07 (0.40) -0.52 (0.79) 
LDL-C 3.90 (1.24) 4.13 0.13 (0.40) -0.53 (0.79) 3.65 (1.31) 3.36 2.06 (0.40) 7.50 (0.79) 3.52 (0.98) 3.46 0.51 (0.40) 0.43 (0.79) 
Tg 2.69 (3.48) 2.05 4.71 (0.40) 25.0 (0.79) 2.26 (2.88) 1.66 4.98 (0.40) 27.1 (0.79) 2.08 (2.49) 1.43 3.85 (0.40) 17.0 (0.79) 
Creatinine 86.6 (29.3) 87.0 0.44 (0.40) 1.43 (0.79) 82.0 (27.8) 76.5 2.85 (0.40) 11.5 (0.79) 91.3 (23.1) 90.0 0.13 (0.40) -0.87 (0.79) 
Urea 4.24 (2.65) 3.75 3.33 (0.41) 14.9 (0.81) 3.75 (2.12) 3.0 2.08 (0.40) 4.99 (0.79) 4.85 (1.39) 4.70 0.36 (0.41) -0.88 (0.79) 
APPENDIX5 
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Mean and SD of Physical and Medical Indices among Intervention Group (N=34) 
Clinical items Related M(SD) Mean rank Sum of rank z score Exact Sig. r 
variable (1-tailed) 
Positive Negative Positive Negative 
rank rank rank rank 
WI 70.0 (16.I7) I5.64 I5.46 I09.50 355.50 -2.532 0.005 -.43 
W2 68.9 (16.35) 
Weight WI 70.0 (I6.17) 
W3 69.3 (16.92) I4.30 I6.8I I43.00 353.00 -2.058 O.OI9 -.35 
W2 68.9 (16.35) 
W3 69.3 (I6.92) I4.56 I5.54 233.00 202.00 -0.335 0.373 -.06 
WI 29.6 (8.62) I8.86 I5.84 132.00 396.00 -2.468 0.006 -.42 
W2 29.2 (8.63) 
BMI WI 29.6 (8.62) 
W3 29.3 (8.74) I4.60 I8.04 146.00 415.00 -2.404 0.008 -.4I 
W2 29.2 (8.63) 
W3 29.3 (8.74) 16.47 17.56 280.00 281.00 -0.009 0.498 
-1.54 
WI 153.5 (16.49) 8.83 I4.11 26.50 324.50 -3.836 0.000 -.66 
W2 139.1 (15.04) 
SBP W1 153.5 (16.49) 
W3 132.6 (15.24) 0.00 16.50 0.00 528.00 -4.981 0.000 -.85 
W2 139.1 (15.04) 
W3 132.6 (15.24) 12.25 10.7I 49.00 182.00 -2.346 0.008 
-.40 
DBP WI 94.4 (8.24) 10.6I 12.89 95.50 180.50 -1.372 0.088 -.23 
W2 90.9 (I 0.83) 
ｾ＠ Ｍ ｾ Ｍ ｾ ｾ＠
WI 94.4 (8.24) 
W3 82.6 (10.24) 9.50 I5.20 9.50 425.50 -4.648 0.000 -.79 
W2 90.9 (1 0.83) 
W3 82.6 (10.24) 15.50 13.14 62.00 289.00 -2.938 0.001 
-.50 
WI 6.03 (1.89) 12.56 21.89 201.00 394.00 -1.650 0.050 -.28 
W2 5.43 (1.26) 
TChol WI 6.03 (1.89) 
W3 5.51 (1.19) 15.70 I7.57 157.00 404.00 -2.207 ＰＮＰＱＳ ｾ＠ -.38 
W2 5.43 (1.26) 
W3 5.51 (1.19) 17.81 16.03 320.50 240.50 -0.715 0.241 
-.12 
W1 0.96 (0.58) 17.70 17.21 354.00 241.00 -0.966 0.170 -.16 
W2 1.08 (0.45) 
HDL-C WI 0.96 (0.58) 
W3 1.04 (0.27) 16.05 18.67 337.00 224.00 -1.010 0.160 -0.17 
W2 1.08 (0.45) 
W3 1.04 (0.27) 14.69 19.77 264.50 296.50 -0.286 0.391 
-0.05 
WI 3.90 (1.24) 14.29 18.55 171.50 389.50 -1.948 0.026 -0.33 
W2 3.65 (1.31) 
LDL-C W1 3.90 (1.24) 
W3 3.52 (0.98) 12.47 20.06 187.00 341.00 -1.440 0.077 -0.25 
W2 3.65 (1.31) 
W3 3.52 (0.98) 17.94 15.87 323.00 238.00 -0.759 0.228 
-0.13 
WI 2.69 (3.48) 13.84 20.75 221.50 373.50 ｾＱＮＲＹＹ＠ 0.099 
-0.22 
W2 2.26 (2.88) 
Tg WI 2.69 (3.48) 
W3 2.08 (2.48) 11.92 19.90 143.00 418.00 -2.457 0.006 
-0.42 
W2 2.26 (2.88) 
W3 2.08 (2.48) 13.68 19.45 191.50 369.50 -1.590 0.057 
-0.27 
------ - --
L__ __ 
- --- '----- -- -
·n WI 86.6 (29 .29) I5.38 I8.05 200.00 361.00 -1.439 0.077 -.25 
W2 82.0 (27.78) 
Creat WI 86.6 (29. 29) 
W3 91.3 _(23.15) I7.72 14.93 319.00 209.00 -1.029 O.I55 -.I8 
W2 82.0 (27.78) 
W3 91.3 (23 .15) I7.62 14.71 458.00 103.00 -3.173 0.001 0.54 
WI 4.24 (2.65) 15.38 I5.59 200.00 265.00 -0.669 0.256 -.II 
W2 3.75 (2.I2) 
Urea WI 4. 24 (2.65) 
W3 4.85 (1.39) 16.25 12.50 390.00 75.00 -3.240 0.000 -.55 
W2 3.75 (2.12) 
W3 4.85 (1.39) I5.31 20.63 413.50 82.50 -3.245 0.000 -.56 
--- -- ---- - --- · -
- ·------- ·. 
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Differences of Physical and Medical Indices between Intervention and Waiting list control group Over Timel and Time3 (N=67) 
Clinical Group N Timet Time3 
items 
Median Mann-Whitney zscore Exact. Sig. Median Mann-Whitney zscore Exact. Sig. 
u (1-tailed) u (1-tailed) 
Weight Intv.Grp 34 65.7 526.500 -0.433 0.335 67.3 348.500 -1.005 0.160 
Ctrl. Grp 33 66.7 64.7 . 
BMI Intv.Grp 34 28.3 477.500 -1.047 0.149 27.4 376.000 -0.573 0.286 
Ctrl. Grp 33 28.1 27.5 
SBP Intv.Grp 34 150.0 308.000 -3.232 0.001 130.0 383.000 -0.486 0.316 
Ctrl. Grp 33 140.0 130.0 
DBP Intv.Grp 34 90.0 309.000 -3.362 0.000 80.0 336.500 -1.282 0.104 
Ctrl. Grp 33 90.0 80.0 
TChol Intv.Grp 34 6.0 497.500 -0.796 0.215 5.26 330.000 -1.295 0.099 
Ctrl. Grp 33 6.28 5.08 
HDL-C Intv.Grp 34 0.63 260.500 -3.769 0.000 1.03 391.500 -0.330 0.373 
Ctrl. Gr_p 33 1.51 1.07 
LDL-C lntv.Gr_I!_ 34 4.13 498.500 -0.387 0.351 3.46 31.000 -5.990 0.000 
Ctrl. Grp 33 3.84 1.12 
I 
Tg Intv.Grp 34 2.05 520.000 -0.514 0.306 1.43 159.500 -3.973 0.000 .. 
Ctrl. Grp 33 1.63 3.14 
Creatinine Intv.Grp 34 87.0 339.000 -2.148 0.016 90.0 367.000 -0.715 0.240 
Ctrl. Grp 33 97.0 82.0 
Urea Intv.Grp 34 3.75 251.500 -1.770 0.039 4.70 288.000 -1.956 0.025 
Ctrl. Grp 33 4.65 3.90 
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Descriptive Statistics for Psychological Measures Subscale among Intervention Group: (N=34) 
Clinical items Wl W2 W3 
M(SD) Mdn S(SE) K(SE) M(SD) Mdn S(SE) K(SE) M(SD) Mdn S(SE) K(SE) 
ESE Scale 
Negative Affect 2.82 (1.18) 2.68 0.28 (0.40) -0.47 (0.79) 2.91 (1.44) 2.89 0.27 (0.40) -1.08 (0.79) 2.17 (0.90) 2.07 1.19 (0.40) 2.35 (0.79) 
Socially Acceptable 
Circumstances Efficacy 2.94 (1.25) 2.94 0.25 (0.40) -0.15 (0.79) 2.81 (1.42) 2.67 0.48 (0.40) -0.35 (0.79) 2.19 (0.97) 2.00 0.92 (0.40) 0.59 (0.79) 
Efficacy 
2.87 (1.18) 2.69 0.25 (0.40) -0.22 (0.79) 2.87 (1.41) 2.87 0.28 (0.40) -0.92 (0.79) 2.18 (0.92) 2.02 1.06 (0.40) 1.56 (0.79) 
ExSE Scale 
Situational/Interpersonal 28.5 (23.6) 25.0 0.43 (0.40) -0.88 (0.79) 42.6 (24.9) 41.7 -0.18 (0.40) -0.89 (0.79) 23.5 (20.3) 20.4 0.35 (0.40) -1.09 (0.79) 
Competing demands 39.1 (29.7) 45.0 0.01 (0.40) -1.27 (0. 79) 45.6 926.2) 50.0 -0.16 (0.40) -0.81 (0.79) 30.8 (26.0) 39.5 -0.08 (0.40) -1.51 (0.79) 
Internal feeling 22.4 (21.2) 17.8 0.68 (0.40) -0.51 (0.79) 30.2 (21.9) 28.6 0.29 (0.40) -1.11 (0.79) 18.4 (17.2) 20.7 0.63 (0.40) -0.53 (0.79) 
IPQ-R 
Identity 0.94 (0.48) 0.87 0.39 (0.40) 0.03 (0.79) 0.89 (0.68) 0.74 0.51 (0.40) -0.79 (0.79) 0.25 (0.38) 0.10 2.32 (0.40) 5.81 (0.79) 
Timeline acute/chronic 2.40 (0.69) 2.25 0.40 (0.40) 0.30 (0.79) 2.73 (0.82) 2.87 0.35 (0.40) 0.58 (0.79) 2.71 (0.85) 2.62 -0.09 (0.40) -1.15 (0.79) 
Time line (cyclical) 3.38 (0.60) 3.50 0.19 (0.40) 0.91 (0.79) 3.38 (0.60) 3.50 0.19 (0.40) 0.91 (0.79) 2.66 (0.54) 2.50 0.39 (0.40) 5.42 (0.79) 
Consequences 2.72 (0.75) 2.60 0.67 (0.40) 0.01 (0.79) 2.51 (0.67) 2.50 -0.07 (0.40) -0.48 (0.79) 2.39 (0.53) 2.40 1.78 (0.40) 6.12 (0.79) 
Personal control 3.78 (0.47) 3.75 0.19 (0.40) 0.29 (0.79) 3.82 (0.66) 4.00 -0.81 (0.40) 2.61 (0.79) 3.90 (0.35) 4.00 -0.90 (0.40) 3.47 (0.79) 
Treatment control 3.86 (0.82) 4.00 -1.15 (0.40) 3.19 (0.79) 3.83 (0.88) 4.00 -1.12 (0.40) 2.25 (0.79) 3.85 (0.51) 4.00 -1.78 (0.40) 5.41 (0.79) 
Illness coherence 3.79 (0.77) 4.00 -2.16 (0.40) 5.68 (0.79) 3.68 (1.04) 4.00 -1.55 (0.40) 2.23 (0.79) 4.00 (0.25) 4.00 0.00 (0.40) 16.5 (0.79) 
'I; 
Emotional Rep. 3.23 (0.88) 3.30 -0.11 (0.40) -0.70 (0.79) 2.83 (0.93) 2.80 0.18 (0.40) -0.65 (0.79) 2.43 (0.69) 2.00 0.71 (0.40) 0.20 (0.79) 
MINICHAL (Qol) 
State of mind 1.85 (0.55) 1.81 0.85 (0.40) 1.09 (0.79) 1.74 (0.51) 1.73 0.51 (0.40) -0.12 (0.79) 1.23 (0.37) 1.09 1.99 (0.40) 3.51 (0.79) 
Somatic manifestation 1.74 (0.64) 1.67 1.53 (0.40) 3.55 (0.79) 1.73 (0.59) 1.67 0.84 (0.40) 0.80 (0.79) 1.23 (0.39) 1.00 2.18 (0.40) 4.75 (0.79) 
l\fiiLC (Form B) 
Internal 4.73 (0.72) 5.00 -0.44 (0.40) -0.08 (0.79) 4.54 (0.79) 4.58 -0.65 (0.40) 0.71 (0.79) 4.25 (0.64) 4.00 2.06 (0.40) 3.25 (0.79) 
Chance 3.56 (0.67) 3.50 0.24 (0.40) -0.04 (0.79) 3.29 (0.64) 3.33 -0.11 (0.40) -0.76 (0.79) 3.05 (0.44) 3.00 -0.45 (0.40) 4.86 (0.79) 
Powerful others 4.08 (0.80) 4.00 -0.65 (0.40) -0.00 (0.79) 3.71 (0.70) 3.83 -0.20 (0.40) -0.47 (0.79) 3.73 (0.47) 3.67 2.73 (0.40) 9.26 (0.79) 
:MHLC (Form C) 
Internal 4.43 (0.66) 4.50 -0.16 (0.40) -0.07 (0.79) 4.30 (0.69) 4.25 0.09 (0.40) 0.28 (0.79) 4.09 (0.49) 4.00 1.81 (0.40) 7.35 (0.79) 
Chance 3.59 (1.01) 3.58 -0.19 (0.40) -0.79 (0.79) 3.29 (0.75) 3.33 -0.46 (0.40) 1.31 (0.79) 3.06 (0.48) 3.00 -0.66 (0.40) 5.09 (0.79) 
Doctors 4.17 (0.75) 4.33 -0.55 (0.40) -0.26 (0.79) 4.05 (0.87) 4.00 -0.68 (0.40) 1.33 (0.79) 4.08 (0.55) 4.00 0.71 (0.40) 6.96 (0.79) 
Other people 3.81 (0.93) 3.67 -0.64 (0.40) 1.11 (0.79) 3.06 (0.81) 3.00 -0.74 (0.40) 0.78 (0.79) 3.05 (0.64) 3.17 -2.04 (0.40) 4.91 (0.79) 
GHQ-12 15.7 (4.14) 15.0 1.49 (0.40) 2.90 (0.79) 15.4 (5.47) 14.5 0.24 (0.40) 0.46 (0.79) 1.99 (0.36) 2.00 -0.19 (0.40) 4.56 (0.79) 
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\. Mean and SD of Psychological Measures Subscale among Intervention Group Over Timet. Time2 and Time3 (N=34) 
I' 
Measures Related M(SD) Mean rank Sum of rank z score Exact Sig. (1-tailed) 
subscale variable Positive rank Negative rank Positive rank Negative rank 
Negative Affect W1 2.82 (1.18) 14.07 13.92 211.00 167.00 -.529 0.303 
W2 2.91 (1.44) 
Wl 2.82 (1.18) 11.05 18.98 110.50 417.5 -2.872 0.002 
W3 2.17 (0.90) 
W2 2.91 (1.44) 11.95 19.52 131.50 429.50 -2.663 0.003 
W3 2.17 (0.90) 
Socially W1 2.94 (1.25) 13.29 14.57 159.50 218.50 -0.709 0.244 
Acceptable W2 2.81 (1.42) 
Circumstances WI 2.94 (1.25) 13.38 17.54 107.00 421.00 -2.937 0.001 
W3 2.19 (0.97) 
W2 2.81 (1.42) 13.00 17.43 130.00 366.00 -2.313 0.010 
W3 2.19 (0.97) 
Efficacy W1 2.87 (1.18) 14.16 16.04 226.50 208.50 -0.195 0.426 
W2 2.87 (1.41) 
W1 2.87 (1.18) 11.78 18.35 106.00 422.00 -2.955 0.001 
W3 2.18 (0.92) 
W2 2.87 (1.41) 11.65 18.07 116.50 379.50 -2.578 0.004 
W3 2.18 (0.922 
Situational/ W1 28.5 (23.6) 14.61 7.92 277.50 47.50 -3.104 0.002 
Interpersonal W2 42.6 (24.9) 
W1 28.5 (23.6) 13.08 15.56 157.00 249.00 -1.049 0.294 
W3 23.5 (20.3) 
W2 42.6 (24.9) 8.14 18.29 57.00 439.00 -3.750 0.000 
-- . 
W3 23.5 (20.3) 
-------
Competing W1 39.05 (29.7) 11.43 10.14 160.00 71.00 -1.554 0.064 
demands W2 45.6 (26.2) 
W1 39.05 (29.7) 10.63 15.96 127.50 223 .50 -1.220 0.114 
W3 30.8 (26.0) 
W2 45.6 (26.2) 9.50 16.50 76.00 330.00 -2.896 0.001 
W3 30.8 (26.0) 
Internal feeling W1 22.3 (21.16) 14.50 9.81 246.50 78.50 -2.270 0.011 
W2 30.2 (21.87) 
W1 22.3 (21.16) 10.50 15.31 126.00 199.00 -0.985 0.325 
W3 18.4 (17.20) 
W2 30.2 (21.87) 13.50 17.50 108.00 420.00 -2.923 0.001 
W3 18.4 (17.20) 
Identity W1 0.938 (0.48) 15.15 14.88 197.00 238.00 -0.444 0.333 
W2 0.89 (0.67) 
W1 0.938 (0.48) 6.88 18.92 27.50 567.50 -4.618 0.000 
W3 0.25 (0.38) 
W2 0.89 (0.67) 3.17 17.38 9.50 486.50 -4.676 0.000 
W3 0.25 (0.38) 
Timeline Wl 2.40 (0.69) 17.89 8.40 322.00 84.00 -2.730 0.003 
acute/chronic W2 2.73 (0.82) 
W1 2.40 (0.69) 18.84 11.68 301.50 163.50 -1.426 0.079 
W3 2.71 (0.85) 
W2 2.73 (0.82) 13.97 17.50 237.50 227.50 -0.104 0.461 
W3 2.71 (0.85) 
Timeline W1 3.38 (0.60) 0.00 0.00 0.00 0.00 0.00 1.000 
(cyclical) W2 3.38 (0.60) 
---4 . - - . . 
WI 3.38 (0.60) 4.67 I6.I9 I4.00 421.00 -4.4I3 0.000 
W3 2.66 (0.54) 
W2 3.38 (0.60) 4.67 16.19 I4.00 42I.OO -4.4I3 0.000 
W3 2.66 (0.54) 
Consequences WI 2.72 (0.75) II.73 I8.38 152.50 3I2.50 -I.65 ｯｾｯｳＭｯ＠
W2 2.5I (0.67) 
WI 2.72 (0.75) 12.80 I7.52 I28.00 368.00 -2.362 0.008 
W3 2.39 (0.53) 
W2 2.51 (0.67) 13.81 19.19 221.00 307.00 -0.809 0.213 
W3 2.39 (0.53) 
Personal control W1 3.78 (0.47) I4.11 16.45 254.00 181.00 -0.797 0.217 
W2 3.82 (0.66) 
W1 3.78 (0.47) 16.I6 12.29 258.50 147.50 -1.289 O.I03 
W3 3.90 (0.35) 
W2 3.82 (0.66) 15.00 13.92 225.00 181.00 -0.507 0.310 
W3 3.90 (0.35) 
Treatment W1 3.86 (0.82) I0.50 11.55 115.50 115.50 0.00 o·.5os 
control W2 3.83 (0.88) 
WI 3.86 (0.82) 11.85 12.12 I18.50 157.50 -0.600 0.280 
W3 3.85 (0.51) 
W2 3.83 (0.88) 12.21 12.79 I46.50 153.50 -0.101 0.463 
W3 3.85 (0.51) 
Illness W1 3.79 (0.77) 6.00 7.86 36.00 55.00 -0.691 0.267 
coherence W2 3.68 (1.04) 
W1 3.79 (0.77) 5.40 3.00 27.00 9.00 -1.294 0.133 
W3 4.00 (0.25) 
W2 3.68 (1.04) 7.50 4.50 60.00 18.00 -1.706 0.055 
W3 4.00 {0.25) 
Emotional Rep. W1 3.23 (0.88) 10.79 16.34 75.50 359.50 -3.086 0.001 
W2 2.83 (0.93) 
Wl 3.23 (0.88) 5.90 16.90 29.50 405.50 -4.070 0.000 
W3 2.43 (0.69) 
W2 2.83 (0.93) 9.30 16.76 93.00 285.00 -2.311 0.010 
W3 2.43 (0.69) 
State of mind W1 1.85 (0.55) 17.25 12.63 138.00 240.00 -1.230 0.112 
W2 1.74 (0.51) 
W1 1.85 (0.55) 8.50 17.85 25.50 535.50 -4.560 0.000 
W3 1.23 (0.37) 
W2 1.74 (0.51) 8.25 16.08 33.00 402.00 -3.993 0.000 
W3 1.23 (0.37) 
Somatic W1 1.74 (0.64) 14.36 15.60 201.00 234.00 -0.360 0.365 
manifestation W2 1.73 (0.59) 
W1 1.74 (0.64) 8.88 15.44 35.50 370.50 -3.828 0.000 
W3 1.23 (0.392 
W2 1.73 (0.59) 8.33 16.74 50.00 385.00 -3.630 0.000 
W3 1.23 {0.39) 
Internal W1 4.73 (0.72) 10.64 16.83 149.00 202.00 -0.680 0.254 
W2 4.54 (0.79) 
W1 4.73 (0.72) 14.39 17.98 129.50 431.50 -2.705 0.003 
W3 4.25 {0.64) 
W2 4.54 (0.79) 12.85 16.13 128.50 306.50 -1.932 0.027 
W3 4.25 (0.64) 
Chance W1 3.56 (0.67) 12.40 16.37 124.00 311.00 -2.026 0.021 
W2 3.29 (0.64) 
\ W1 3.56 (0.67) 10.72 18.76 96.50 431.50 -3.140 0.001 
W3 3.05 (0.44) 
W2 3.29 (0.64) 10.50 19.32 136.50 328.50 -1.980 0.024 
W3 3.05 (0.44) 
Powerful others W1 4.08 (0.80) 13.50 17.02 121.50 374.50 -2.489 0.006 
W2 3.71 (0.70) 
W1 4.08 (0.80) 13.18 18.24 145.00 383.00 -2.229 0.012 
W3 3.73 (0.47) 
W2 3.71 (0.70) 18.77 14.95 244.00 284.00 -0.377 0.357 
W3 3.73 (0.47) 
Internal W1 4.43 (0.66) 11.00 16.42 154.00 197.00 -0.548 0.297 
W2 4.30 (0.69) 
W1 4.43 (0.66) 11.89 17.05 107.00 358.00 -2.596 0.004 
W3 4.09 (0.49) 
W2 4.30 (0.69) 16.00 15.25 160.00 305.00 -1.495 0.069 
W3 4.09 (0.49) 
Chance W1 3.59 (1.01) 10.18 18.12 142.50 235.50 -1.119 0.135 
W2 3.29 (0.75) 
W1 3.59 (1.01) 12.45 19.27 137.00 424.00 -2.568 0.005 
W3 3.06 (0.48) 
W2 3.29 (0.75) 12.50 15.45 112.50 293.50 -2.066 0.019 
W3 3.06 (0.48) 
Doctors W1 4.17 (0.75) 12.68 13.25 139.50 185.50 -0.622 0.272 
W2 4.05 (0.87) 
W1 4.17 (0.75) 13.58 15.30 176.50 229.50 -0.608 0.278 
W3 4.08 (0.55) 
W2 4.05 (0.87) 15.57 15.43 233.50 231.50 -0.021 0.494 
t W3 4.08 (0.55) 
I' Other people Wl 3.81 (0.93) 7.58 16.93 45.50 389.50 -3.73 0.000 
W2 3.06 (0.81) 
W1 3.81 (0.93) 7.70 15.43 38.50 339.50 -3.628 0.000 
W3 3.05 (0.64) 
W2 3.06 (0.81) 16.50 15.53 247.50 248.50 -0.010 0.498 
W3 3.05 (0.64) 
GHQ-12 W1 15.7 (4.14) 15.08 14.00 196.00 210.00 -0.160 0.440 
W2 15.4 (5.47) 
WI 15.7 (4.14) 0.00 17.50 0.00 595.00 -5.093 0.000 
W3 1.99 (0.36) 
W2 15.4 (5.47) 0.00 17.50 0.00 595.00 -5.091 0.000 
W3 1.99 (0.36) 
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\I Differences of Mean and SD of Psychological measures between Intervention and Waiting list control group Over Timet and Time3 (N=67) 
Measures Timet Time3 
subscale Group N Mean(SD) Mann-Whitney U z score Asymp. Sig. Mean (SD) Mann-Whitney U z score Asymp. Sig. 
(1-tailed) (1-tailed) 
ESE Scale 
Negative Intv.Grp 34 2.82 (1.18) 402.500 -1997 0.023 2.17 (0.91) 512.000 -0.202 0.422 
Affect 
Ctrl. Grp 33 2.37 (0.49) 2.18 (0.30) 
SAC Intv.Grp 34 2.94 (1.25) 403.000 -1.992 0.023 2.19 (0.97) 456 .. 000 -0.965 0.169 
Ctrl. Grp 33 2.53 (0.64) 2.24 (0.47) 
Efficacy Intv.Grp 34 2.86 (1.18) 409.500 -1.909 0.028 2.18 (0.92) 480.000 -0.630 0.267 
Ctrl. Grp 33 2.43 (0.54) 2.20 (0.36) 
ExSE Scale Intv.Grp 34 28.5 (23.61 305.000 -3.303 0.000 23.5 (20.3) 328.000 -2.708 0.003 
SI 
Ctrl. Grp 33 11.2 (13.6) 10.6 (14.1) 
CD Intv.Grp 34 39.1 (29.7) 319.000 -3.136 0.001 30.9 (26.0) 374.500 -2.130 0.016 
Ctrl. Grp 33 17.9 (21.1) 16.4 (22.2) 
IF Intv.Grp 34 22.4 (21.2) 322.000 -3.117 0.001 18.4 (17.2) 308.500 -3.031 0.001 
·)1 Ctrl. Grp 33 7.21 (9.50) 5.83 (9.26) 
IPQ-R 
Identity Intv.Grp 34 0.94 (0.48) 69.000 -6.227 0.000 0.25 (0.38) 408.000 -1.643 0.051 
Ctrl. Grp 33 0.16 (0.23) 0.12 (0.23) 
Time line 
acute/chronic Intv.Grp 34 2.40 (0.70) 276.500 -3.607 0.000 2.71 (0.85) 291.000 -3.138 0.001 
Ctrl. Grp 33 3.03 (0.56) 3.34 (0.62) 
Time line 
(cyclical) Intv.Grp 34 3.38 ( 0.60) 108.500 -5.818 0.000 2.66 (0.54) 187.500 -4.714 0.000 
Ctrl. Grp 33 2.55 (0.23) 3.07 (0.12) 
Consequences 
Intv.Grp 34 2.72 (0.75) 400.500 -2.071 0.019 2.39 (0.53) 408.000 -1.667 0.048 
Ctrl. Grp 33 2.33 (0.26) 2.28 (0.12) 
Personal 
control lntv.Grp 34 3.78 (0.47) 325.000 -3.029 0.001 3.90 (0.35) 151.000 -5.092 0.000 
Ctrl. Grp 33 3.46 (0.33) 3.36 (0.37) 
Treatment 
control Intv.Grp 34 3.86 (0.82) 361.500 -2.571 0.005 3.85 (0.51) 202.000 -4.619 0.000 
Ctrl. Grp 33 3.54 (0.41) 3.61 (0.23) 
Illness 
coherence lntv.Grp 34 3.79 (0.77) 523.500 -0.683 0.269 4.00 (0.25) 477.500 -1.408 0.169 
Ctrl. Grp_ 33 3.82 (0.39) 3.90 (0.30) 
------------------------ . - ·---··--· ·-· . 
Emotional Intv.Grp 34 3.24 (0.88) 162.000 -5.277 0.000 2.43 (0.69) 411.500 -1.779 0.038 
representation 
Ctrl. Grp 33 2.13 (0.33) 2.17 (0.40) 
MINICHAL Intv.Grp 34 1.86 (0.56) 142.500 -5.378 0.000 1.23 (0.37) 232.500 -4.818 0.000 
Mind 
Ctrl. Grp 33 1.18(0.41) 1.00 (0.00) 
Somatic Intv.Grp 34 1.75 (0.64) 103.500 -6.087 0.000 1.24 (0.39) 291.500 -4.009 0.000 
manifestation 
Ctrl. Grp 33 1.05 (0.15) 1.00 (0.03) 
MHLC lntv.Grp 34 4.74 (0.72) 165.000 -5.149 0.000 4.25 (0.64) 366.500 -2.581 0.005 
(Form B) 
Internal Ctrl. Grp 33 3.97 (0.12) 3.96 (0.08) 
Chance Intv.Grp 34 3.56 (0.671 247.500 -4.250 0.000 3.05 (0.44) 523.000 -0.073 0.431 
Ctrl. Grp 33 3.03 (0.12) 3.03 (0.12) 
Powerful others Intv.Grp 34 4.08 (0.80) 289.000 -3.491 0.000 3.74 (0.47) 477.000 -0.701 0.245 
Ctrl. Grp 33 3.68 (0.15) 3.61 (0.15) 
MHLC Intv.Grp 34 4.43 (0.66) 285.500 -3.652 0.000 4.09 (0.49) 441.500 -1.660 0.070 
(Form C) 
Internal Ctrl. Grp 33 3.96 (0.07) 3.98 (0.051 
Chance Intv.Grp 34 3.59 (1.01) 335.000 -3.023 0.001 3.06 (0.48) 520.500 -0.122 0.463 
Ctrl. Grp 33 3.01 (0.04) 3.04 (0.14) 
Doctors Intv.Grp 34 4.17 (0.751 421.000 -1.945 0.026 4.09 (0.55) 454.500 -1.458 0.095 
Ctrl. Grp 33 3.98 (0.12) 3.98 (0.08) 
Other people Intv.Grp 34 3.81 (0.93) 265.500 -3.783 0.000 3.05 (0.64) 494.500 -0.457 0.325 
Ctrl. Grp 33 3.23 (0.24) 3.22 (0.25) 
ｇｈｑｾＱＲ＠ Intv.Grp 34 1.31 (0.34) 36.000 -6.946 0.000 1.99 {0.36) 509.500 -0.383 0.284 
Ctrl. Grp 33 2.05 (0.35) 2.00 (0.01) 
APPENDIX 10 
Association between physical and medical indices with psychological 
measures among Intervention group 
146 
Outcome Predictor 
BMI Eating Self-Efficacy 
Change Negative Affect 
Socially Acceptable Circumstances 
Competing Demands 
Situational/Interpersonal 
Internal Feelings 
Identity 
Time (acute/chronic) 
Timeline Cyclical 
Consequences 
Personal Control 
Treatment Control 
Illness Coherence 
Emotional Representations 
State ofMind 
Somatic manifestation 
Internal (MHLC Form B) 
Chance 
Powerful Others 
Internal (MHLC Form C) 
Chance 
Doctor 
Other People 
GHQ 
* Cannot be computed because the asymptotic SE equals zero 
-No statistics are computed because CYCLCHA2 is a constant 
X2 (p value) 
7.52 (0.11) 
4.30 (0.37) 
11.54 (0.02) 
0.95 (0.92) 
3.52 (0.47) 
3.35 (0.50) 
4.52 (0.34) 
2.10 (0.72) 
-
2.53 (0.64) 
2.41 (0.66) 
4.23 (0.38) 
1.99 (0.74) 
3.41 (0.49) 
5.00 (0.29) 
1.87 (0.76) 
3.33 (0.50) 
3.32 (0.51) 
6.35 (0.17) 
3.91 (0.42) 
3.63 (0.46) 
2.29 (0.68) 
2.96 (0.56) 
3.21 (0.52) 
'A (p value) -r (p value) p(p value) 
0.00 * 0.10 (0.16) 0.26 (0.07) 
0.00 * 0.05 (0.48) 0.14 (0.22) 
0.00 * 0.22 (0.01) 0.35 (0.02) 
0.00 * 0.01 (0.96) - 0.11 (0.27) 
0.00 * 0.03 (0.80) 0.05 (0.38) 
0.00 * 0.03 (0.74) - 0.14 (0.21) 
0.00 * 0.06 (0.38) - 0.01 (0.48) 
0.00 * 0.02 (0.84) 0.07 (0.35) 
- - -
0.00 * 0.06 (0.45) - 0.01 (0.47) 
0.00 * 0.05 (0.47) 0.08 (0.32) 
0.00 * 0.07 (0.32) - 0.02 (0.46) 
0.00 * 0.01 (0.92) -0.10 (0.29) 
0.00 * 0.06 (0.42) - 0.14 (0.21) 
0.00 * 0.09 (0.21) 0.00 (0.49) 
0.00 * 0.03 (0.72) 0.09 (0.31) 
0.00 * 0.02 (0.86) - 0.06 (0.36) 
0.00 * 0.02 (0.81) 0.05 (0.40) 
0.00 * 0.04 (0.63) 0.05 (0.40) 
0.00 * 0.06 (0.43) 0.08 (0.32) 
0.00 * 0.04 (0.65) - 0.10 (0.28) 
0.00 * 0.03 (0.78) - 0.01 (0.48) 
0.00 * 0.03 (0.74) 0.13 (0.23) . 
0.00 * 0.03 (0.71) 0.13 (0.23) . 
Outcome Predictor 
Systolic BP Eating Self-Efficacy 
Change Negative Affect 
Socially Acceptable Circumstances 
Competing Demands 
Situational/Interpersonal 
Internal Feelings 
Identity 
Time (acute/chronic) 
Timeline Cyclical 
Consequences 
Personal Control 
Treatment Control 
Illness Coherence 
Emotional Representations 
State of Mind 
Somatic manifestation 
Internal (MHLC Form B) 
Chance 
Powerful Others 
Internal (MHLC Form C) 
Chance 
Doctor 
Other People 
GHQ 
* Cannot be computed because the asymptotic SE equals zero 
-No statistics are computed because CYCLCHA2 is a constant 
X2 (p value) 
7.48 (0.11) 
9.94 (0.04) 
3.64 (0.46) 
4.93 (0.30) 
6.38 (0.17) 
0.41 (0.98) 
2.17 (0.70) 
3.73 (0.44) 
-
10.61 (0.03) 
2.30 (0.68) 
1.49 (0.83) 
2.39 (0.67) 
1.02 (0.91) 
3.75 (0.44) 
2.40 (0.66) 
3.82 (0.43) 
0.84 (0.93) 
1.68 (0.79) 
3.73 (0.44) 
7.27 (0.12) 
1.97 (0.74) 
1.87 (0.76) 
10.10 (0.34) 
A. (p value) -r (p value) p(p value) 
0.00 * 0.08 (0.24) - 0.25 (0.08) 
0.09 (0.71) 0.18 (0.02) - 0.29 (0.05) 
0.00 * 0.05 (0.56) 0.24 (0.09) 
0.00 * 0.07 (0.31) - 0.05 (0.39) 
0.00 * 0.05 (0.51) -0.18 (0.16) 
0.00 * 0.00 (0.99) - 0.01 (0.47) 
0.00 * 0.03 (0.77) - 0.09 (0.32) 
0.00 (1.00) 0.06 (0.40) 0.29 (0.05) 
- - -
0.00 * 0.08 (0.29) - 0.11 (0.28) 
0.00 * 0.03 (0.75) - 0.20 (0.13) 
0.00 * 0.03 (0.74) 0.05 (0.39) 
0.00 * 0.03 (0.78) - 0.05 (0.38) 
0.00 * 0.02 (0.91) - 0.13 (0.23) 
0.00 * 0.07 (0.36) - 0.10 (0.29) 
0.00 * 0.04 (0.64) - 0.26 (0.07) 
0.00 * 0.04 (0.65) - 0.02 (0.45) 
0.00 * 0.01 (0.94) - 0.18 (0.15) 
I 
0.00 * 0.04 (0.67) - 0.20 (0.13) 
0.00 * 0.04 (0.58) - 0.02 (0.46) 
0.00 * 0.14 (0.06) - 0.02 (0.46) 
0.00 * 0.03 (0.76) 0.04 (0.42) 
0.00 * 0.02 (0.88) - 0.07 (0.34) 
0.06 (0.71) 0.12 (0.20) - 0.08 (0.34) 
If 
Outcome Predictor 
Diastolic BP Eating Self-Efficacy 
Change Negative Affect 
Socially Acceptable Circumstances 
Competing Demands 
Situational/Interpersonal 
Internal Feelings 
Identity 
Time (acute/chronic) 
Timeline Cyclical 
Consequences 
Personal Control 
Treatment Control 
Illness Coherence 
Emotional Representations 
State of Mind 
Somatic manifestation 
Internal (MHLC Form B) 
Chance 
Powerful Others 
Internal (MHLC Form C) 
Chance 
Doctor 
Other People 
GHQ 
* Cannot be computed because the asymptotic SE equals zero 
-No statistics are computed because CYCLCHA2 is a constant 
X2 (p value) 
2.06 (0.73) 
2.23 (0.69) 
2.03 (0.73) 
4.43 (0.35) 
7.33 (0.12) 
7.63 (0.11) 
0.51 (0.97) 
0.44 (0.98) 
-
7.88 (0.10) 
1.69 (0.79) 
0.61 (0.96) 
5.12 (0.28) 
9.13 (0.06) 
5.16 (0.27) 
4.79 (0.31) 
2.43 (0.66) 
3.28 (0.51) 
4.38 (0.36) 
5.62 (0.23) 
3.82 (0.43) 
5.00 (0.29) 
9.90 (0.04) 
8.88 (0.45) 
/.., (p value) 't (p value) p (p value) 
0.00 (1.00) 0.02 (0.78) 0.03 (0.44) 
0.05 (0.80) 0.03 (0.72) - 0.02 (0.45) 
0.05 (0.80) 0.03 (0.77) 0.04 (0.42) 
0.10 (0.65) 0.05 (0.34) 0.11 (0.26) 
0.10 (0.67) 0.05 (0.18) - 0.11 (0.27) 
0.15 (0.43) 0.06 (0.14) - 0.00 (0.50) 
0.00 * 0.01 (0.98) - 0.10 (0.29) 
0.00 * 0.01 (0.98) - 0.03 (0.44) 
- - -
0.25 (0.19) 0.13 (0.08) - 0.42 (0.01) 
0.00 (1.00) 0.03 (0.80) - 0.11 (0.26) 
0.00 (1.00) 0.01 (0.97) - 0.02 (0.45) 
0.05 (0.71) 0.07 (0.36) - 0.03 (0.44) 
0.15 (0.51) 0.15 (0.05) - 0.01 (0.48) 
0.15 (0.25) 0.06 (0.30) 0.19 (0.15) 
0.10 (0.53) 0.08 (0.29) - 0.14 (0.21) 
0.00 (1.00) 0.03 (0.69) 0.07 (0.34) 
0.05 (0.7) 0.04(0.53) - 0.23 (0.1 0) 
0.05 (0.81) 0.06 (0.41) - 0.12 (0.26) 
0.07 (0.65) 0.07 (0.28) 0.08 (0.32) 
0.10 (0.53) 0.02 (0.39) - 0.04 (0.42) 
0.10 (0.64) 0.03 (0.30) - 0.06 (0.36) 
0.20 (0.39) 0.15_(0.051 - 0.20 (0.13) 
0.00 (1.00) 0.09 (0.41) - 0.04 (0.42) 
Outcome Predictor 
TChol Eating Self-Efficacy 
Change Negative Affect 
Socially Acceptable Circumstances 
Competing Demands 
Situational/Interpersonal 
Internal Feelings 
Identity 
Time (acute/chronic) 
Timeline Cyclical 
Consequences 
Personal Control 
Treatment Control 
Illness Coherence 
Emotional Representations 
State of Mind 
Somatic manifestation 
Internal (MHLC Form B) 
Chance 
Powerful Others 
Internal (MHLC Form C) 
Chance 
Doctor 
Other People 
GHQ 
* Cannot be computed because the asymptotic SE equals zero 
-No statistics are computed because CYCLCHA2 is a constant 
X2 (p value) 
1.78 (0.41) 
0.63 (0.73) 
3.64 (0.16) 
1.54 (0.46) 
2.03 (0.36) 
0.05 (0.97) 
0.78 (0.68) 
2.16 (0.34) 
-
0.02 (0.99) 
2.91 (0.23) 
2.64 (0.27) 
2.38 (0.31) 
1.56 (0.46) 
5.74 (0.06) 
1.83 (0.40) 
1.01 (0.61) 
0.96 (0.62) 
0.51 (0.78) 
1.01 (0.61) 
6.39 (0.04) 
0.09 (0.96) 
2.75 (0.25) 
11.77 (0.23) 
A, (p value) t (p value) p(p value) 
0.19 (0.40) 0.05 (0.42) - 0.23 (0.1 0) 
0.06 (0.71) 0.02 (0.74) - 0.19 (0.15) 
0.25 (0.39) 0.11 (0.17) - 0.27 (0.06) 
0.13 (0.59) 0.05 (0.48) 0.16 (0.18) 
0.19 (0.49) 0.06 (0.37) 0.25 (0.07) 
0.00 * 0.00 (0.98) 0.17 (0.16) 
0.06 (0.65) 0.02 (0.69) - 0.04 (0.42) 
0.13 (0.41) 0.06 (0.35) 0.08 (0.33) 
- - -
0.00 * 0.00 (0.99) - 0.01 (0.47) 
0.25 (0.31) 0.09 (0.24) - 0.39 (0.01) 
0.19 (0.53) 0.08 (0.28) - 0.36 (0.02) 
0.19 (0.25) 0.07 (0.32) -0.17 (0.17) 
0.13 (0.67) 0.05 (0.47) - 0.26 (0.07) 
0.25 (0.43) 0.17 (0.06) - 0.32 (0.03) 
0.19 (0.43) 0.05 (0.41) -0.16 (0.18) 
0.13 (0.56) 0.03 (0.61) - 0.10 (0.28) 
0.13 (0.53) 0.03 (0.63) 0.19 (0.14) 
0.06 (0.74) 0.02 (0.78) - 0.01 (0.49) 
0.13 (0.59) 0.03 (0.61) - 0.12 (0.25) 
0.38 (0.10) 0.19 (0.05) 0.32 (0.04) 
0.00 * 0.00 (0.96) - 0.09 (0.31) 
0.19 (0.17) 0.08 (0.26) - 0.01 (0.47) 
0.19 (0.20) 0.12 (0.22) - 0.05 (0.39) 
'\ 
Outcome Predictor 
HDL Eating Self-Efficacy 
Change Negative Affect 
Socially Acceptable Circumstances 
Competing Demands 
Situational/Interpersonal 
Internal Feelings 
Identity 
Time (acute/chronic) 
Timeline Cyclical 
Consequences 
Personal Control 
Treatment Control 
Illness Coherence 
Emotional Representations 
State ofMind 
Somatic manifestation 
Internal (MHLC Form B) 
Chance 
Powerful Others 
Internal (MHLC Form C) 
Chance 
Doctor 
Other People 
GHQ 
* Cannot be computed because the asymptotic SE equals zero 
-No statistics are computed because CYCLCHA2 is a constant 
X2 (p value) 
4.91 (0.09) 
1.05 (0.59) 
2.43 (0.30) 
1.79 (0.41) 
3.29 (0.19) 
1.20 (0.37) 
0.09 (0.96) 
051 (0.77) 
-
2.17 (0.34) 
1.69 (0.43) 
3.39 (0.18) 
0.97 (0.62) 
0.95 (0.62) 
0.93 (0.63) 
0.03 (0.99) 
2.42 (0.30) 
1.25 (0.53) 
5.12 (0.08) 
2.42 (0.30) 
8.41 (0.02) 
3.44 (0.18) 
3.56 (0.17) 
8.89 (0.45) 
----
I 
A. (p value) -c (p value) p(p value) I 
0.21 (0.17) 0.15 (0.09) - 0.21 (0.12) 
0.07 (0.71) 0.03 (0.60) - 0.20 (0.13) 
0.07 (0.82) 0.07 (0.31) - 0.25 (0.08) 
0.07 (0.71) 0.05 (0.42) 0.32 (0.03) 
0.21 (0.31) 0.10 (0.20) 0.19 (0.14) 
0.07 (0.81) 0.06 (0.38) 0.31 (0.04) 
0.00 * 0.00 (0.96) - 0.01 (0.48) 
0.00 (1.00) 0.02 (0.78) 0.07 (0.35) 
- - -
0.14 (0.31) 0.06 (0.35) - 0.07 (0.36) 
0.07 (0.65) 0.05 (0.44) - 0.13 (0.23) 
0.21 (0.36) 0.10 (0.19) - 0.25 (0.07) 
0.00 * 0.03 (0.62) 0.07 (0.35) 
0.07 (0.65) 0.03 (0.63) 0.17 (0.17) 
0.07 (0.71) 0.03 (0.64) - 0.22 (0.11) 
0.00 * 0.00 (0.99) - 0.10 (0.29) 
0.14 (0.48) 0.07 (0.31) 0.24 (0.09) 
0.07 (0.65) 0.04 (0.54) 0.08 (0.33) 
0.21 (0.07) 0.15 (0.08) 0.01 (0.48) 
0.14 (0.48) 0.07 (0.31) - 0.07 (0.35) 
0.36 (0.15) 0.25 (0.02) 0.37 (0.02) 
0.21(0.31) 0.10 (0.19) - 0.23 (0.09) 
0.07 (0.84) 0.11 (0.18) 0.14 (0.22) 
0.17 (0.34) 
---
0.09 (0.50) __ -_Q-ll (0.26) 
;( 
Outcome Predictor 
LDL Eating Self-Efficacy 
Change Negative Affect 
Socially Acceptable Circumstances 
Competing Demands 
Situational/Interpersonal 
Internal Feelings 
Identity 
Time (acute/chronic) 
Timeline Cyclical 
Consequences 
Personal Control 
Treatment Control 
Illness Coherence 
Emotional Representations 
State of Mind 
Somatic manifestation 
Internal (MHLC Form B) 
Chance 
Powerful Others 
Internal (MHLC Form C) 
Chance 
Doctor 
Other People 
GHQ 
* Cannot be computed because the asymptotic SE equals zero 
-No statistics are computed because CYCLCHA2 is a constant 
X2 (p value) 
2.38 (0.31) 
0.28 (0.87) 
2.62 (0.27) 
1.40 (0.50) 
3.83 (0.15) 
1.51 (0.47) 
0.01 (1.00) 
2.05 (0.36) 
-
1.14 (0.57) 
0.43 (0.81) 
3.23 (0.20) 
2.24 (0.33) 
0.35 (0.84) 
4.22 (0.12) 
0.06 (0.97) 
1.26 (0.53) 
3.16 (0.21) 
0.21 (0.90) 
1.71 (0.43) 
7.17 (0.03) 
0.20 (0.90) 
1.95 (0.38) 
9.16 (0.17) 
"A (p value) 't (p value) p (p value) 
0.08 (0.78) 0.07 (0.32) - 0.23 (0.10) 
0.00 * 0.01 (0.88) - 0.13 (0.23) 
0.08 (0.80) 0.08 (0.28) - 0.32 (0.03) 
0.00 * 0.04 (0.51) 0.14 (0.22) 
0.00 * 0.11 (0.16) 0.25 (0.08) 
0.00 * 0.04 (0.48) 0.16 (0.19) 
0.00 * 0.00 (1.00) 0.15 (0.20) 
0.00 * 0.06 (0.37) 0.05 (0.39) 
- - -
0.00 * 0.03 (0.58) 0.05 (0.40) 
0.00 * 0.01 (0.81) - 0.46 (0.00) 
0.08 (0.78) 0.10 (0.21) - 0.36 (0.02) 
0.08 (0.71) 0.07 (0.34) 0.25 (0.08) 
0.00 * 0.01 (0.84) 0.19 (0.15) 
0.23 (0.25) 0.12 (0.13) - 0.11 (0.28) 
0.00 * 0.00 (0.97) 0.02 (0.45) 
0.00 * 0.04 (0.54) - 0.13 (0.24) 
0.15 (0.53) 0.09 (0.22) 0.24 (0.09) 
0.00 * 0.01 (0.90) 0.01 (0.47) 
0.00 * 0.05 (0.44) - 0.06 (0.38) 
0.31 (0.28) 0.21 (0.03) 0.40 (0.01) 
0.00 * 0.01 (0.91) -0.10 (0.29) 
0.08 (0.65) 0.06 (0.39) 0.17 (0.17) 
0.29 (0.24) 0.16 (0.23) - 0.12 (0.25) 
Outcome Predictor 
TgChange Eating Self-Efficacy 
Negative Affect 
Socially Acceptable Circumstances 
Competing Demands 
Situational/Interpersonal 
Internal Feelings 
Identity 
Time (acute/chronic) 
Timeline Cyclical 
Consequences 
Personal Control 
Treatment Control 
illness Coherence 
Emotional Representations 
State of Mind 
Somatic manifestation 
Internal (MHLC Form B) 
Chance 
Powerful Others 
Internal (MHLC Form C) 
Chance 
Doctor 
Other People 
GHQ 
ＭＭ ｾｾｾ Ｍｾ Ｍ Ｍ ｾｾ ＭＭ Ｍ ｾ＠
-
* Cannot be computed because the asymptotic SE equals zero 
-No statistics are computed because CYCLCHA2 is a constant 
x/ (p value) 
0.41 (0.81) 
2.03 (0.36) 
0.96 (0.62) 
1.54 (0.46) 
0.72 (0.70) 
0.94 (0.62) 
0.16 (0.92) 
0.28 (0.87) 
-
2.87 (0.24) 
2.73 (0.26) 
0.45 (0.80) 
0.74 (0.69) 
2.10 (0.35) 
2.51 (0.29) 
0.44 (0.80) 
1.36 (0.51) 
0.56 (0.76) 
2.86 (0.24) 
0.17 (0.92) 
0.39 (0.82) 
1.26 (0.53) 
3.15 (0.21) 
ＺＮＮ｟｟｟｟｟ｾＭ ＭＭ ｾ＠
12.69 (0.18) 
A. (p value) t (p value) p (p value) 
0.06 (0.65) 0.01 (0.82) - 0.04 (0.41) 
0.19 (0.49) 0.06 (0.37) - 0.13 (0.24) 
0.13 (0.56) 0.03 (0.63) 0.07 (0.36) 
0.13 (0.59) 0.05 (0.48) 0.01 (0.47) 
0.06 (0.82) 0.02 (0.71) - 0.10 (0.29) 
0.06 (0.81) 0.03 (0.63) 0.03 (0.43) 
0.00 * 0.01 (0.93) - 0.01 (0.49) 
0.00 * 0.01 (0.87) 0.18 (0.15) 
-
-
-
0.19 (0.51) 0.09 (0.25) 0.01 (0.47) 
0.19 (0.17) 0.08 (0.27) 0.03 (0.44) 
0.06 (0.76) 0.01 (0.80) 0.01 (0.47) 
0.06 (0.83) 0.02 (0.70) - 0.07 (0.36) 
0.19 (0.25) 0.06 (0.36) 0.11 (0.27) 
0.19 (0.49) 0.07 (0.30) - 0.28 (0.06) 
0.06 (0.80) 0.01 (0.81) - 0.34 (0.03) 
0.13 (0.56) 0.04 (0.52) - 0.21 (0.11) 
0.06 (0.65) 0.02 (0.76) 0.10 (0.28) 
0.25 (0.24) 0.08 (0.25) 0.09 (0.31) 
0.00 * 0.01 (0.92) - 0.06 (0.37) 
0.06 (0.78) 0.01 (0.83) - 0.09 (0.32) 
0.13 (0.59) 0.04 (0.54) 0.05 (0.39) 
0.19 (0.53) 0.09 (0.22) - 0.14 (0.22) 
0.00 (1.00) 0.11 (0.27) - 0.11 (0.27) 
\ 
Outcome Predictor 
Creatinine Eating Self-Efficacy 
Change Negative Affect 
Socially Acceptable Circumstances 
Competing Demands 
Situational/Interpersonal 
Internal Feelings 
Identity 
Time (acute/chronic) 
Timeline Cyclical 
Consequences 
Personal Control 
Treatment Control 
Illness Coherence 
Emotional Representations 
State of Mind 
Somatic manifestation 
Internal (1viHLC Form B) 
Chance 
Powerful Others 
Internal (MHLC Form C) 
Chance 
Doctor 
Other People 
GHQ 
* Cannot be computed because the asymptotic SE equals zero 
-No statistics are computed because CYCLCHA2 is a constant 
X2 (p value) 
2.16 (0.34) 
1.64 (0.44) 
1.04 (0.59) 
1.19 (0.55) 
3.21 (0.20) 
1.13 (0.57) 
1.01 (0.60) 
6.24 (0.04) 
-
1.03 (0.60) 
1.59 (0.45) 
4.62 (0.10) 
0.63 (0.73) 
1.22 (0.54) 
1.19 (0.55) 
1.35 (0.51) 
4.31 (0.12) 
1.26 (0.53) 
2.30 (0.32) 
5.28 (0.07) 
10.36 (0.01) 
0.69 (0.71) 
2.40 (0.30) 
6.06 (0.73) 
'A (p value) 't (p value) p(p value) 
0.08 (0.78) 0.07 (0.35) - 0.19 (0.14) 
0.08 (0.71) 0.05 (0.45) - 0.15 (0.21) 
0.00 * 0.03 (0.60) - 0.19 (0.15) 
0.00 * 0.04(0.56) 0.25 (0.08) 
0.00 * 0.10 (0.21) 0.07 (0.35) 
0.00 * 0.03 (0.58) 0.18 (0.17) 
0.00 * 0.03 (0.61) 0.22 (0.11) 
0.31 (0.09) 0.19 (0.05) 0.11 (0.27) 
- - -
0.00 * 0.03 (0.61) 0.09 (0.32) 
0.08 (0.65) 0.05 (0.46) - 0.01(0.47) 
0.23 (0.40) 0.14 (0.11) - 0.05 (0.38) 
0.00 * 0.02 (0.74) 0.14 (0.22) 
0.00 * 0.04 (0.55) - 0.08 (0.33) 
0.00 * 0.04 (0.56) - 0.31 (0.04) 
0.00 * 0.04 (0.52) -0.32 (0.04) 
0.15 (0.59) 0.13 (0.12) 0.27 (0.07) 
0.00 * 0.04 (0.54) 0.18 (0.16) 
0.00 * 0.07 (0.33) 0.06 (0.38) 
0.23 (0.40) 0.16 (0.08) 0.21 (0.13) 
0.39 (0.15) 0.31 (0.01) 0.52 (0.00) 
0.00 * 0.02 (0.72) 0.07 (0.35) 
0.15 (0.41) 0.07 (0.31) 0.30 (0.05) 
0.00* 0.04 (0.95) - 0.32 (0.04) . 
Outcome Predictor 
Urea Eating Self-Efficacy 
Change Negative Affect 
Socially Acceptable Circumstances 
Competing Demands 
Situational/Interpersonal 
Internal Feelings 
Identity 
Time (acute/chronic) 
Timeline Cyclical 
Consequences 
Personal Control 
Treatment Control 
Illness Coherence 
Emotional Representations 
State of Mind 
Somatic manifestation 
Internal (MHLC Form B) 
Chance 
Powerful Others 
Internal (MHLC Form C) 
Chance 
Doctor 
Other People 
--
9HQ 
* Cannot be computed because the asymptotic SE equals zero 
-No statistics are computed because CYCLCHA2 is a constant 
X2 (p value) A. (p value) 
4.89 (0.30) 0.13 (0.56) 
8.43 (0.08) 0.07 (0.65) 
4.33 (0.36) 0.07 (0.80) 
9.28 (0.06) 0.33 (0.15) 
6.11 (0.19) 0.13 (0.62) 
2.85 (0.58) 0.07 (0.80) 
2.86 (0.58) 0.00 * 
5.89 (0.21) 0.20 (0.17) 
- -
2.75 (0.60) 0.00 * 
2.71 (0.61) 0.00 * 
3.25 (0.52) 0.13 (0.56) 
2.58 (0.63) 0.07 (0.71) 
5.74 (0.22) 0.20 (0.49) 
2.45 (0.65) 0.07 (0.71) 
5.06 (0.28) 0.13 (0.56) 
2.52 (0.64) 0.13 (0.52) 
4.18 (0.38) 0.13 (0.52) 
1.41 (0.84) 0.00 * 
5.01 (0.29) 0.07 (0.76) 
6.54 (0.16) 0.20 (0.36) 
3.78 (0.44) 0.07 (0.74) 
6.34 (0.18) 0.27 (0.09) 
6.06 (0.42) 0.00 * 
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t (p value) p (p value) 
0.08 (0.32) -0.19 (0.15) 
0.06 (0.42) -0.09 (0.31) 
0.07 (0.37) - 0.21 (0.13) 
0.23 (0.01) 0.34 (0.03) 
0.13 (0.09) 0.41 (0.01) 
0.05 (0.51) 0.21 (0.13) 
0.02 (0.88) 0.04 (0.43) 
0.12 (0.11) - 0.01 (0.49) 
- -
0.03 (0.82) 0.06 (0.38) 
0.02 (0.84) -0.14 (0.23) 
0.06 (0.43) - 0.29 (0.06) 
0.04 (0.71) - 0.11 (0.27) 
0.13 (0.09) - 0.09 (0.32) 
0.03 (0.79) 0.03 (0.43) 
0.08 (0.29) - 0.16 (0.19) 
0.05 (0.50) - 0.16 (0.19) 
0.06 (0.46) 0.26 (0.08) 
0.01 (0.94) 0.07 (0.35) 
0.07 (0.38) - 0.13 (0.23) 
0.11 (0.14) 0.41 (0.01) 
0.04 (0.67) 0.15 (0.21) 
0.14 (0.07) 0.29 (0.06) 
ｾ＠
0.06 (0.70) - 0.10 (0.30) 
-
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